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Abstract 
CD8` T cell interactions with cognate self-antigen can result in entirely opposing 
responses: productive activation leading to autoimmunity, or the induction of 
peripheral tolerance. The fact that self-antigens are cross-presented by bone 
marrow-derived dendritic cells (DC) to CD8+ T cells, suggests that DC may 
determine how self-specific CD8+ T cells will respond. Using a well-established 
model of peripheral self-tolerance we examined how DC stimulate naive self- 
reactive CD8' T cell responses. Moreover, we have investigated how alteration of 
the functional properties of DC affects the balance between autoimmunity and 
tolerance. - 
InsHA mice express the haýmagglutinin (HA) protein from Influenza virus on their 
pancreatic islet ß cells. Following adoptive transfer into InsHA mice, CL4 CD8' T 
cells, which express a TcR with high avidity for a dominant KdHA epitope, undergo 
limited proliferation in pancreatic lymph nodes, but do not differentiate into 
effector CTL. As a result, host InsHA mice do not develop autoimmune diabetes. 
Such activation in InsHA mice is termed `abortive' and is thought result in the 
functional loss of KdHA-specific CD8+ T cells, which accompanies the induction of 
peripheral tolerance in InsHA mice. 
The data presented in this thesis demonstrate that DC can acquire epitopes from 
InsHA ß cells via interactions involving adhesion molecules, and cross-present such 
epitopes to activate CL4 CD8` T cells. Our results show that immature DC induce 
abortive activation amongst CL4 CD8+ T cells, whereas matured DC- generate 
productive activation. The magnitude of each of signals 1 (peptide dose), 2 (co- 
stimulation) and 3 (cytokines) are key in determining whether DC drive abortive or 
productive activation of CL4 CD8` T cells. Significantly, we have demonstrated 
that Kd peptide-pulsed immature DC can be successfully employed in vivo to 
induce peripheral tolerance amongst CL4 CD8` T cells, whilst control experiments 
with matured DCs induce autoimmunity. 
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Chapter 1: Introduction 
1.1 The immune system 
Many organisms exist whose life cycle demands a higher organism as a host. 
However, colonisation of a higher organism by bacteria, viruses, protozoa or other 
parasites often has a detrimental effect on the host. Therefore, in addition to 
physical and chemical barriers that limit ingress by such pathogens, animals and 
man have evolved an intricate immune system to purge itself of any unwelcome 
micro-organism. Upon encounter with invading pathogens, the innate immune 
system is immediately activated leading to local inflammation at the site of 
infection. Innate immune cells such as macrophages, granulocytes and natural 
killer cells attempt to destroy pathogens by a combination of secreted anti- 
microbial products, phagocytosis and cellular cytotoxicity. Eutherian mammals 
have an additional immune system: the adaptive immune system. An adaptive 
immune response takes several days to develop. However, the adaptive immune 
system provides an highly efficient and effective mechanism to control infection 
by those micro-organisms that have evolved methods of protection or evasion that 
allow escape from the innate immune system. 
The adaptive immune system is based on developing vast numbers of T and B 
lymphocytes each with a single antigen-specificity, which allows the recognition 
of a great variety of immunogenic molecules. Equally important, are highly 
conserved mechanisms of antigen processing and presentation, which degrade 
proteins into antigenic peptide fragments that are offered to lymphocytes for 
recognition. On encounter with its cognate antigen, a lymphocyte is activated to 
clear infected cells or extracellular pathogens. B cells mount an anti-microbial 
response by producing antibodies which that specifically coat their pathogen, 
neutralising its function or through opsonisation, initiate innate immunity. This 
humoral immune response to specific antigens is aided by CD4' T cells, which 
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respond to peptides presented in the context of major histocompatibility complex 
(MHC) class II molecules by professional antigen presenting cells. CD8' T cells are 
activated by peptides presented on the surface of cells containing intracellular 
pathogens and once activated are able to kill such infected cells. As the adaptive 
immune system recognises specific antigens to generate responses, it is necessary 
to distinguish between self and foreign antigens; thereby mounting immune 
responses against foreign pathogens, but remaining tolerant of self-peptides. In 
the steady state, as the adaptive immune system does not respond to self- 
epitopes, individuals are said to have induced the state of tolerance to self- 
antigens. Complex mechanisms of self-tolerance have therefore evolved to 
prevent inappropriate activation of T cells, the failure of such mechanisms leads 
to autoimmunity and destruction of self-tissue. 
Experiments detailed in this thesis examine the activation and the fate of CD8' T 
cells following their encounter with cognate epitopes expressed either as self- 
antigen or non-self antigen. To address how the possible consequences of such 
interactions, self-tolerance or productive activation, are controlled, this study 
utilises a transgenic murine model of self-tolerance induction amongst CD8` T cells 
specific for pancreatic islet ß cell-expressed self-epitopes. If these T cells are 
activated productively, destruction of the pancreas ensues leading to 
dysregulation of glucose metabolism and autoimmune diabetes. However, these 
potentially auto-reactive CD8+ T cells can be activated by cognate epitopes in an 
altered non-pathogenic manner, for which the term "abortive activation" has 
been coined (Morgan et at., 1999a). 
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1.2 Central T cell tolerance 
Normal peripheral T cells recognise antigenic peptides in the context of self-MHC 
molecules via their T cell receptor (TcR) (Zinkernagel, 1974). To generate an 
effective T cell repertoire with a diverse range of antigen specific TcRs, random 
rearrangement of TcR genes in CD4'CD8' thymocytes occurs during intrathymic 
maturation. Thymocytes then upregulate CD4 and CD8 and express a pre-TcR 
before undergoing processes of T cell selection. T cells that are able to recognise 
peptides presented by self-MHC on thymic cortical epithelial cells (TCEC) receive 
signals that prevent apoptosis (Bevan, 1977; Kisielow and von Boehmer, 1995). 
This is referred to as positive selection (Fig. 1.1). 
The result of positive selection is the production of an array of immature T cells 
each expressing different TcRs giving a highly diverse repertoire of specificities, 
including a sub-population of T cells having a high reactivity to self-peptides 
(D'Adamio et at., 1993; Davis and Bjorkman, 1988). Most auto-reactive T cells are 
deleted before they leave the thymus through central tolerance mechanisms. At 
this stage, potentially auto-reactive T cells with high avidity TcRs for self -epitopes 
are eliminated through negative selection processes (Fig. 1.1). Thymocytes which 
form too strong a ligand with self-epitopes expressed on bone marrow-derived 
thymic antigen presenting cells (APC) and medullary thymic epithelial cells 
(mTEC) undergo clonal deletion through apoptosis in situ (Bevan, 1977; Kappler et 
at., 1987; Surh and Sprent, 1994; von Boehmer and Sprent, 1976). 
In order to generate effective central tolerance, it is essential that the panel self- 
antigens expressed in the thymus includes those whose expression is normally 
restricted to peripheral tissues. Indeed, both human and murine mTECs express a 
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wide range of peripheral self-antigens (Derbinski et al., 2001), therefore it is 
likely that such cells allow successful negative selection, despite the fact that 
mTECs are less efficacious APCs than thymic dendritic cells. One mechanism 
controlling such ectopic expression of organ-specific antigens involves the 
transcription factor Aire (autoimmune regulator), which is almost exclusively 
expressed by mTECs (Anderson et at., 2002). The importance of Aire was first 
identified in autoimmune polyendocrinopathy syndrome type 1 (APS1), which is 
associated with an inherited mutation in the Aire gene locus (1997; Nagamine et 
at., 1997). Further studies in Aire"' mice demonstrated that this transcription 
factor was responsible for the expression of many hundreds of antigens in the 
thymus (Anderson et at., 2002; Liston et at., 2003). Aire has also been shown to 
enhance antigen presentation by mTECs by an as yet unknown mechanism 
(Anderson et at., 2005). It is likely that other transcription factors are also 
involved in licensing expression of many more self-antigens in the thymus for the 
process of negative selection 
It is unclear whether positive and negative selection occur simultaneously or 
sequentially. Mature naive T cells that have been selected to survive by positive 
selection, but do not recognise self-epitopes expressed in the thymus with high 
avidity, migrate from the thymus to circulate in the periphery, where they can 
interact with specific antigen/MHC complexes. 
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Figure 1.1: Central tolerance 
A. " Haematopoietic progenitor cells arrive in the thymus from the bone 
marrow. These cells are negative for both CD4 and CD8 (double negative 
thymocytes). 
B. " Through processes of gene rearrangement, thymocytes express a TcR and 
express both CD4 and CD8 co-receptors (double positive thymocytes). 
" TcRs interact with self-peptides presented by MHC complexes on thymic 
C. cortical epithelial cells (TCEC). 
" Those double positive thymocytes that are able to recognise MHC are 
positively selected to survive. 
" Those double positive thymocytes that fail to recognise self-MHC die by 
neglect. 
D .e 
Positively-selected thymocytes interact with self-peptides presented by 
thymic dendritic cells. 
" Those that respond with high avidity to self-peptide are deleted by 
negative selection through activation induced cell death. 
" CD4'CD8' thymocytes responding with low avidity to self-peptide, 
downregulare either CD4 or CDB. 
" Populations of mature naive CD4' and CD8' T cells exit the thymus to 
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1.3 Peripheral T cell tolerance 
Not all self-epitopes are expressed in the thymus, some self-epitopes are 
expressed at too low a level to induce negative selection (Klein et at., 2000), 
whilst other self-epitopes are cryptic and are not produced by normal antigen 
processing and presentation (Anderton et at., 2002). Therefore, some potentially 
auto-reactive T cells may escape mechanisms of central tolerance (Klein et at., 
2000; Ohashi et al., 1991; Oldstone et al., 1991), exit the thymus and circulate in 
the periphery (Kitze et at., 1988; Naquet et at., 1988; Schwartz, 1989). Self- 
specific T cells can be isolated from the periphery of both humans and mice (Kitze 
et at., 1988; Naquet et at., 1988), but the fact that most individuals do not 
develop autoimmunity, suggests that peripheral mechanisms of self-tolerance 
must exist. Using TcR transgenic T cells and mice in which a model antigen is 
targeted for expression on peripheral tissues, various mechanisms of peripheral 
tolerance to tissue specific proteins have been identified (Fig. 1.2 Kanagawa, 
1988; Kurts et at., 1996; Lo et at., 1992; Ohashi et at., 1991; Oldstone et at., 
1991; Sakaguchi et at., 1995; Thornton and Shevach, 1998; Fig. 1.2 Vezys et at., 
2000). 
1.3.1 Ignorance 
Peripheral tolerance to tissue specific self-epitopes can be due to "ignorance" of 
the self-antigen, where auto-reactive T cells circulate in the periphery, but are 
prevented from encountering their cognate antigen or the self-antigen is not 
expressed at a high enough level to reach a threshold to activate potentially 
autoimmune T cells (Barker and Billingham, 1977; Ferber et at., 1994; Heath et 
al., 1998; Ohashi et al., 1991; Oldstone et al., 1991). This may be associated with 
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Figure 1.2: Mechanisms of peripheral tolerance 
A. Ignorance: Self-reactive T cells are prevented from encountering cognate 
antigen which is sequestered in tissues behind immunological barriers, or fail 
to recognise self-antigen with enough avidity to become activated. 
B. Anergy: Self-reactive T cells recognise self-antigens, but without co- 
stimulation become non-responsive. 
C. Deletion: Interaction between self-reactive T cells and antigen stimules 
activation induced cell death, through Fas-FasL interactions, similar to 
negative selection in central tolerance. 
D. Regulation: Activation of self-reactive T cells is prevented by populations of 
regulatory T cells, through secreted factors or cell-cell contact. Immune 
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T cells expressing a TcR with low affinity for self-antigens, which have thus 
escaped thymic deletion. Often self-tolerance by ignorance can be reversed by 
the activation of auto-reactive T cells by an external stimulus. For example, in 
double transgenic mice expressing both the lymphocytic choriomeningitis virus 
(LCMV) glycoprotein (GP) on pancreatic ß cells and a transgenic TcR specific for a 
LCMV DbGP epitope, autoimmune diabetes does not develop. However 
administration of LCMV to these mice leads to CD8+ T cell mediated diabetes 
(Ohashi et al., 1991; Oldstone et al., 1991). Also naive cells do not tend to 
circulate through tissues, but when activated by viral-epitopes and co-stimulation, 
T cells are then able to migrate into tissues and mediate autoimmunity. 
1.3.2 Induction of anergy and peripheral deletion 
If potentially auto-reactive peripheral T cells are activated by cognate self- 
antigen, autoimmunity does not always ensue. TcR engagement, without co- 
stimulation, (Kurts et at., 1997a) or in a non-inflammatory cytokine environment 
results in the induction of anergy amongst T cells (DeSilva et al., 1991; Groux et 
at., 1996; Quitt and Schwartz, 1987; Sloan-Lancaster et at., 1993), a state of 
cellular functional unresponsiveness induced by partial activation (Jenkins and 
Schwartz, 1987; Nossal and Pike, 1980; Schwartz, 1996). It has been suggested 
that the induction of anergy in vivo could be a mechanism that prevents 
autoimmunity (Blackman et al., 1991; Blackman et al., 1990; Lechler et al., 2001, 
Burkly, 1989 #6). Another consequence of the interaction of self-reactive T cells 
with their cognate peptide/MHC in the absence of co-stimulation is that they may 
be deleted extrathymically (Critchfield et at., 1994; Huang and Crispe, 1993). 
Thymectomised RIP-mOVA transgenic mice, expressing chicken ovalbumin (OVA) 
on pancreatic islet ß cells (Kurts et at., 1996), were grafted with a thymus from 
non-transgenic mice. Thymus-grafted RIP-mOVA mice were then lethally 
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irradiated and reconstitution with bone marrow from OT-1 transgenic mice, which 
express a TcR specific for a dominant OVA epitope. Analyses of secondary 
lymphoid tissue revealed that there was a loss of peripheral OVA-specific CD8' T 
cells in these mice demonstrating that tolerance had been induced by peripheral 
deletion. Therefore, peripheral deletion may occur following the interactions 
between naive T cells with a peripheral, non-thymically expressed, antigen (Kurts 
et at., 1997b). 
1.3.3 Regulatory T cells 
Autoimmune responses can also be prevented by regulatory T cells (Maloy and 
Powrie, 2001). Many studies have been performed to examine the role of 
regulatory T cells in preventing inappropriate activation of self-specific T cells 
(reviewed in Piccirillo and Thornton, 2004). For example, spontaneous 
autoimmunity in neonatally thymectomised mice can be prevented by the transfer 
of an anergic subset of CD4' T cells which also express CD25 (Asano et at., 1996; 
McHugh et at., 2002; Sakaguchi et at., 1995; Shimizu et at., 2002; Thornton and 
Shevach, 1998). Regulatory T cells have been shown to inhibit the activation of 
both CD4' T cells and CD8' T cells in vitro. Populations of regulatory T cells may 
inhibit productive activation of other populations of T cells by the secretion of 
cytokines, such as IL-10 (Buer et at., 1998; Groux et al., 1997; Sheng et at., 1998), 
or TGF-p (Nakamura et at., 2004; Zhang et at., 2001), as well as via cell-cell 
contact mechanisms (Nakamura et at., 2001; Takahashi et al., 1998; Thornton and 
Shevach, 1998). The fact that regulatory T cells can prevent activation of T cells 
specific for self-epitopes in vivo has also been shown in response to tumour 
antigens. Tumour cells which often express self-epitopes are tolerated by the 
immune system (Matzinger, 1994), and it has been shown that the depletion of 
CD25' CD4+ regulatory T cells breaks such tolerance and anti-tumour immune 
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responses are initiated (Jones et at., 2002; Shimizu et at., 1999; Van Meirvenne et 
al., 2005). However, many studies have investigated the röte of regulatory T cells 
in peripheral tolerance and this mechanism of tolerance induction is not the main 
focus of this thesis. 
1.3.4 Abortive activation 
Our laboratory utilises InsHA transgenic mice which express the haemagglutinin 
(HA) from influenza virus A/PR/8 HINZ (PR8) on pancreatic islet ß cells, under the 
control of the rat insulin promoter (RIP). InsHA mice are profoundly tolerant to 
their (i cell-expressed HA and do not develop autoimmune diabetes even after 
immunisation with replicating PR8 (Lo et at., 1992). Studies showed that 
tolerance to the HA protein is not due to T cell ignorance of p cell expressed HA 
(Morgan et at., 1996), but is associated with the functional loss of CD8' T cells 
with high avidity to the dominant KdHA epitope (Morgan et at., 1998). Although 
when activated, the remaining low avidity T cells specific for KdHA, showed no 
differences in cell surface phenotype as compared with high avidity KdHA-specific 
T cells activated following PR8 immunisation of InsHA negative non-transgenic 
mice (Nugent et at., 2000). Lethally irradiated, thymectomised InsHA mice 
reconstituted with bone marrow and thymic grafts from non-transgenic mice, 
remained tolerance to HA, even after immunisation with PR8 (Lo et at., 1992). 
These findings therefore suggest that induction of peripheral tolerance to KdHA in 
InsHA mice can occur by a peripheral mechanism. Functional loss of CD8` T cells 
with high avidity for KdHA is preceded by proliferation. However, such 
proliferation is limited and does not induce an effector function, as evidenced by 
lack of interferon-y (IFN-y) production and lack of autoimmunity. This response by 
CD8' T cells is termed abortive activation (Hernandez et at., 2001). Therefore, 
whereas the productive activation of K°HA-specific CD8` T cells in PR8-immunised 
- 11 - 
Chapter 1: Introduction 
mice leads to immunity, abortive activation leads to the induction of peripheral 
tolerance. 
1.4 CD8+ T cell biology 
1.4.1 The role of CD8' T cells in immunity and autoimmunity 
One of the major functions of CD8` T cells is to effect the removal of intracellular 
pathogens from the host. CD8+ T cells become productively activated by infected 
cells which present viral or intracellular bacterial peptides on MHC class I 
molecules (Sondet and Bach, 1975). Such activation is often productive, resulting 
in clonal expansion to produce vast numbers of CD8' T cells, specific for peptides 
from the infectious agents, which mediate tysis of any infected cells (Butz and 
Bevan, 1998). Cytotoxicity is generated by effector cytotoxic T lymphocytes (CTL) 
that differentiate from naive CD8' T cells. CTL are generated in secondary 
lymphoid tissue (lymph nodes or spleen) and through altered expression of 
adhesion molecules become able to extravasate via inflamed endothelium into 
infected tissues (Picker, 1994). The TcR allows CTL to then recognise infected 
cells and through the induction of apoptosis by ligating Fas on the target cells 
and/or through secretion of cytolytic enzymes, such as perforins and granzymes, 
eradicate the infected cells (Kojima et at., 1994; Kreuwet and Sherman, 2001). 
CTL also produce cytokines, such as (IFN, Salgame et at., 1991) and tumour 
necrosis factor-a (TNF, Harty et at., 2000), which enhance inflammation and 
activate the innate immune system. 
Following the clearance of the pathogen, most CTL become clonally exhausted 
and removed from the periphery, however some pathogen-specific CD8` T cells 
differentiate into memory T cells (Doherty et at., 1994). Memory cells are 
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produced during clonal expansion from naive T cells via a specific differentiation 
pathway (Kaech and Ahmed, 2001). Memory CD8' T cells survive long-term and 
function to provide a rapid recall in response to infection with a pathogen the 
immune system has previously encountered. Recent reports have indicated that 
memory T cells form a heterogeneous population, which can be divided into two 
broad subsets: central memory T cells and effector memory T cells (Sallusto et 
at., 2004). These subsets have been defined for both CD4' and CD8' memory T 
cells based on their expression of activation and homing molecules and effector 
function (Reinhardt et at., 2001; Wherry et at., 2003). Central memory T cells 
preferentially home to secondary lymphoid tissue, due to expression of CD62L, 
where they may persist. Also, in vitro central memory T cells can proliferate and 
differentiate into effector T cells (Sallusto et at., 2004). Whilst effector memory 
T cells preferentially home into peripheral tissues, such as the lung, where they 
can produce Thl/Tcl cytokines in response to antigen, but are short lived 
(Klonowski et at., 2004). It has been suggested that both central memory T cells 
and effector memory T cells can be generated from the same precursors as a 
result of the level of stimulation through TcR and through cytokines (Lanzavecchia 
and Sallusto, 2000). Other studies have proposed that effector memory T cells 
can differentiate into central memory T cells (Wherry et at., 2003). 
All nucleated cells express MHC class I, which makes host tissues vulnerable to 
autoimmune attack by self-specific CD8+ T cells. The classical MHC class I 
presentation pathway presents endogenous antigens at the cell surface, these can 
be from infectious agents or from self-proteins. Although, central tolerance 
mechanisms prevent the circulation of many auto-reactive cells, CD8' T cells 
specific for self-antigens can be found in the periphery (Naquet et at., 1988). 
Peripheral tolerance mechanisms prevent inappropriate activation of such T cells, 
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but CD8' T cell-mediated autoimmunity does occur; in some cases it is the initial 
tissue damage by CD8+ T cells which sets up conditions for tissue destruction by 
innate and humoral immunity. For example, studies have demonstrated a role for 
CD8+ T cells in autoimmune disease of the central neverous system (multiple 
sclerosis, Babbe et at., 2000; multiple sclerosis, Traugott, 1987) and pancreas 
(diabetes, Wang et at., 1996; Wong et at., 1998). This section describes in detail 
the requirements for CD8+ T cell activation, how CD8+ T cell activation takes place 
and the consequences of CD8+ T cell activation. 
1.4.2 Activation of CD8+ T cells and co-stimulation 
To activate naive CD8' T cells two signals are required (Bretscher and Cohn, 
1970). Signal 1 results from interactions between the TcR and a cognate peptide 
(the peptide for which the TcR has high avidity) presented by self-MHC class I 
molecules. Signal 2 results from the ligation of various non-antigen specific 
receptors expressed by CD8` T cells with co-stimulatory molecules expressed by 
the APC (Whitmire and Ahmed, 2000). Activation through the TcR in the absence 
of co-stimulation induces a state of anergy amongst CD8' T cells (Schwartz, 1990). 
Whilst T cell activation via signals 1 and 2 results in altered gene expression 
leading to proliferation and differentiation to CTL. Recent studies have indicated 
that a third signal is also required to initiate full CD8` T cell activation (Curtsinger 
et at., 2005a). Signal 3 is normally described as the action of a cytokine produced 
by APCs or other responding T cells, such as IL-12 or IL-2 that promotes CD8' T 
cells survial (Curtsinger et al., 2003a). 
Signal 1 is induced in T cells by multiple peptide/TcR interactions. Firstly, an 
immunological synapase forms, with a raft of TcRs associated with CD8 and other 
transmembrane components, including CD3 and CD45 (Siegel et at., 1991). The 
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CD3 signalling complex initiates signal transduction via a cascade of kinases and 
adaptor proteins. A certain number of TcR/MHC-peptide interactions are required 
to raise the amount of signalling above a threshold level to initiate T cell 
activation (Valitutti et at., 1995). The number of interactions required to activate 
T cells varies between different TcRs. For example, in one study CD8` T cells 
generated CTL following engagement of a single TcR complex with a single 
peptide/MHC complex (Sykulev et at., 1996). 
The interaction between TcR and peptide/MHC complex results in phosphorylation 
of tyrosine activation sites on the intracellular portion of CD3 by the protein 
tyrosine kinases Lck and Fyn. Full phosphorylation of CD3 allows the recruitment 
of the protein kinase ZAP-70 (Chan et at., 1991). ZAP-70 is then activated by Lck 
or Fyn to phosphorylate the linkers (adaptor proteins) LAT and SLP-76 (Peterson et 
at., 1998). These proteins allow the transduction of signalling events via several 
pathways: the RAS pathway and two phospholipase Cy (PLCy)-mediated pathways, 
which result in altered gene expression (Izquierdo et at., 1992; Kim et at., 1989; 
Presky et at., 1990). The RAS pathway activates mitogen activated protein 
kinases (MAP kinases), which through a cascade phosphorylate each other to 
activate the transcription factor - AP-1, which induces effector T cell 
differentiation (Su et at., 1994). PLCy both initiates the inositol triphosphate 
pathway, which activates the nuclear factor of activated T cells (NFAT) by 
increasing intracellular Cat' levels and activates the transcription factor NFKB 
through the action of protein kinase C (reviewed Quintana et at., 2005). Both 
NFAT and NFi B act on gene transcription promoting IL-2 production, cell 
proliferation and differentiation (Rayter et at., 1992). 
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It appears that signalling through the TcR following stimulation by peptide/MHC 
complex is not merely a matter of an "on" signal, when the stimulation has 
surpassed its threshold. Altered peptide ligands (APL; cognate peptides with one 
or more amino acid substitution) can interact with TcRs as full agonists, partial 
agonist, superagonists, or antagonists (Sloan-Lancaster and Allen, 1995; Vidal et 
a!., 1996). Activations of T cells with APL can result in many different outcomes 
depending on the TcR and APL used: no activation (Kanai et al., 1997), the 
induction of anergy (Sloan-Lancaster et a!., 1996), proliferation without 
differentiation (Irie et al., 2003), induction of activated cell surface phenotype 
without proliferation (Chen et al., 1996), prolonged survival (Matsushita et al., 
1997), increased INFy production (Matsuoka et a!., 1996) or increased 
proliferations compared with unaltered cognate antigen (Guyver and Nicholson, in 
press). As APL only stimulate TcRs, these results indicate that signal 1 can 
produce a range of activations, which may either involve increasing or decreasing 
the magnitude of signal or involve the use of different combinations of signalling 
pathways. For example, differences in CD3 phosphorytation and subsequent 
recruitment of ZAP-70 were observed amongst APL stimulated CD4' T cells (Sloan- 
Lancaster et at., 1994), and APL utilised different Ca 2+ signalling pathways (Chen 
et al., 1998). 
Full activation is rarely possible without additional co-stimulation (Mueller and 
Jenkins, 1995), although T cell activation may be induced through different 
balances between signal 1 and signal 2. In one study, stimulation with high levels 
of peptide could elicit CD8+ T cell responses, in the absence of co-stimulation. 
However, CD8' T cell proliferation was curtailed after a short time (Cai and 
Sprent, 1996). In other studies, when high doses of peptide were used to initiate 
a primary response, anergy was induced amongst T cells despite the presence of 
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co-stimulation. It was suggested that this response might be as a result of T cells 
being stimulated too much; inducing (AICD, Firpo et at., 2002). Studies have 
shown that co-stimulation can occur through several pathways: interaction of B7 
family members (such as CD80 and CD86) on APCs with their receptors (e. g. CD28, 
CTLA-4) on T cells, as well as through interactions with TNF-R family members 
(such as 4-1 BBL on APCs with 4-1 BB on activated T cells). 
The function of B7 family members in providing signal 2 to T cells is well defined 
(reviewed in Carreno and Collins, 2002). The classical B7 molecules are CD80 and 
CD86, which are expressed by activated DCs and B cells (Freeman et at., 1991; 
Hathcock et al., 1994). CD80 and CD86 can both bind to CD28 or CTLA-4 
expressed by T cells, although their interactions with these receptors appear to 
have different affinities: CD80 has greater affinity for its receptors than CD86, but 
CD80 and CD86 both have higher affinity for CTLA-4 than CD28 (Collins et at., 
2002; Linsley et at., 1994). Separate roles for CD28 and CTLA-4 co-stimulation 
have been described: interaction of B7 molecules with the CD28, which is 
constitutively expressed by T cells, in combination with signal 1 allows full T cell 
activation (Liu et a!., 1992). Whilst interaction with CTLA-4, which is only 
expressed by activated T cells (Linsley et al., 1992), by B7 molecules inhibits T 
cell effector function and regulates IL-2 production (Walunas et at., 1994). 
There are other members of the B7 family that have their own ligands. PD-1 is 
expressed bit cells and interacts with PD-1 L (Agata et at., 1996). The role of PD- 
1 is unclear: PD-1 deficient mice develop spontaneous autoimmunity (Nishimura 
and Honjo, 2001), suggesting a role for PD-1L in preventing T cell activation; on 
the other hand, PD-1 has shown to enhance IFN-y production, suggesting a role for 
PD-1 L in activating T cells (Dong et al., 1999). Another B7 family member is ICOS- 
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L; ICOS/ICOS-L interactions appear to favour Th2 polarisation of CD4' T cells (Dong 
et at., 2001). In contrast, ICOS-L also stimulates the production of IFN-y by 
effector CTL and activates CD4' T cells (Rottman et at., 2001; Wallin et at., 2001). 
However, the fact that ICOS is only upregulated by T cells following initial co- 
stimulation (McAdam et at., 2000), suggests that ICOS may not be involved in 
activation of nave T cells (Wallin et al., 2001). 
The TNF-R superfamily components expressed by T cells are also able to receive 
co-stimulatory signals from APCs. 4-1 BB expression by T cells is only observed 
after activation (Kwon et at., 2002). The ligand for this molecule has been 
detected on mature dendritic cells (Ferlazzo et at., 1999) and interaction 
between 4-1 BB and 4-1 BBL can enhance T cell responses (Merero et al., 1997). 4- 
1 BB co-stimulation preferentially stimulates CD8` T cells (Halstead et at., 2002). 
Although CD4` T cells can be stimulated though 4-11313, additional co-stimulatory 
interactions are required for full activation. Another, TNF-R family member, 
0X40, can provide co-stimulation when ligated by OX40L on APCs (Gramaglia et 
at., 1998); such interaction can enhance both proliferation and cytokine 
production of Thl and Th2 cells (Flynn et at., 1998). OX40/OX40L co-stimulation 
is mainly confined to CD4' T cells, which begin to express 0X40 following 
activation (Taraban et at., 2002). Interestingly, dual stimulation of both 0X40 and 
4-1BB by their respective ligands promoted CD8` T cells to differentiate into 
effector CTL and, in contrast to CD4' T cell activation, the effect of both TNF-R 
family members in combination was greater than an additive effect (Lee et at., 
2004). 0X40 and 4-1 BB co-stimulation in the absence of B7 stimulus was involved 
in the enhancement of survival and effector function (cytotoxicity/cytokine 
production), but not in proliferation. 
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Another member of the TNF-R family is CD40, this molecule is mainly involved in 
the co-stimulation of CD4' T cells (Quezada et at., 2004). However, the 
interaction between CD40 and CD40L on APCs is bidirectional (Yellin et at., 1994): 
not only does CD40L provide co-stimulation of CD4' T cells, but its engagement 
increases the production of IL-12 and other inflammatory cytokines by APCs 
(Stuber et at., 1996). Additionally Ligation of CD40 on DCs with CD40L can mature 
DCs, upregulating the expression of other co-stimulatory molecules such as CD80 
and CD86 (Cella et at., 1996). 
The adhesion molecule CD54 has also been shown to be able to provide co- 
stimulatory signals potent enough to activate naive CD8' T cells in the absence of 
classical co-stimulatory molecules in vitro. Carcinoma cells, which do not express 
CD80/CD86 are able to directly initiate activation of naive CD8' T cells through 
peptide/TcR interactions to form effector CTL. This activation can be prevented 
by blocking CD54 or its ligand CD11a on T cells with monoclonal antibodies 
(Jenkinson et al., 2005). 
Stimulation of CD8' T cells with signals 1 and 2 does not necessarily lead to 
differentiation to effector CTL (Schmidt and Mescher, 2002). Instead, one 
laboratory has hypothesised that a signal 3 in the form of an inflammatory 
cytokine is also required to achieve full cytolytic function from naive CD8' T cells 
using IL-12 (Curtsinger et al., 2003a) or type 1 IFNs (Curtsinger et al., 2005b) as 
adjuvants. A system of activating CD8' T cells with artificial APCs was employed, 
in which microbeads were coated with anti-CD3 antibodies or antigen-coupled 
MHC fusion proteins as well as anti-CD80/CD86 antibodies. Artificial APCs 
facilitated the study of the effects of signal 1,2 and 3, as no cytokines derived 
from APCs were present, thus the levels of each signal could be controlled. In 
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particular, stimulation of TcR transgenic OVA-specific OT-1 CD8' T cells with anti- 
CD3 coated artificial APCs led to normal CD8' T cell proliferation and 
degranulation, but impaired the production of granzymes and so cytotolytic 
function was prevented. Addition of IL-12 to CD8' T cells co-cultured with 
artificial APCs did not increase proliferation or degranulation, but did induce 
normal granzyme production and cytotoxicity (Curtsinger et at., 2005a). Further 
experiments indicated that the lack of cytotoxicity may be linked to impaired Cat' 
signalling following TcR engagement (Curtsinger et at., 2005a). However; it was 
previously shown that very high engagement of TcR can overcome a requirement 
for signal 3 to activate CD8' T cells leading to fully functional CTL (Curtsinger et 
at., 2003b). 
The majority of published reports concerning the signalling processes involved in T 
cell activation are based on studies of CD4' T cells. Many studies assume that 
similar signalling processes occur in CD8' T cells (Zamoyska and Lovatt, 2004), and 
simply refer to 'T cell signalling'. However some important differences between 
signalling in CD4+ and CD8' T cells have been suggested (Julius et at., 1993). For 
example, activation of T cells to produce IFN-y involves the Jak-STAT signalling 
pathway (Darnell et at., 1994). The Jak-STAT pathway leads to induction of the 
transcription factor T-bet which is essential for the production of IFN-y by CD4' T 
cells (Szabo et at., 2000). However, T-bet is not essential for IFN-y production by 
CD8' T cells, as evidenced by experiments with T-bet''' mice (Preiser et at., 2002). 
Although in CD8' T cells, T-bet can play a role in IFN-y signalling, as transfection 
of T-bet into CD8' T cells can lead to IFN-y production (Mullen et at., 2001). Also, 
disruption of other signalling elements in the Jak-STAT pathway, such as STAT-1, 
does prevent normal activation of CD8' T cells (Meraz et at., 1996). These 
experiments indicate that both CD8' and CD4' T cells and can make IFN-y under 
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the control of T-bet, whilst in CD8'T cells the Jak-STAT pathway may also be able 
to activate a different transcription factor to signal for IFN-y production. 
Differences have also been reported in MAP kinase pathways between CD4' and 
CD8` T cells (reviewed in Rincon and Pedraza-Alva, 2003). It therefore appears 
that CD8' and CD4' T cell activation, although similar, may be distinct. 
1.4.3 Differentiation of CD8` T cells 
CD8+ T cells are activated by a combination of signals (chapter 1.4.2) leading to 
proliferation and the acquisition of effector functions. Following differentiation 
into effector CTL, activated CD8' T cells express an altered cell surface phenotype 
as compared to naive CD8+ T cells. For example, CD8+ T cells upregulate CD25 
(the a-chain of the high affinity IL-2 receptor) after TcR signal transduction 
(Kabouridis and Tsoukas, 1990). Through the association of CD25 with IL-2Rß and 
common cytokine receptor y chains, activated T cells become highly sensitive to 
IL-2 stimulation (Fung and Greene, 1990). CD25 is key to the productive activation 
of T cells as stimulation by IL-2 enhances T cell proliferation and survival and also 
promotes the production of further IL-2 (Reem et at., 1985). Anergic T cells are 
unable to produce their own IL-2 (Schwartz, 1990) and such T cells may be 
rescued with the addition of exogenous IL-2, which leads to CD25 upregulation 
(Schwartz, 2003). CD8` T cells also downregulate surface molecules following 
activation, for example CD62L (L-selectin, Jung et at., 1988). CD62L mediates 
adhesion of naive T cells to high endothelial venules (HEV), allowing further 
interactions between T cells/HEV-expressed proteins, leading to extravasation of 
the T cell through tight junctions and into lymph nodes (Gallatin et at., 1983). 
Naive T cells downregutate CD62L and upregulate other adhesion molecules, such 
as CD49d. Following such alterations in adhesion molecule expression, activated T 
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cells cannot undergo lymphocyte recirculation, but can instead migrate into 
tissues, where they can carry out their effector functions. 
CD4+ effector T cells have been divided into two subsets based on their cytokine 
secretion profiles. Th1 and Th2 CD4' effector T cells are identified based on their 
cytokine secretion (Th1: IFN-y, TNF-a; Th2: IL-4, IL-5, IL-10; (Cherwinski et at., 
1987; Mosmann et at., 1986). Th1 cells assist in the activation of phagocytosis of 
extracellular pathogens, whilst Th2 cells stimulate the humoral response, 
activating antigen-specific B cells through IL-4. It is widely, although not 
universally, accepted that CD8` effector T cells can also be divided into two 
subsets based on their cytokine secretion profiles. Most CTL secrete cytokines 
associated with Thl type cells and so are termed T cytotoxic-1 cells (Tc1) while 
studies have also generated CD8' T cells with a Th2-like cytokine secretion profile 
(Tc2, Sad et at., 1995). 
Secretion of the Tc1 cytokines, IFN-y and TNF-a, has been linked to the 
acquisition of effector response amongst CD8' T cells. IFN-y and TNF-a have both 
been associated with the induction of autoimmune diabetes. Tcl cytokines 
mediated cytotoxicity amongst pancreatic islet cells in vitro (Campbell et at., 
1988) and administration of Tcl cytokines accelerated diabetes in NOD mice 
(Yang et at., 1994). However, when LCMV-activated T cells were transferred into 
RIP-LCMV-gp/RIP-tet-TNF-a mice, which expressed both the glycoprotein from 
LCMV and inducible TNF-a on pancreatic p cells, the effect of TNF-a was 
dependant on the stage of autoimmunity. Whilst TNF-a expression resulted in 
increased autoimmune diabetes during the induction of the disease, TNF-a 
expression induced during later phases abrogated disease (Christen et al., 2001). 
IFN-y and TNF-a secretion is also associated with inducing the activation of 
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macrophages (Winston et at., 1999), which have a major role in mediating tissue 
destruction during autoimmunity (Molter et at., 1992). Interestingly, Th2/Tc2- 
type cytokines IL-4 and IL-10 have been shown to be associated with the 
prevention of diabetes in NOD mice (Lee et at., 1996; Mueller et at., 1996). 
Although, many studies refer to activated CD8' T cells as Tcl or Tc2 cells based on 
their cytokine production, there is some controversy over whether or not CD8' T 
cells can be so clearly subdivided into such subsets. In many cases such Tcl /Tc2 
classification seems arbitrary: for example some Tc2 make similar levels of INFy 
compared with Tcl cells (Sad et at., 1995), whereas other Tc2 cells make IL-4, but 
no IL-10 (Sad and Mosmann, 1995), whilst other groups report IL-10-producing Tc2 
cells (Noble et at., 2006). Unlike Th1 /Th2 polarisation, little evidence for a 
separate function of Tcl /Tc2 cells has been demonstrated in vivo, and the 
function of Tc2 cells generated in vitro is directly related to the method used to 
generate them (Kemp et at., 2005). 
1.4.4 Post-activation migration of T cells to tertiary lymphoid sites 
It has been suggested that deletion of clonally exhausted T cells following a 
productive infection occurs mainly at the site of activation (Webb et at., 1990). 
Other studies have demonstrated that some T cells home to non-organised 
lymphoid sites after activation where they undergo clonal deletion, particularly 
gut associated lymphoid tissue (GALT) and the liver (Hall and Smith, 1970; Huang 
et at., 1994a; Le Bon et at., 1999; Ponsford, 1973; Sprent, 1976; Wack et at., 
1997). GALT consists of both organised secondary lymphoid tissue (Peyer's 
patches and mesenteric lymph nodes) and lymphocytes scattered throughout the 
gut mucosa mainly in the lamina propria (LP). Other lymphocytes can be observed 
between epithelial cells, these intraepithelial lymphocytes (IEL) have a distinct 
-23- 
Chapter 1: Introduction 
phenotype and are thought to have a specialised effector function (Mowat and 
Viney, 1997) 
The mesenteric LN drain the GALT and contain lymphocytes which preferentially 
home to mucosal tissue (Philips-Quastiata and Lamm, 1988). Homing is also 
demonstrated by other GALT components as well as by intrahepatic lymphocytes 
(Huang et at., 1994a). For example, following adoptive transfer of donor IEL into 
homologous Rag'" or lethally irradiated mice, cells preferentially populate the gut 
epithelium of these recipients (Rocha et al., 1994). 
The mucosal addressin cellular adhesion molecule, MadCAM, is expressed on 
normal mucosal endothelium (Briskin et at., 1993). During leukocyte 
recirculation, CD62L, expressed on the cell surface of naive lymphocytes, binds 
MadCAM and facilitates extravasation into mucosal tissue (reviewed in Picker, 
1994). Upon activation of T cells, CD62L is rapidly downregulated and selective 
homing to mucosal surfaces is brought about by the expression of an alternative 
MadCAM ligand, the integrin a4ß7 (Kunkel and Butcher, 2002), the a chain of which 
(CD49d) is often upregulated in activated T cells (Dutton et at., 1998). Receptors 
for chemokines expressed on T cells, such as CCR9, are also important in mucosal 
targeting to the GALT of the small intestine (Zabel et at., 1999). T cells within 
the epithelial layer of the small intestine are found to express an alternative 
integrin, aEß7, which binds to a cell surface adhesion molecule expressed on 
epithelial cells (Kilshaw, 1993). The ligand for aE has been shown to be E- 
cadherin and is thought to be involved in retaining IEL in the mucosal epithelia 
(Corps et at., 2001). In aE '' knock-out mice there is a reduction of T cells in both 
the IEL and LP lymphocyte compartments, but no effect is observed on the T cell 
populations within the organised GALT (Schon et at., 1999). These findings 
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suggest that specific adhesion molecules are involved in the homing and 
subsequent retention of T cells in specific lymphoid compartments. Experiments 
carried out in vitro indicate that the expression of an alternative integrin can be 
induced by activation (Kilshaw and Murant, 1991). 
Early studies also indicated that lymphocytes activated by an antigen in vivo 
before intravenous transfer accumulate in the walls of the gut before being 
cleared (Hall and Smith, 1970; Sprent, 1976). These experiments also indicated 
that the specificity of the T cell activation did not affect the homing of the T cells 
to the small intestine (Sprent, 1976; Sprent and Miller, 1972) and previously 
activated lymphocytes infiltrate into small intestinal lamina propria (Griscelli et 
at., 1969; Sprent, 1976). 
There is also evidence that the liver is a major site of T cell disposal, containing a 
great proportion of T cells that are undergoing apoptosis (Crispe and Mehal, 1996). 
A TcR transgenic mouse strain (Clone K), when injected with its cognate antigenic 
peptide (the T antigen of SV40 560-568), exhibits abortive activation of these 
specific T cells followed by their peripheral deletion (Geiger et at., 1992). The 
disappearance of the Clone K cells from peripheral lymphoid tissue is accompanied 
by their accumulation in the liver while undergoing apoptosis (Crispe and Huang, 
1994). 
Populations of activated intrahepatic lymphocytes undergoing apoptosis show the 
following phenotypes: CD4'CD8TcRt0 or CD4'CD87cR'B220` (Huang et at., 1994b). 
Studies have shown that these cells preferentially accumulate in Lpr mice which 
have a defect in the Fas gene (Theofilopoulos et at., 1985), suggesting a role for 
Fas: FasL interaction in the induction of apoptosis in this system. 
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Studies with another transgenic system, where T cells are activated following the 
administration of cognate peptide, have also revealed a number of sites for the 
disposal of CD8' T cells. F5 mice express a transgenic TcR on many peripheral 
CD8` T cells that recognises an influenza virus nucleoprotein peptide (NP68). T 
cells from F5 mice showed increased apoptosis and migration following injection 
of the NP68 peptide (Wack et at., 1997). Immunohistochemical analysis showed 
that the CD8' T cells infiltrated the liver, lungs, small intestine, skin and kidneys. 
Furthermore a high proportion of apoptosing T cells were detected in the liver, 
lungs and kidneys, using the TUNEL technique. Repeat experiments in Rag''"F5 
mice showed a similar result, thus indicating that the disposal mechanism is 
independent of other lymphocytes. (Wack et at., 1997). Although the migration of 
F5 CD8' T cells to certain distal sites was linked to an increase in apoptosis, little 
apoptosis was observed amongst the population of T cells migrating to the LP. 
This is consistent with studies by Le Bon et at and Webb Et Sprent, which showed 
that T cells activated by MMTV superantigen homed to Peyer's patches and LP, 
apoptosis was only seen in the organised GALT (Le Bon et at., 1999; Webb and 
Sprent, 1993). 
Homing to non-organised lymphoid tissue has also been described in murine 
models following productive infection (Finke and Acha-Orbea, 2001). When 
activated T cells undergo clonal exhaustion and disappear from the periphery by 
in situ apoptosis (Sytwu et at., 1996) some T cells survive as memory T cells. 
Subsets of these cells selectively home to most non-lymphoid organs (Kim et at., 
1997; Kim et at., 1999), in particular, many memory T cells home to the LP. LPL 
memory T cells were shown to have a different phenotype to those found in other 
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tissues and responded more vigorously to restimulation than other memory cells 
(Masopust et al., 2001). 
As described, T cells resident in the liver as welt as in the LP and IEL of the small 
intestine express certain adhesion molecules that allow preferential homing back 
to these sites. For example, the integrin a4ß7 expressed by T cells within the LP 
binds MadCAM on mucosal endothelium to allow localisation of activated T cells to 
the LP (Kunkel and Butcher, 2002). Similarly, T cell-expressed aEP7 localises T 
cells to the IEL (Corps et at., 2001), and interactions with vascular adhesion 
protein 1 may be essential for liver-specific migration (Lalor et at., 2002). It is 
clear from many studies that subsequent to activation many CD4` and CD8` traffic 
into these tertiary lymphoid sites (Hall and Smith, 1970; Huang et al., 1994a; Le 
Bon et al., 1999; Ponsford, 1973; Sprent, 1976; Wack et at., 1997). It is likely 
that this restricted homing is driven by interactions between adhesion molecules 
upregulated by activated T cells (e. g. CD49d) and the tissue-specific addressins 
previously described (e. g. MadCAM). 
We suggest that as well as playing a role in the clearance of post-activation 
clonally exhausted T cells, particular non-organised tertiary lymphoid tissues also 
represent sites for the accumulation of memory T cells and/or induced regulatory 
T cells. Those activated T cells which home to the liver appear to be targeted for 
removal by apoptosis, as determined by the high levels of TUNEL staining amongst 
such T cells (Crispe and Mehat, 1996). That these IHL have been previously 
activated elsewhere is suggested by their unusual phenotypes; as a 
down regulation of expression of TcR and co-receptors is associated with prolonged 
activation (Paillard et al., 1990). On the other hand, these phenotypes and 
evidence of high levels of apoptosis are not observed in activated T cells homing 
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to the LPL and IEL. However, these sites do contain large populations of memory 
T cells, as well as a high proportion of T cells that express potentially auto- 
reactive TcRs. 
1.5 Interactions between antigen presenting cells and T cells 
1.5.1 Antigen presentation 
Surveillance of intracellular proteins is required in order to detect pathogens that 
infect host cells. Cytosolic proteins are continually sampled and digested into 
peptides by proteases before transportation to the cell surface and presentation 
by MHC class I molecules. In this manner, cells infected by viruses or intracellular 
bacteria can be recognised and an immune response initiated. All nucleated cells 
process and present endogenous antigens on MHC class I molecules and the 
mechanism for this has been well described (summarised in Fig. 1.3, adapted from 
Lehner and Trowsdale, 1998). 
Proteasomes along with other proteinases are responsible for cleaving endogenous 
proteins into peptide fragments (Rock et at., 1994). These organelles degrade 
endogenous cytosolic proteins (including viral proteins) as well as defective 
proteins, proteins transported from the endoplasmic reticulum (ER) and exogenous 
proteins from endosomes via catalytic sites (Yewdelt et at., 2001). Post 
proteasomal modification of peptide fragments also occurs via the action of 
proteases in the cytoplasm (Rock et at., 2004). The resulting peptides are then 
trafficked into the ER by the transporter associated with antigen processing (Suh 
et at., 1994). TAP spans the ER membrane and consists of two components, TAP1 
and TAP2. Mice with mutation or knocked-out TAP1 or TAP2 are unable to 
efficiently present MHC class I restricted epitopes (Momburg et al., 1992). Once 
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Figure 1.3: Processing and presentation of endogenous antigens by MHC class 
I molecules 
A. " heavy MHC class I chains (a chains) are transported into the ER 
" MHC class Ia chains assemble with ER membrane-bound calnexin and 
become partially-folded 
" MHC class Ia chains associate with P2-microglobulin, releasing calnexin from 
the complex 
" calnexin is replaced by the chaperone protein calreticulin 
" MHC class I binds to part of a tapasin protein. Other chaperone molecules 
are also invovled 
B. " proteins are degraded by the proteasome in the cytosol producing peptide 
fragments 
"a TAP transporter interacts with tapasin bound to MHC I 
" protein fragments are transported into the ER via TAP 
" protein fragments bind to the peptide binding groove of the MHC class I 
molecule, leading to full folding of the MHC class I molecule 
C. " the MHC class I/peptide complex is released from its chaperone molecules 
" the complex is transported via the Golgi apparatus to the cell surface in 
vesicles 
" the MHC class 1/peptide complex is expressed on the cell surface 
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B. Proteins are degraded into peptides in the cytosol by proteasomes, before 
transportation into the ER by TAP proteins and loading onto MHC class I 
molecules. TAD 
C. MHC class I/peptide complexes are transported via the Golgi apparatus for 
expression on the cell surface. 
Cytosol 
Cell surfa 
Figure 1.3: Processing and presentation of endogenous antigens by MHC 
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inside the lumen of the ER, further trimming of peptides may take place, 
reducing the length of peptides to 8-10 amino acids, by the action of amino 
peptidases (Snyder et at., 1994). To prevent the presentation of peptides outside 
this degradation pathway, in particular external antigens once MHC class I is 
expressed at the cell surface, it is imperative that MHC class I molecules do not 
escape from the ER until bound to an appropriate peptide. To this end, MHC class 
I molecules do not fully fold and must remain stabilised in the ER by a complex of 
other proteins until tight docking of a peptide takes place. 
After synthesis, the unfolded, nascent MHC I heavy a chain becomes associated 
with an ER transmembrane chaperone protein, calnexin, which induces partial 
folding of MHC class I (Suh et al., 1994). Although, calnexin may not be essential 
as demonstrated in a calnexin mutant cell line in which MHC class I-restricted 
presentation occurred (Scott and Dawson, 1995). Calnexin is then exchanged for a 
soluble homologue, calreticulin, when ß2 microglobulin (ß2m) binds to MHC 
heavy chain (Pamer and Cresswell, 1998). Other chaperone proteins may also be 
involved, such as Erp57 which binds to MHC class I heavy chain to prevent the 
formation of intramolecular disulphide bonds within MHC class I in the ER (Lehner 
and Trowsdale, 1998). 
The MHC class I complex is stabilised to the TAP by bridging with several tapasin 
molecules (Ortmann et al., 1997). One study has also indicated that tapasin 
molecules may play a röte in peptide editing in the ER (Suh et al., 1999). 
Following, peptide binding to MHC class I, the complex disassociates from TAP, 
tapasin and calrecticulin, before being transported to the cell surface in vesicles 
after passing through golgi complex (Lehner and Trowsdale, 1998). Many MHC 
-30- 
Chapter 1: Introduction 
class I/peptide complexes are then presented at the cell surface to CD8` T cells 
prior to protein recycling. 
Early work demonstrated following transfer of allogeneic cells, CTL responses 
were generated in the host as a result of presentation of MHC class I restricted 
antigens, despite the fact that the transferred target cells expressed allogeneic 
MHC class I molecules that were unable to interact with host CD8' T cells (Bevan, 
1976). More recently it has been shown that exogenous MHC class I-restricted 
peptides can also be presented to CD8` T cells (Sigal et at., 1999). This pathway is 
referred to as cross-presentation and requires professional APCs. Cross- 
presentation is thought to be essential to prime naive CD8+ T cells to induce an 
initial anti-viral CD8' T cell response (Sigat and Rock, 2000). Experiments have 
demonstrated that macrophages can cross-present antigens in vitro (Norbury et al., 
1995; Reis e Sousa and Germain, 1995). B cells can also cross-present antigens in 
vitro (Rock et a/., 1990), whilst in other studies B cells have been manipulated to 
cross-present MHC class I-restricted antigens in vivo by introduction of antigen 
using a gene gun (Hon et at., 2005) or antigen linked to CpG-DNA (Heit et al., 
2004). However, under steady state conditions in vivo only DCs have been shown 
to be involved in cross-presentation (Heath et at., 2004). Therefore this thesis has 
focussed only on cross-presentation by DCs. 
Many studies have been conducted in order to determine how exogenous antigens 
are processed and presented by DCs (reviewed in Groothuis and Neefjes, 2005). 
Current proposed pathways of cross-presentation are depicted in figure 1.4. DCs 
can internalise extracellular antigens in several ways: by phagöcytosis (Ackerman 
and Cresswell, 2004), or by receptor-mediated endocytosis, such as via FcgR 
(Rodriguez et at., 1999) or CD205 on DCs (Bonifaz et at., 2004). These 
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Figure 1.4: Putative pathways of cross-presentation of exogenous antigen by 
MHC class I molecules 
No 
A Exogenous proteins are taken up by endosomes 
B Proteins leave the endosome and enter the cytosol where they are 
degraded by proteasomes 
C Proteins are degraded to peptide fragments and enter the ER via TAP. 
These peptides are then loaded onto MHC class I and presented in the same 
manner as the classical endogenous processing and presentation pathway (Fig. 
1.3) 
D Other proteins are degraded in the endosome. Peptide fragments leave 
the endosome enter the ER via TAP. These peptides are then loaded onto MHC 
class I and presented in the same manner as endogenous presentation 
E Peptide fragments leaving the endosome can also traffic into vesicles 
containing recycled MHC class I molecules 
F MHC I molecules are recycled by internalisation by vesicles, during this 
process any peptides loaded are lost 
G Vesicles from the ER or those containing recycled MHC class I molecules 
associated with novel exogenous peptides fuse with the plasma membrane, 
allowing surface expression of MHC class I complexes 
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Figure 1.4: Putative pathways of cross-presentation of exogenous antigens 
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mechanisms lead to exogenous antigens being contained in endosomes in the APC 
(Fig. 1.4A). Proteins must then be degraded into peptide fragments for MHC class 
I presentation; two possible processes have been suggested to mediate protein 
cleavage: digestion in the endosome (Fig. 1.4D ft E) and transport into the cytosol 
for degradation by proteosomes in a similar manner to classical MHC class I 
presentation (Fig. 1.1 B, Rock and Shen, 2005). 
Treatment of APCs with inhibitors of proteasome function inhibits cross- 
presentation of certain antigens (Norbury et al., 1995). Additionally, a 
requirement for TAP has been demonstrated for cross-presentation (Huang et at., 
1996). Cross-presentation can also be inhibited by Brefeldin A (Reis e Sousa and 
Germain, 1995), which prevents vesicle transport out of the ER. Taken together 
these studies suggest that exogenous proteins are degraded by proteasomes, 
before transportation via TAP into the ER where the peptide fragments are loaded 
onto MHC class I molecules and transported to the cell surface in vesicles. The 
mechanism by which proteins are able to leave endosomes is unknown, however 
experiments in yeast indicate a röte for the chaperone Sec6l (Stirling et at., 
1992). 
Endocytic proteasomes also exist (Shen et at., 2004) and it has been suggested 
that exogenous peptides may be digested by such enzymes in endosomes, rather 
than in the cytosot by proteasomes (Fig. 1.4D Imai et al., 2005). One possibility is 
that peptide fragments generated in endosomes may enter the cytosot before 
trafficking into the ER via TAP (Trombetta and Mellman, 2005). Intriguingly, 
certain bacterial proteins can be cross-presented by TAP-deficient APCs and by 
Brefeldin A-treated APCs (Bachmann et at., 1995). This implies that cross- 
presentation can take place without transport of peptides into or out of the ER; 
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the loading of peptides must therefore take place outside the ER. Although, 
mechanisms are in place to prevent MHC class I molecules leaving the ER with an 
empty peptide-binding groove (Fig. 1.3), it is possible for cytosolic peptides to 
encounter MHC class I molecules which are being recycled from the cell surface 
and exchange endogenous proteins for exogenous ones (Fig. 1.4E 7F Gromme et 
at., 1999; Fig. 1.4E 7F Rock, 1996). 
A report also suggests that DCs can acquire exogenous antigen from live cells, 
rather than from extracellular proteins produced as a result of cell lysis (Harshyne 
et at., 2001). It is likely that peptides could be directly exchanged through gap 
junctions. In particular, DCs posses the ability to couple to cells with transient 
gap junctions as they migrate through tissues (Neijssen et at., 2005). Other 
studies have demonstrated that DCs can bind to other live cells via integrins or 
scavenger receptors (Albert et at., 1998a). Previous studies suggested that cross- 
presentation could result from phagocytosis of MHC class I-restricted antigens by 
DCs, which were trafficked into the ER as a result of fusion of phagosomes and the 
ER (Guermonprez et at., 2003; Houde et at., 2003). However, a recent study 
which demonstrates that phagosomes in both DCs and macrophages consist only of 
plasma membrane and do not fuse with the ER at any time point (Touret et at., 
2005), confutes the hypothesis that fusion of phagosomes with the ER is a pathway 
for cross-presentation. In view of this, the phagosome-ER fusion pathway for 
cross-presentation has not been considered in detail in this thesis. 
1.5.2 A röte for bone marrow-derived APCs in the induction of peripheral 
tolerance 
In transgenic murine models of peripheral tolerance utilising RIP to target neo-self 
antigen expression to pancreatic ß cells, it is possible that ß cells, which express 
MHC class I molecules, directly present HA peptides to peripheral T cells. Other 
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studies have demonstrated the capacity of ß cells to present antigen and thus 
induce T cell anergy (Markmann et at., 1988). However, naive CD8' T cells are 
unlikely to be able to enter pancreatic tissues to encounter ß cell presented KdHA 
(Kunkel and Butcher, 2002; Mackay, 1993; Picker, 1994). Other studies have 
indicated that encounter with (3 cell-specific epitopes can occur as a result of 
cross-presentation of such MHC class I-restricted epitopes by populations of short- 
lived bone marrow derived APCs (Kurts et at., 1996). OVA specific T cells (OT-1 T 
cells) undergoing tolerance after adoptive transfer into RIP-mOVA mice, homed to 
lymph nodes which drained OVA expressing tissues. However, when OT-1 T cells 
were transferred into mice which were defective in H-2b presentation of OVA to 
OT-1 cells (lethally irradiated RIP-mOVA mice reconstituted with H-2bml or H-2bme 
mutant bone marrow), OT-1 T cells were not activated to divide (Kurts et at., 
1996). Further studies showed that cross-presentation of Kb-restricted OVA 
peptides in the draining lymph nodes also resulted in the upregulation of Fas 
expression indicating that elimination of OT-1 T cells activated by cross- 
presentation is likely to be due to apoptosis (Kurts et at., 1998). 
Several types of bone-marrow derived APCs could be involved in cross- 
presentation of ß cell-derived epitopes to- naive ß cell specific CD8r T cells: 
macrophages, B cells and DCs. Studies using macrophages show little evidence for 
in vivo cross-presentation of self-peptide and this type of APC does not appear to 
migrate from tissues into lymph nodes (Reviewed in Heath and Carbone, 2001). 
We have recently demonstrated that B cells loaded with self-epitopes are able to 
induce abortive activation self-specific CD8' T cells in vivo (Fraser, JM et at., 
2006. In press). Also B cells can cross-present self-antigens (Ke and Kapp, 1996), 
however this is not thought to be a typical in vivo mechanism. Although B cells 
are known to be potential tolerising APCs (Bennett et at., 1998; Fuchs and 
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Matzinger, 1992), they are not normally found in non-lymphoid tissues. A number 
of studies have revealed that dendritic cells (DCs) in an immature state, have the 
ability to sample antigen in tissue and then on maturation can migrate to lymph 
nodes to present peptide to T cells (Ardavin, 2003; Betz et at., 2002b; 
Chattergoon et at., 2003). Evidence in other models of cross-tolerance 
demonstrate the capacity of subsets of dendritic cells to induce tolerance of CD8' 
T cells specific for aß cell-expressed peripheral antigen (Betz et at., 2002a). 
Based on these findings, this thesis focuses on cross-presentation of self-antigens 
by dendritic cells. The putative roles for cross-presentation by dendritic cells in 
both induction of tolerance amongst self-specific CD8' T cells and generation of 
anti-viral CTL is summarised in Figure 1.5. 
1.5.3 Dendritic cells 
DC are highly specialised antigen presenting cells. Myeloid DC develop from bone 
marrow progenitor cells before circulating in the periphery to patrol tissues. 
Immature DC (iDC) resident in non-lymphoid tissues have a high capacity for 
antigen capture and processing (chapter 1.5.1), however iDC have a relatively 
poor capacity to prime naive T cells (Inaba et at., 1992a; Inaba et at., 1992b). 
Following antigen capture, iDC undergo a process of maturation, leading to a high 
capacity to prime T cells, but an inability to capture antigens (Cella et at., 1997). 
Previous studies have demonstrated expression of a wide range of DC surface 
proteins, such as Fcy receptors (CD16/CD32, (Regnault et at., 1999), DEC-205 
(Swiggard et at., 1995) CD36 (Beiz et at., 2002c), and CD51 (Albert et at., 1998a), 
that may be involved in the uptake of antigenic molecules from cells undergoing 
apoptosis or necrosis. It has been suggested that CD51 and CD36 are crucial in the 
initiation of endocytosis of exogenous antigen by iDCs (Albert et at., 1998a). 
Furthermore, direct "nibbling" of antigens from live cells by DCs involves CD36 
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Figure 1.5: Putative role of cross-presentation in initiation of immunity and 
tolerance induction 
As nave CD8' T cells do not traffic through non-lymphoid tissue, it is likely 
that mechanisms of cross-presentation by DC induce initial activation of CDs"' T 
cells in secondary lymphoid tissue to generate CTL or tolerance induction. 
Peripheral tolerance induction 
A. Tissue-resident DCs acquire self-antigen from peripheral cells. 
B. DCs cross-presenting sample self-antigens traffic to secondary lymphoid 
tissue. 
C. In the absence of CD4` T cell help and maturation of DC, potentially 
auto-reactive CD8` T cells undergo tolerance induction following 
interaction with iDC cross-present self-antigens. 
Initiation of CTL 
D. Tissue-resident DCs acquire viral antigen from infected peripheral cells. 
E. DCs are matured by interaction with PAMP (e. g. through ligation of 
TLRs) as well as processing and cross-presenting viral antigens. Such 
mDC traffic to secondary lymphoid tissue. 
F. Viral-specific CTL are generated from naive CD8' cells in lymphoid 
tissue following interactions with viral antigens cross-presented by 
mDC. Such productive activation may also require help from activated 
CD4+ T cells. 
G. CTL migrate from lymph nodes to sites of inflammation and respond to 
presentation of endogenous antigen by virally infected cells. 
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(Harshyne et at., 2001). However, potentially auto-reactive T cells are tolerised 
in CD36 and CD51 knock-out mice, therefore neither CD36, nor CD51 is individually 
essential for the induction of peripheral self-tolerance (Beiz et at., 2002c; Schutz 
et al., 2002). 
Maturation of iDCs may be induced by various signals such as LPS through TLR4 
ligation, inflammatory cytokines, such as IL-1p, antibody complexes and via 
activated T cells though CD40-CD40L interactions (Banchereau and Steinman, 
1998; Schuurhuis et al., 2000; Visintin et al., 2001; Wesa and Galy, 2001). 
Maturation of DC induced by such signals upregulates co-stimulatory, adhesion and 
MHC class I and class II molecules at the cell surface (Gallucci et al., 1999). 
Matured DC (mDC) also secrete inflammatory cytokines such as IL-12 and IFN-y 
(Macatonia et at., 1993). Following epitope uptake and encounter with maturing 
stimuli, DCs migrate. into lymphoid tissue, where they associate with T cells 
mediating responses specific to the antigen presented (Ingulli et at., 1997). The 
röte of mDCs in the induction of immune responses is well described (Banchereau 
et at., 2000), however more recently studies have indicated that iDCs may play a 
röte in induction of tolerance (Steinman et at., 2003). 
DCs found in lymph nodes or spleen are a heterogeneous population, but express 
high levels of co-stimulatory molecules, such as CD80 (Freeman et at., 2000), 
CD86 (Hathcock et at., 1994), 4-1 BBL (Shuford et at., 1997), CD40 (Vremec and 
Shortman, 1997), and OX40L (Chen et at., 1999), consistent with a mDC phenotype 
subsequent to migration into lymphoid tissue from the periphery. Such DCs 
secrete IL-1ß and IL-12 (de la Salle et at., 1997), which along with co-stimulatory 
molecules contribute to T cell priming. mDCs can activate CD4' and CD8' T cells 
to generate immunity, through expression of co-stimulatory molecules and high 
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levels of MHC class I and II molecules presenting peptides. Unsurprisingly, transfer 
of peptide-pulsed DCs purified from peripheral lymphoid tissue, also results in 
both CD4` and CD8` T cell activation in vivo (Maldonado-Lopez et at., 1999; Ruedl 
and Bachmann, 1999). 
DCs do not only induce an immune response, DCs can also induce T cell deletion. 
Potentially auto-reactive T cells interacting with DCs presenting self-peptides in 
the thymus with high avidity function undergo activation induced cell death 
(Nossal, 1994). Thus, through the acquisition and presentation of self-peptides, 
DCs maintain central T cell tolerance. It has been postulated that DCs can also 
induce tolerance in the periphery (Steinman et al., 2000). It is thought that T cell 
interaction with antigens presented by iDC, which have acquired self-antigens 
from intact tissues in the absence of inflammatory signals and do not mature, 
does not lead to the induction of an autoimmune response, but leads to tolerance. 
For example, transgenic mice which have inducible expression of LCMV-derived 
CTL epitopes on DCs, become tolerant to LCMV after the transgene is switched on. 
Infection of such mice with LCMV after LCMV-epitope expression was induced on 
DCs did not lead to an LCMV-specific CD8` T cell response. In contrast, when 
LCMV-epitope expression was not induced on DCs, LCMV immunisation generated 
LCMV-specific effector CTL (Probst et al., 2003). These data imply that without 
inflammatory signals to mature DCs, peptide presentation by DCs induces T cell 
tolerance. 
In another study, OVA protein was targeted to DCs using an anti-DEC-205 antibody 
(OVA-aDEC-205). As described in chapter 1.4.1, the DEC-205 receptor can 
mediate antigen uptake by DEC-205-expressing DCs, thus OVA/aDEC-205 is 
selectively taken up by DCs and presented. Administration of OVA/aDEC-205 led 
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to proliferation of OT-1 OVA-specific CD8' T cells, but OT-1 did not differentiate 
to effector CTL, instead they were functionally deleted from the peripheral 
repertoire (Bonifaz et at., 2002). This study demonstrates that abortive activation 
leading to tolerance can occur following presentation of peptides by DCs. 
Interestingly, tolerance induction appeared to require iDC, as the administration 
of anti-CD40 antibodies, which initiate DC maturation (Lutz et al., 1999), at the 
same time as OVA/aDEC205 administration, activated OT-1 cells to generate OVA- 
specific CTL effector function (Bonifaz et at., 2002). Such experiments provide in 
vivo data supporting the hypothesis that iDCs generate prepherial tolerance 
induction amongst self-specific CD8' T cells in the steady state, i. e in the absence 
of infection. 
In addition to studies which have examined DC presentation of self-antigen in situ, 
many laboratories have studied the properties of DCs purified from secondary 
lymphoid tissue (Inaba et at., 1992b; Thomas et at., 1993; Thomas and Lipsky, 
1994; Vremec et at., 1992). DCs traffic to lymphoid tissue after antigen encounter 
and maturation, therefore, DCs isolated from lymphoid tissue are unlikely to be 
naive and so unlikely to function as iDCs in tolerance induction. Other 
laboratories have employed cell culture techniques to generate bone marrow- 
derived DC (BMDC) ex vivo to examine their properties (Inaba et at., 1992a; 
Scheicher et at., 1992; Yamaguchi et at., 1997). Such techniques involve the 
culture of bone marrow progenitor cells with granulocyte-macrophage colony 
stimulating factor (GM-CSF) that initiates differentiation to DCs (Lutz et at., 
1999). Although BMDCs generated ex vivo are likely to be immature compared 
with lymphoid-isolated DC, the mechanical manipulation involved in extraction, 
culture and harvest of BMDCs may alter the phenotype of DC to a more mature 
status (Gallucci et at., 1999; Vremec et at., 1992). Despite this, iDC, generated 
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ex vivo have been successfully employed as tolerogenic DCs (Steinman et at., 
2003). Ex vivo-generated iDCs can also be matured to produce mDCs via the 
addition of stimuli including bacterial LPS (Lutz et at., 1999), ligating CD40 on DCs 
with anti-CD40 antibodies (Vecchi et at., 1999) and treatment of iDCs with 
inflammatory cytokines, such as TNF-a (Vecchi et at., 1999). 
mDC generated from ex vivo culture of bone marrow cells, were able to induce 
immune responses in a similar manner to DCs in vivo (Fonteneau et at., 2001). 
Although other studies found that CD4' T cell help was required by DCs to initiate 
full CD8' T cell activation (Keene and Forman, 1982; Lanzavecchia, 1998). In 
addition, other reports have shown that iDCs generated ex vivo also function in a 
similar manner to their natural counterparts in vivo to induce tolerance (reviewed 
in Steinman et at., 2003). In one study, DCs cross-presenting antigens acquired 
from Influenza virus-infected apoptotic cells were co-cultured with HA-specific 
CD8' T cells. Such CD8` T cells proliferated, but did not produce IFN-y (Albert et 
at., 2001). However, co-culture of similar naive HA-specific CD8' T cells with DCs 
in the presence of Influenza-specific CD4' T cells did result in IFN-y production. As 
these CD4' T cells did not produce effector cytokines, it was suggested that ex 
vivo-generated iDCs induced T cell tolerance. While ex vivo-generated DCs were 
matured by CD4' T cells, possibly via CD40-CD40L interactions, thus presentation 
of Influenza-derived peptides by such matured DCs generated productive 
activation of CD8+ T cells (Albert et at., 2001). 
Increasing evidence implicates iDCs in the induction of peripheral tolerance. 
However, iDCs generated ex vivo as well as those examined in vivo, are a 
heterogeneous population with regard to the cell surface phenotypes (Lutz et al., 
1999; Vremec and Shortman, 1997). It has been hypothesised that a 
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phenotypically distinct subset of DCs is responsible for peripheral tolerance 
induction (Beiz et at., 2002b). Data from several experiments have indicated that 
CD8` DCs play an important role in the induction of tolerance. For example, 
adoptive transfer of naive HA-specific T cells into transgenic RAG"" mice, which 
expressed HA under the control of the CD8 promoter, led to the induction of 
peripheral tolerance (Lambolez et at., 2002). As such mice lack CD8' T cells, the 
HA-transgene is only expressed by CD8' DCs, thus in this case peripheral tolerance 
induction must be due to CD8' subset of DCs. In another study, OVA-specific OT-1 
CD8+ T cells underwent tolerance induction in RIP-mOVA mice, which express OVA 
as a self-antigen on pancreatic ß cells, only when BM-APCs were available (Kurts 
et at., 1996). As part of this tolerance induction, OT-1 CD8+ T cells proliferate in 
response to cross-presented antigen in pancreatic lymph nodes (PLN Kurts et at., 
1997b). Further transgenic mice, RIP-YSS mice, were generated to detect any 
trafficking of the OVA transgene. Such mice expressed an hybrid protein (YSS) 
consisting of an OVA peptide (OT-1 cognate peptide) fused to a peptide from 
herpes simplex virus-1 glycoprotein B (gB) OVA, under the control of the RIP 
promoter. Adoptively transferred OT-1 CD8+ T cells proliferated in RIP-YSS PLN 
before being deleted. This tolerance induction process required BM cells. DCs 
were isolated from RIP-YSS PLN and separated into CD8+ and CD8" subsets. Using a 
gB-sensitive hybridoma, the presence of the YSS hybrid protein was detected in 
CD8` DCs and not in CD8" DCs or the non-DC fraction (Beiz et at., 2002a). These 
data imply that CD8+ DCs in the PLN cross-present self-antigens to tolerise ß cell- 
specific CD8+ T cells. 
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1.6 CL4 TcR transgenic CD8+ T cells and the InsHA model of peripheral 
tolerance induction 
Our laboratory utilises H-2d BALB/c InsHA transgenic mice that express the 
haemagglutinin (HA) protein from influenza virus A/PR/8 HINI (PR8) under the 
control of the RIP promoter. The HA transgene is expressed on pancreatic islet 
cells, as detected by histological staining with anti-HA monoclonal antibody, with 
no expression in exocrine pancreatic tissue or thymus or spleen (Lo et at., 1992). 
More recently, RT-PCR confirmed that the expression of HA in InsHA mice was 
limited to pancreatic ß cells (Personal communication with Dr David Morgan). 
InsHA mice are profoundly tolerant to their ß cell-expressed HA and thrive without 
autoimmune pathology (measured up to 14 months): no changes in pancreas 
morphology, no pancreatic infiltrate or insulitis as observed by histology and no 
clinical diabetes as detected by measurement of glucose concentration in urine 
and blood (Lo et at., 1992). When naive InsHA mice are immunised with live 
replicating PR8, no autoimmunity is observed and no insulitis is detected by 
histological examination of pancreas. That this self-tolerance occurs by a 
peripheral mechanism was supported by studies in which lethally irradiated 
thymectomised InsHA mice were reconstituted with bone marrow and thymic 
grafts from conventional non-transgenic mice. Such InsHA mice also remained 
tolerance to HA, even after immunisation with PR8 (Lo et at., 1992). 
InsHA mice had impaired responses to PR8 by both peripheral CD4+ and CD8' T 
cells as compared with non-transgenic control mice (Lo et al., 1992). Although, 
no deficiency in B cell responses against PR8 were observed. In later studies, the 
induction of peripheral tolerance in InsHA mice was demonstrated to be 
associated with the functional loss of CD8' T cells with high avidity to the 
dominant KdHA epitope (Morgan et at., 1998). 
-43- 
Chapter 1: Introduction 
To follow the fate of nave high avidity KdHA specific CD8' T cells during the 
process of peripheral tolerance induction, Clone 4 (CL4) mice, which express a 
transgene for a TcR that recognises the dominant KdHA epitope, were utilised. 
Following adoptive transfer into InsHA mice, naive CL4 CD8' T cells undergo an 
abortive activation in the pancreatic lymph nodes (PLN), before they are 
functionally lost from the repertoire (Morgan et at., 1999a; Morgan et at., 1996). 
Histological examination of pancreata from InsHA mice that received adoptive 
transfer of CL4 CD8' T cells reveals no insulitis or other pathology. This abortive 
activation does not generate Self-tolerance amongst naive Kd-HA specific CL4 TcR 
bearing CD8' T cells is a slow process and is dependent on the number of CL4 cells 
transferred: for example, 102 naive CL4 T cells takes only a few days, whilst 
tolerance induction amongst 104 naive CL4 T cells takes greater than 4 months 
(Morgan et at., 1998). 
Studies showed that peripheral tolerance to self-antigens can occur as a result of 
cross-presentation of MHC class I-restricted epitopes by populations of short-lived 
bone marrow derived APCs (Kurts et at., 1996; Kurts et at., 1998). Similar studies 
were also carried out in our laboratory using InsHA chimeric recipients, which 
were generated by reconstituting irradiated H-2d InsHA mice with T cell depleted 
bone marrow from either conventional non-transgenic BALB/c H-2d (H-2d BM4H-2d 
InsHA) or BALB/k H-2k (H-2k BM-)H-2d InsHA) donors. When CL4 T cells were 
adoptively transferred into these H-2k BM-=H-2d InsHA chimeras no activation of 
CL4 cells was observed in any lymphoid compartment, whereas in the H-2dBM 4H- 
2d InsHA mice abortive activation was seen in the PLN (Fraser and Morgan, 
unpublished data). The data from these experiments suggest that the abortive 
activation of CL4 CD8' T cells following their transfer into InsHA mice is due to the 
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cross-presentation of the dominant KdHA epitope by bone-marrow derived APCs 
rather than by direct presentation of endogenous antigen by HA expressing 0 cells. 
Other studies by Sherman and co-workers have now directly compared the 
properties and phenotype of transferred CL4 CD8' T cells activated in the PLN in 
InsHA mice in the presence (productive activation), or absence (abortive 
activation), of immunisation with PR8 (Hernadez et at, 2001). CL4 CD8' T cells 
that have undergone several rounds of division in the PLN in the absence of PR8, 
show no cytolytic activity in vivo and also can not be stimulated to produce IFN-y. 
Both productively and abortively activated CL4 CD8+ T cells upregulate the 
activation markers CD44 and CD69 but unlike productively activated cells, 
abortively activated CL4 CD8' T cells do not exhibit other hallmarks of effector 
cells: CD25 expression and CD62L downregulation (Cerwenka et al., 1998; 
Hernandez et al., 2001). It was also shown that the partial activation of CL4 in 
InsHA PLN did not lead to normal effector T cells as evidenced by the fact that 
they failed to lyse KdHA peptide-pulsed targets in vivo. Nevertheless CL4 CD8' T 
cells that were activated in the presence of PR8 were able to mediate the 
destruction of these transferred targets (Hernandez et al., 2001). 
CD8' T cells interact with their cognate antigen presented by APCs in the context 
of MHC class I; in an inflammatory cytokine environment, with appropriate co- 
stimulation, this encounter leads to activation of T cells and initiation of an 
immune response. Such productive activation of CD8` T cells and the role of the 
antigen presentation are well understood. However, how interactions between 
self-epitopes and potentially auto-reactive CD8' T cells which lead to peripheral 
tolerance induction occurs is not yet fully understood. In the InsHA model, 
tolerance is a slow process, which appears to be limited by the amount of antigen 
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available (Morgan et at., 1999a). It is unknown whether the limitation in KdHA 
presentation is due to limiting availability of KdHA epitopes or whether this is due 
to restricted numbers of APCs involved in KdHA presentation. Preliminary 
experiments in this study involved transferring various numbers of CL4 CD8' T cells 
into PR8 immunised BALB/c mice or InsHA mice. The data revealed that very low 
amounts of KdHA peptide are available in the PLN of InsHA mice. It was therefore 
of interest to understand how this antigen might be presented to T cells, as 
mimicry of the natural system of KdHA peptide transport and presentation which 
occurs in the InsHA mouse could increase the amount of antigen available for T 
cell encounter. Such increases may aid defining mechanisms of peripheral self- 
tolerance induction amongst CD8' T cells. The breakdown of these mechanisms 
may be important in understanding type 1 diabetes inductions. It is possible that 
such mechanisms of peripheral self-tolerance are also used by tumour cells to 
evade deletion by the immune system. 
It has been suggested that deletion of clonally exhausted T cells following a 
productive infection occurs primarily at the site of activation (Webb et al., 1990). 
CL4 CD8` T cells transferred into PR8-immunised InsHA mice demonstrate 
increasing levels of apoptosis with increasing cycles of cell division, as detected 
by annexin V binding (Hernandez et at., 2001; Koopman et at., 1994). It is also 
claimed that in situ apoptosis accounts for the clearance of adoptively transferred 
CL4 CD8' T cells undergoing tolerance in the PLN of InsHA recipients (Hernandez 
et at., 2001). However, these data are unconvincing as less than 7% of the CL4 
CD8` T cells exhibited annexin V binding. Also, the majority of annexin V-binding 
cells were present amongst the undivided CL4 CD8` T cells and of those cells 
undergoing tolerance induction, the amount of bound annexin V was lower than 
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the positive control. Therefore we suggested that the precise mechanism by 
which HA-specific CD8' T cells are tolerised in InsHA mice is unclear. 
1.7 Research objectives 
The aims of this study are: 
i) To determine how the induction of peripheral tolerance amongst 
abortively activated CD8' T cells encountering self-antigen is 
mediated. 
ii) To examine how abortive activation of CD8` T cells can be mediated. 
iii) To investigate what factors govern how CD8' T cells respond to their 
cognate antigen. 
In order to achieve these aims, experiments were performed to elucidate how 
auto-reactive HA-specific CD8+ T cells were functionally deleted from the 
periphery of InsHA mice. By comparing abortive activation to productive 
activation, the mechanism by which the state of peripheral tolerance is 
maintained in InsHA was more completely understood. The röte that BM-APCs play 
in the initiation of abortive activation was also investigated; in particular the 
possibility of a tolerogenic DC was explored. This work allowed an in vitro model 
of abortive activation amongst CD8' T cells to be established. This research also 
examined a possible method for antigen capture from pancreatic ß cells by APCs. 
Furthermore, CD8' T cells were activated by cross-presented antigens in vitro to 
identify and determine how the balance between abortive and productive 
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2.1 Mice 
2.1.1 Strains 
Transgenic BALB/c InsHA, homozygous for the InsHA transgene and BALB/c CL4 
TcR transgenic mice, heterozygous for the CD8' Clone 4 TcR transgene, were 
utilized as previously described (Morgan et at., 1998; Morgan et at., 1996). 
BALB/c CL4'/' transgenic mice were also bred to express a congenic form of the 
Thyl T cell marker, Thyl. 1 (CD90.1). Congenic B10. D2 Ly5.2 CL4 mice were 
generated by backcrossing B10. D2 Ly5.1 CL4 mice with Ly5.2 B6 mice (a kind gift 
from Dr A. M. Pullen, University of Bristol, UK), for at least 4 generations. B10. D2 
Ly5.1 InsHA mice were also utilised (Lo et at., 1992). 
All transgenic mice, as well as non-transgenic BALB/c mice and B10. D2 mice, were 
bred and housed at the University of Bristol Animal Services Unit and maintained 
under barrier conditions, according to regulations set down by the Home Office. 
All mice used in this study were aged between 6 and 16 weeks. 
2.1.2 Genotyping of mice 
To produce BALB/c Thy1.1''` CL4''' mice, mate BALB/c Thy1.1''' CL4I . mice were 
bred with female BALB/c Thy1.1''` non-transgenic mice and the offspring were 
genotyped to confirm transgene positive mice. Blood was taken by cutting the tail 
vein with a scalpel blade and collected in a tube containing blood buffer (1 x PBS 
supplemented with 5% vol. /vol. FCS (GIBCO BRL, Paisley, UK), 20mM EDTA (Sigma- 
Aldrich, Poole, UK) and 0.08% wt. /vol. NaN3 (Sigma-Aldrich) to prevent clotting. 
Red blood cells were lysed by incubating with FACS Lysis buffer (BD Pharmingen, 
Oxford, UK) for 10 minutes. The cell suspension was typed using flow cytometric 
analyses (as described) using anti-CD8a-FITC and antiVß8.1 /Vß8.2-PE antibodies 
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(BD Pharmingen). CL4 TcR Transgene positive mice were identified as having in 
excess of 90% of their CD8+ peripheral blood lymphocytes expressing a V08 TcR 
(Morgan et al., 1996). 
2.1.4 Immunisation of recipient mice 
Where indicated mice were immunised i. p. with 1200 units of live influenza virus 
A/PR/8/34 HINZ in the form of allantoic fluid in PBS. Virus was produced as 
described below in section 2.3.6. 
2.1.5 Assessment of Diabetes 
Mice in observational groups were tested for the onset of diabetes using Bayer 
Diastix (Bayer Corparation, Germany). Mice diagnosed with glycosuria were re- 
tested two days later by analysis of venous blood using a Gtucotrend 2 blood 
glucose meter with Accu-Chek glucose strips (Roche Molecular Biochemicals, 
Lewes, UK). Diabetes was defined as blood glucose level elevated greater than 14 
mmol/L. 
2.2 Antibodies 
Monoclonal antibodies specific for various murine cell surface markers were used, 
conjugated to either biotin (BIO), or one of five fluorochromes: 1) Fluorescein 
Isothiocyanate (FITC), 2) R-Phycoerythrin (PE), 3) Tricolor (TC), 4) Peridinin 
Chorophyll Protein (PerCP) or 5) Allophycocyanin (Apc). Where biotinylated 
primary antibodies were used, a secondary fluorochrome conjugated streptavidin 
(SA) was used (See appendix 1). 
Anti-mouse Fcylll/II receptor (CD16/32) rat IgG2b antibody (24G2) is secreted by 
the hybridoma cell line 24G2 (Unkeless, 1979). This cell line was cultured in a 
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Celline Bioftask (Integra Biosciences, Letchworth, UK) and the antibody-rich 
supernatant was used to block cell surface FcyIII/II receptors prior to binding 
specific antibodies for both FACS staining and MACS microbead separation. 
2.3 Stock solutions 
2.3.1 Serum 
Foetal Calf Serum (FCS) was purchased from Invitrogen (Paisley, UK) and heat 
inactivated at 56° C for 30 minutes. 
2.3.2 Water 
Double distilled water (ddHZO) was dispensed from a Select water purification 
system (Purlte, Oxford, UK); resisitivity of this water was at least 15 MQ cm. For 
molecular biology using RNA and DNA autoclaved ultra-pure water from an 
Elgastat purification system was used (University of Bristol Department of 
Pathology and Microbiology media services). 
2.3.3 Salt solutions 
Sterile phosphate-buffered saline (PBS) and Tris-Borate-EDTA (TBE) was prepared 
by University of Bristol Department of Pathology and Microbiology media services 
according to standard recipes. 
Hanks' Balanced Salt Solution (HBSS, 5.4 mM KCl (BDH, Poole, UK), 0.3 mM 
Na2HPO4 (BDH), 0.4 mM KH2PO4 (BDH) 137 mM NaCI (Sigma-Aldrich) 5.6 mM D- 
glucose (Sigma-Aldrich) in distilled waster, pH 7.2) supplemented with HEPES- 
bicarbonate buffer (HEPES, 10 mM HEPES (N-(2-Hydroxyethyt)piperazine-N'-(2- 
ethanesulfonic acid; Sigma-Aldrich) and 25mM NaHCO3 (BDH) in distilled water, pH 
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7.2) was used in the isolation of intraepithelial lymphocytes (IEL) and lamina 
propria lymphocytes (LPL). 
FACS staining was carried out using staining buffer (SB, consisting of 5.4mM KCl 
(BDH), 1.3 mM Na2HPO4 (BDH), 0.06 mM MgCL2.6H20 (BDH), 1.3 mM CaCl2.2H2O 
(BDH), 0.06 mM MgSO4 (Sigma-Aldrich), 0.5 mM KHZP04 (BDH), 137 mM NaCl 
(Sigma), 5.6 mM D-glucose (Sigma), 2% vol. /vol. FCS (Invitrogen) and 0.08% 
wt. /vol. NaN3 (Sigma-Aldrich) in distilled water, pH 7.2). Cells-were resuspended 
in FACSFIowl (BD Cytometry Systems, Oxford, UK) prior to acquisition. 
Separation using magnetic cell sorting (MACS) was carried out in MACS buffer (1X 
PBS with 0.5 % wt. /vol. BSA (Sigma-Aldrich) and 5mM EDTA (Sigma-Aldrich). 
2.3.4 Cell culture Media 
Complete tissue culture media consisted of RPMI 1640 without L-glutamine 
(Invitrogen or Sigma-Aldrich) supplemented with 2 mM glutamine (Invitrogen), 50 
U/ml penicillin/ streptomycin (Invitrogen), 0.1 mM 2-mercaptoethanol 
(Invitrogen), and 10% vol. /vol. FCS (Invitrogen). 
2.3.5 Isotonic Percol 
100% percol (Sigma-Aldrich) was made up with 10% vol. /vol. 10X HBSS and 10% 
vol. /vol. 1OX HEPES-bicarbonate buffer to give an isotonic 80% percoll solution in 
ddH20. Various densities of percoll were generated by diluting isotonic 80% 
percoll with HBSS/HEPES solution. 
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2.3.6 Production of Influenza virus A/PR/8. 
PR8 was propagated from a seed virus stock, Influenza virus A/PR/8/34/HINI (LGC, 
Protochem, UK). Fertilised ROSS1 hen eggs (Maurice Millards Ltd, Trowbridge, UK) 
were incubated in a humidified egg turning incubator (Western Incubators Ltd, 
Burnham-on-Crouch, UK) at 37° C for 8 days. The eggs were inoculated with 50 Rl 
of a 1000 HAU/ml PR8 stock solution, avoiding rupture of the allantonic 
membrane. The eggs' shells were seated with beeswax, to maintain internal 
sterility. The eggs were then returned to the egg incubator. After 48 hours the 
embryos were killed by cooling the eggs to 4° C for 2 hours. Then, using sterile 
technique, the eggs were opened and the allantonic fluid aspirated using a 
Pasteur pipette. Debris and red blood cells were pelleted by centrifugation and 
clarified allantollic fluid containing virus was retained. The titre of the virus was 
determined using an haemagglutination assay. Briefly, doubting dilutions of virus 
were incubated in a 96 well plate with chicken RBCs and the 50% 
haemagglutination endpoint recorded. Sterile PBS was added to the allantonic 
fluid to obtain a virus titre of 1200 HA units/ml. Virus was stored at -70° C. 
2.3.7 KdHA peptide 
KdHA cognate peptide, IYSTVASSL, was synthesised using a AMS 422 Multiple 
Peptide Synthesiser (Abimed, Lagenfeld, Germany) to a purity of 95%. Stock 
solutions of KdHA at 100mg/ml in dimethyl suiphoxide (DMSO, Sigma-Aldrich) were 
stored at -70°C until required. Stock solutions were diluted in PBS prior to use. 
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2.4 Cell isolations 
2.4.1 Cell counting 
All cell concentrations were measured using a microscopic counting method. 
Briefly, aliquots of cells were diluted with 0.04% trypan blue solution (Sigma- 
Aldrich) and transferred to a brightline harmocytometer counting chamber (Sigma- 
Aldrich). The haemocytometer was viewed under a medium-power microscope and 
cell number enumerated. Cell viability was assessed by examining trypan blue dye 
exclusion. 
2.4.2 Isolation of lymphocytes from peripheral lymphoid tissue 
Animals were euthanised by cervical dislocation and sterilised with 70% vol. /vol. 
IMS. Lymph nodes or spleen were excised aseptically and placed in sterile 
complete RPMI media. Single cell suspensions were prepared by disrupting in 1 ml 
complete media through 70 µm cell strainers (BD Falcon, Oxford, UK) into 35 mm 
petri dishes using sterile syringe plungers. The cells were harvested into 14 ml 
conical tubes (Greiner Bio-one, Stonehouse, UK) and the petri dishes were washed 
with 10 ml complete media. Cells were petteted by centrifuging at 400g for 5 
minutes and cell debris was discarded in the supernatant. At this point, red blood 
cells were lysed from the splenocyte suspensions by resuspending in 900 µl 
distilled water and mixing for 5 seconds. Lysis of the lymphocytes was stopped by 
adding 100 µl 10X PBS, followed by 10 ml complete media. Debris was removed by 
passing the suspension through a 40 µm cell strainer (BD Falcon). 
2.4.3 Intraepithelial lymphocyte isolation and purification 
Isolation and purification of murine intraepithelial lymphocytes (IEL) was carried 
out according to protocols previously described- (Lefrancois and Lycke, 1997; 
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Muller et at., 2000). Having first removed the fat and Peyer's patches (PP), the 
small intestines were opened longitudinally and cut into 5-10mm sections. The 
intestinal pieces were washed several times in HBSS/HEPES + 2% vol. /vol. FCS to 
remove attached faces. Cells from the epithelial layer, were detached from their 
basement membrane and brought into solution by stirring at 37°C in HBSS/HEPES + 
5% vol. /vol. FCS +2 mM DTT (Sigma-Aldrich) + 0.5 mM EDTA (Sigma-Aldrich) for 30 
minutes. Residual intact gut tissue was removed by decanting first through a 70 
µm cell strainer (BD Falcon) followed by a 40 µm cell strainer (BD Falcon). The 
filtrates were then centrifuged at 300g for 5 minutes and then resuspended in 
HBSS/HEPES + 2% vol. /vol. FCS before being incubated for 30 minutes at 37°C, in 
air with 5% vol. /vol. CO2 in order to stabilise the cells before further enrichment. 
Cell suspensions were centrifuged at 300g for 5 minutes and the pellets 
resuspended in isotonic 44% vol. /vol. Percoll solution (Sigma-Aldrich) and 
underlayed with 67% vol. /vol. isotonic Percoll. Density centrifugation at 800g for 
15 minutes was then used to separate the lymphocyte population from epithelial 
cells. Cells at the interface were aspirated into HBSS/HEPES + 5% vol. /vol. FCS 
and centrifuged at 400g for 10 minutes, in order to dilute the percoll. Cells were 
resuspended in HBSS/HEPES + 5% vol. /vol. FCS for analyses. 
2.4.4 Isolation and purification of lamina propria lymphocytes 
Gut tissue was prepared as described above, first PP and fat were removed and 
the tissue cut into small pieces which were then washed in HBSS/HEPES + 2% 
vol. /vol. FCS. Epithelial cells were removed from the LP by incubating the gut 
pieces in HBSS/HEPES + 2% vol. /vol. FCS +5 mM EDTA (Sigma-Aldrich) at 37° C 
with stirring for 15 minutes. This process was repeated two more times; each 
time the cell suspension was decanted off and replaced with fresh HBSS/HEPES + 
2% vol. /vol. FCS +5 mM EDTA. The pieces of tissue were then washed three times 
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in HBSS/HEPES + 5% vol. /vol. FCS, to remove the EDTA. The lymphocytes were 
then liberated from the LP by digestion with media consisting of HBSS/HEPES + 5% 
vol. /vol. FCS with magnesium and calcium salts (1.3 mM CaCl2 (Sigma-Aldrich), 
0.05 MgCL2 (Sigma-Aldrich) and 0.06 mM MgSO4 (Sigma-Aldrich) + 0.1% vol. /vol. 
wt. /vol. collagenase D (Roche), + 0.002% wt. /vol. DNase I (Sigma-Aldrich). 15 ml 
of this digestion media was added to each group of LP and incubated at 37° C for 
25 minutes in a siliconised (Sigmacoat, Sigma-Aldrich) Erlenmeyer flask with 
vigorous stirring. The supernatant was then collected by decanting through a 70 
µm cell strainer (BD Falcon). The tissue pieces were then returned to their flask 
and another 15 ml of digestion media was added and incubated for a further 
digestion. This procedure was repeated so that in all, three digestion incubations 
were carried out and a total of 45 ml of cell suspension was collected. The cell 
suspension was then passed through a 40µm cell strainer (BD Falcon) before 
centrifugation at 300g for 5 minutes. The cell pellet was resuspended in 10 ml 
HBSS/HEPES + 5% vol. /vol. FCS and was transferred to an FCS coated 14 ml conical 
tube and underlayed with 3 ml FCS. Cells were centrifuged at 300g for 4 minutes 
and the supernatant discarded. The pellet was resuspended in 8 ml of 44% 
vol. /vol. isotonic percol and underlayed- with 67% vol. /vol. isotonic percol. 
Lymphocytes were harvested as for IEL. 
2.4.5 Isolation and purification of intrahepatic lymphocytes 
The mice were euthanised and the abdomen was opened and the hepatic portal 
vein cannulated with a 25G needle. The liver was perfused with 5 ml cold PBS 
using a syringe. The liver was then removed and the gall bladder discarded. The 
liver was cut into pieces and disrupted through a 70 µm cell strainer. The liver 
slurry was collected in 40 ml RPMI 1640 + 5% vol. /vol. FCS and centrifuged at 300g 
for 10 minutes at 4° C, discarding the supernatant containing cell debris. The 
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pellet was resuspended in 10 ml serum-free RPMI 1640 + 0.02% wt. /vol. 
collangenase IV (Sigma-Aldrich) + 0.002% (wt. /vol. ) DNase I (Sigma) per liver and 
transferred to an Erlenmeyer flask and incubated at 37° for 40 minutes with 
stirring at 250 RPM. After digestion, the slurry was divided equally into 10 ml 
aliquots in 50 ml conical tubes and to each of these 30 ml ice-cold serum-free 
RPMI 1640 was added before centrifugation for 3 minutes at 30g, 4° C. The pellet 
containing the larger hepatocytes was then discarded and the supernatant 
containing IHL, Kupffer cells and some hepatocytes, was centrifuged at 300g for 
10 minutes, 40 C and the pellet resuspended in 1.6 ml RPMI 1640 per liver. To 
each tube containing cells in RPMI 1640,2.4 ml 40% wt. /vol. metrizamide (Sigma) 
in PBS was added and gently mixed. IHL were then purified by underlaying with 1 
ml RPMI 1640, followed by centrifuging at 1500g for 20 minutes, 4° C. Cells 
collected from the interfaces were resuspended in 14 ml RPMI 1640 and pelleted 
at 400g for 10 minutes, before counting and resuspending prior to FACS staining 
(Crispe, 1997; Huang and Crispe, 1993; Le Bon et at., 1999). 
2.4.7 Isolation of respiratory tract lymphocytes 
Respiratory tract lymphocytes (RTL) were isolated and purified using a protocol 
based on experience of isolation of IHL with adaptations from RTL procedures 
described by other laboratories (Calder et at., 2004; Khalil and Greenberg, 1989). 
Mice were injected with 200 µl Phenobarbital sodium (a kind gift from Dr C. 
Calder, University of Bristol) and perfused via left ventricle with 10 ml of ice-cold 
PBS supplemented with 10 U/ml heparin (Sigma). Lungs were excised and minced 
into small tissue pieces. This tissue was washed twice with HBSS/HEPES + 2% 
vol. /vol. FCS and tissue pieces were collected by decanting supernatants. Tissues 
were transferred to an Erlenmeyer flask and 15 ml of serum-free RPMI 1640 + 
0.02% wt. /vol. coltagenase IV (Sigma-Aldrich) + 0.002% wt. /vol. DNase I (Sigma- 
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Aldrich) was added. Flasks were incubated at 37°C for 40 minutes with stirring at 
250 RPM. After digestion, the slurry was divided equally into 10 ml aliquots in 50 
ml conical tubes and to each of these 30 ml ice-cold serum-free RPMI 1640 was 
added before centrifugation for 3 minutes at 30g, 4° C. The pellet was discarded 
and the supernatant was centrifuged at 400g for 10 minutes, 4° C. The pellet was 
then resuspended in 1.6 ml RPMI 1640 per 4 lungs. To each tube containing cells 
in RPMI 1640,2.4 ml 40% wt. /vol. metrizamide (Sigma-Aldrich) in PBS was added 
and gently mixed. RTL were then purified by underlaying with 1 ml RPMI 1640, 
followed by centrifuging at 1500g for 20 minutes, 4° C. Cells collected from the 
interfaces were resuspended in 14 ml RPMI 1640 and pelleted at 400g for 10 
minutes, before counting and resuspending prior to FACS staining 
2.4.8 Isolation of vaginal lymphocytes 
Vaginal lymphocytes (VL) were isolated using a method adapted from previously 
described protocols (Roig de and Burgos, 1968; Schon et al., 1999). Vaginal tracts 
excised from euthanised female mice were opened longitudinally and cut into 5- 
10mm sections. The vaginal pieces were washed several times in HBSS/HEPES + 
2% vol. /vol. FCS. The lymphocytes were then liberated from the vaginal 
epithelium and lamina propria by collagenase digestion carried out as described 
for the digestion of small intestine LP. The cell suspension was centrifuged for 3 
minutes at 30g and RT to remove large cell debris. Supernatants were then 
passed through 40µm cell strainers, and cells collected by centrifugation at 500g 
for 5 minutes. The pellet was resuspended in 8 ml of 44% vol. /vol. isotonic percol 
and underlayed with 67% vol. /vol. isotonic percol. This discontinuous gradient 
was then centrifuged at 800g for 15 minutes and VL were harvested as described 
for IEL. 
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2.4.9 Isolation of bone marrow cells 
Bone marrow (BM) was prepared from the long bones and pelvis of 6-8 week old 
mice by first removing the flesh, and cutting off the bone ends then flushing out 
the bone marrow with HBSS + 10% vol. /vol. FCS using a 5m[ syringe with a 25G 
needle. BM cells were disaggregated and counted before centrifugation at 500g 
for 10 minutes. 
2.4.10 Isolation of pancreatic islet /3 cells 
Pancreata were excised from euthanised mice and kept on ice in HBSS/HEPES until 
digestion. Pancreata were digested 4 at a time in HBSS-HEPES supplemented with 
1.5mg/ml collagenase P (Roche) for 8 minutes at 37°C with vigorous agitation. For 
the final 2 minutes of this incubation collagenase P was diluted to 0.75 mg/ml in 
10ml. Digested tissue was washed twice by adding ice cold HBSS/HEPES + 10% 
vol. /vol. FCS, centrifuging at 200g for 1 minute at 4°C and discarding supernatant. 
Tissue slurry was then passed through a metal strainer before two further washes. 
To purify islet cells a discontinuous flotation gradient was used. Cell debris was 
centrifuged at 200g for 1 minute at 4°C and all supernatant was discarded. Pellets 
were resuspended in 8ml 25% wt. /vol. Ficoll Type 400 (Sigma-Aldrich) in 
HBSS/HEPES and 5ml layers of 23% wt. /vol., 20% wt. /vol. and 11% wt. /vol. Ficoll 
Type 400 in HBSS/HEPES were overlayed in descending order. The gradients were 
then centrifuged at 1000g for 10 minutes at 20°C. The 23%, 20% and 11% 
fractions were harvested individually, diluted in HBSS/HEPES + 10% vol. /vol. FCS 
and islet cells were collected by centrifugation at 200g for 1 minute at 4°C. 
Fractions were then pooled and washed twice in HBSS/HEPES and individual islet 
cells were liberated from encapsulated islets by resuspending in HBSS/HEPES 
supplemented with Trypsin-EDTA (0.25% wt. /vol. trypsin and 1mM EDTA, 
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Invitrogen) and incubating for 5 minute at 37°C with shaking. Cells were washed in 
complete media and were centrifuged at 300g for 5 minutes. Pellets were 
resuspended in 2ml complete media, passed through a 70µm strainer (BD Falcon) 
and incubated overnight in 12 well plates at 37°C in a humidified incubator with 5% 
vol. /vol. CO2. Islet cells were washed twice and counted the following day before 
use in culture. 
2.5 Cell purification 
2.5.1 Cell separation using positive selection MACS 
Populations of lymphocytes were resuspended at 1x 107 cells per 80 µl MACS 
buffer. FcyIII/II receptors were blocked by incubating the cells with 10 µl per 1x 
107 cells of 24G2 supernatant for 5 minutes on ice. Lymphocytes were mixed with 
10 µl per 1x 107 cells of MACS magnetic beads conjugated to antibodies (Miltenyi 
Biotec Ltd, Bisley, UK) and incubated on ice. After 20 minutes cells were washed 
with 10 ml ice-cold MACS buffer, then pelleted by centrifugation. LS MACS +ve 
separation columns (Miltenyi Biotec) were placed in MACS midi magnets (Miltenyi 
Biotec) and pre-soaked with 2 ml MACS buffer. Cells were added to the column in 
0.5 ml cold MACS buffer and washed through with a further 2 ml of buffer. The 
elutent was collected and passed over the MACS column one more time. All 
unbound non-magnetic cells were eluted by washing the column through with 10 
ml MACS buffer. Columns were then removed from the magnets and cells bound 
to antibody coupled microbeads collected by passing 5 ml MACS buffer through the 
column using a plunger. 
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2.5.2 Purification of CL4 CD8' T cells 
Single cell suspensions were generated from peripheral lymph nodes (including 
cervicals, axillary, brachial, pancreatic, inguinal, mesenteric and para-aortic) and 
spleens from CL4 transgenic mice. CD8' CL4 T cells were enriched using the 
positive MACS cell separation technique as in chapter 2.5.1, for this procedure 
anti-CD8 microbeads (Miltenyi Biotec) were used. The cells were counted and 
their purity assessed by staining with anti-CD8a-FITC and anti-Vß8-PE antibodies 
and analysing by flow cytometry. Cell purities were determined by FACS analysis. 
2.5.3 Purification of B cells 
Spleens were aseptically excised from freshly euthanised BALB/c mice and single 
cell suspensions in tissue culture media were prepared as above. Anti-B220 
microbeads (Miltenyi Biotec) were used to positively select B cells using the MACS 
cell separation technique described in chapter 2.5.1. 
2.6 Labelling cells with CFSE 
Cells were resuspended at 5x 107 cells per ml in PBS. 1 µl of 5 mM CFSE 
(Molecular Probes Inc., Eugene, Oregon) was added per 2.5 x 107 cells. Cells were 
then incubated at 37°C in the dark. After 10 minutes, 10 ml of cold PBS was 
added to stop the reaction. The cells were then petleted at 400g for 5 minutes 
and resuspended in PBS (Lyons et at., 2001). Approximately 5x 104 cells were 
removed and analysed by FACS to test for CFSE incorporation. 
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2.7 Adoptive transfer of CD8+ CL4 cells 
MACS purified CD8' CL4 T cells were adoptively transferred into recipient mice by 
injection into the tail vein. 5-10 x 106 cells were injected into each recipient 
mouse in 200 µl PBS. 
2.8 Production of antigen presenting cells 
2.8.1 Whole splenocytes 
Sptenocytes from conventional BALB/c non-transgenic mice were prepared by 
disruption of intact spleens using syringe plungers and 40 µm cell strainers. 
Erythrocytes were lysed by a5 second incubation in ice-cold distilled water. 
2.8.2 Naive and activated B cells 
Naive B cells were enriched from splenocytes by MACS, as described in chapter 
2.5.3, and used as APCs or further manipulated. To produce activated B cells, 
naive B cells were resuspended in complete media supplemented with 7pg/ml 
dextran sulphate (Sigma-Aldrich) and 25 pg/ml LPS (Sigma) were incubated for 72 
hours in a humidified incubator at 37° C, 5% vol. /vol. CO2. Cells were then 
washed three times with complete media and used in culture. 
2.8.3 Bone marrow-derived dendritic cells 
Bone marrow (BM) cells were harvested from BALB/c mice as described above. 
Cells were passed through a 40µm cell strainer (BD Falcon) and were washed twice 
in complete media and centrifuged at 500g for 10 minutes. Macrophages were then 
depleted as follows: BM cells were resuspended in 20mi complete media, 
transferred in a tissue culture flask (Corning, NY, USA) and cultured in a humidified 
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incubator for two hours at 37°C with 5% vol. /vol. CO2. Supernatants were then 
removed, leaving behind adherent cells and centrifuged at 500g for 10 minutes. 
Pellets were resuspended in complete media supplemented with 25 ng/ml GM-CSF 
(produced as described below) at a concentration of 0.4 x 106 BM cells per ml. 5ml 
of cell suspension was placed per well of 6-well tissue culture plates (Corning). 
Plates were incubated in a humidified incubator for 10 days at 37°C with 5% 
vol. /vol. CO2. On days 3,6 and 8,2ml of media was removed from each well and 
replaced with 2ml of fresh complete media supplemented with 25 ng/ml GM-CSF. 
To generate matured bone marrow-derived DC (BMDC): LPS (from E. coli 026: B6, 
Sigma-Aldrich) was added to give a final concentration of 1pg/ml LPS to some wells 
for the final 18 hours of culture. On day 10 non-adherent cells were harvested with 
a Pasteur pipette. DCs were then enumerated and a sample was examined by flow 
cytometry for purity and expression of markers of maturity/activation. BMDC were 
then washed three times and used for co-culture or adoptive transfer. 
2.8.4 Irradiation of APCs 
APCs were resuspended in 14 ml complete media and irradiated with 3000 RADs 
using a 137Cs source in a Gamma Irradiation unit RX30/55 (Gravatom Projects, 
Gosport, UK). Subsequent to irradiation, cells were washed once in complete 
media. 
2.8.5 Pulsing cells with KdHA peptide 
APCs were resuspended in 1 ml complete media and Kd-HA peptide was added to 
give required concentration. Cells were then incubated in a humidified incubator 
at 37° C, 5% vol. /vol. CO2 for one hour. Unbound peptide was then removed by 
washing three times with 12 ml complete media. Cells were pelleted by 
centrifugation at 400g for 5 minutes and resuspended as necessary. Unputsed 
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cells were treated in the same way, minus the addition of peptide. In certain 
experiments, excess peptide was not washed off, rather it was added directly to 
the co-cultures and left in for the duration of the assay. 
2.8.6 Treatment of APCs with cytochalasin D 
Populations of APCs were incubated in 1 ml complete media supplemented 1µg/ml 
cytochalasin D (CCD, Sigma-Aldrich) for 1 hour in a humidified incubator at 37°C 
with 5% vo. I/vol. CO2. CCD-treated APCs were then washed -three times in 
complete media prior to cell culture. This step was carried out concurrently with 
any peptide-pulsing step. 
2.8.7 Treatment of APCs with blocking antibodies 
APCs were resuspended at appropriate concentration for final culture and blocking 
antibodies added at the correct concentrations (see Appendix 2). Cell suspensions 
were incubated for 30 minutes in a humidified incubator at 37°C with 5% vol. /vol. 
CO2. Co-cultures were then set up and the antibodies remained present throughout 
the duration of the assay. 
2.9 In vitro cell culture 
2.9.1 Culture of P815 target cells 
P815 mastocytoma cells were maintained in complete media in a humidified 
incubator at 37°C with 5% vol. /vol. CO2. Cells were passaged 24 hours prior to 
assay. 
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2.9.2 Production of GM-CSF 
GM-CSF secreting X63 cells, a kind gift from Dr. Franca Ronchese (Malaghan 
Institute of Medical Research, Wellington School of Medicine, New Zealand) were 
cultured in complete media in a humidified incubator at 37°C with 5% vol/vol CO2. 
GM-CSF-containing supernatant was harvested from the X63 cells 6 days following 
final passage. Cells were removed by centrifugation (10 minutes, 300g) and 
supernatant was sterilised by filtration (0.22{ßm PES membrane Stericup, Millipore, 
Watford, UK). GM-CSF concentration was determined by ELISA (as described 
below) and stock solutions were diluted in complete media. Aliquots were stored at 
-20°C prior to use. 
2.9.3 D10 CD4' clone cells 
D10 cells, Th2 polarised CD4` T cell clones specific for conalbumin, (a kind gift 
from Dr. F. S. Wong, Department of Pathology and Microbiology, University of 
Bristol) were grown for 12 days in complete media supplemented with 10% T cell 
growth factor (IL-2 containing supernatant from stimulation of rat splenocytes 
with ConA and 10 pg/ml conalbumin (Sigma-Aldrich). On days 1 and 7 cells were 
fed with 6x 106 /ml irradiated B10. BR murine splenocytes (a kind gift of Dr A. M. 
Pullen, Department of Pathology and Microbiology, University of Bristol). On day 
12, D10 cells were stimulated in complete media with the addition of 250 ng/ml 
lonomycin (Sigma-Aldrich) and 10 ng/ml PMA (Sigma-aldrich) for 5 hours. Cell 
suspensions were then centrifuged at 300g for 5 minutes at 4°C and supernantants 
were collected and stored at -20°C. Cells were resuspended in MACS buffer and 
CD4` T cells were enriched by MACS isolation (as previously described), using anti- 
CD4 microbeads (Miltenyi Biotech). 
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2.9.4 Production of activated CL4 T cells 
CL4 CD8+ T cells were prepared as described in chapter 2.5.2 and resuspended at 
1x 106 cells/ml in sterile complete media. Cells were plated out into 24 well 
tissue culture plates at 1 ml per well. These T cells were co-cultured with 
homologous, irradiated KdHA peptide-pulsed splenocytes prepared as described 
above (2.8.5) and resuspended at 6x 106 cells/ml. Homologous splenocytes were 
also left unpulsed and resuspended at 6x 106 cells/ml. 1 ml of splenocytes was 
added to each well of CL4 cells. Cultures were maintained in a humidified 
incubator at 37° C, 5% vol. /vol. CO2 for 1-7 days, before harvesting with a 
Pasteur pipette. 
2.9.5 Experimental co-culture 
T cells and APCs were co-cultured in 200pl/well complete media in 96-well `U'- 
bottomed plates (Corning). Cultures were maintained in a humidified incubator 
containing 5% vol. /vol. CO2 at 37° C. 
2.10 In vitro analysis of cell function 
2.10.1 Assay of cell proliferation 
APCs were prepared as described in chapter 2.8 and treated accordingly 
depending on the nature of the experiment and co-cultured with responder CL4 
CD8' T cells at a ratio of 1: 1 in triplicate wells. 
Cultures were maintained in a humidified incubator at 37°C, 5% vol. /vol. CO2 for 
48 hours. For the final 8 hours of culture 1 µCi/well 3H-thymidine (Amershan Life 
Sciences, Little Chalfont, UK), in 25 µl complete media was added. Cells were 
harvested onto glass fibre filter mats (Cox Scientific, Kettering, UK) using a 24 
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well harvester (Skatron, Lier, Norway) and seated into sample bags (Wallac-0y, 
Turku, Finland) with 3 ml Betaplate Scint (Wallac-0y). 3H-thymidine incorporation 
was deterimed using a 1450 Microbeta liquid scintillation counter with Microbeta 
for Windows 2.7 (Wallac-0y). Data was analysed and graphs plotted using 
Graphpad Prism (GraphPad Software, San Diego, CA, USA). 
2.10.2 Cellular cytotoxicity assay 
Target P815 cells at a concentration of 1x 106 cells/ml were radioactively 
labelled by adding 100 µCi 51Chromium to 1 ml aliquots of cell suspension, in the 
form of sodium chromate (Amersham Life Sciences) and incubating at 37°C for two 
hours. Concurrently, target cells were pulsed with KdHA peptide or left unpulsed. 
Subsequent to this incubation, cells were washed three times in complete media 
and collected by centrifugation at 300g for 5 minutes. 1x 104 cells target cells 
were transferred in 100pt complete media to a 96 well 'U'-bottomed plate. 
Effector cells were then added in 100pt complete media at numbers to give a 
range of effector: target cell ratios of between 30: 1 - 0.1: 1. Control wells were 
also set up without effector cells, whereby 100pt complete media was added. 
Further wells were prepared to control for differences in labelling between target 
cell subsets: to these wells 50pt complete media and 50p1 25% vol. /vol. HCt (BDH) 
in dH2O were added to target cells to give maximum cell lysis. All experimental 
conditions were set up in duplicate. Plates were incubated in a humidified 
incubator at 37°C, 5% vol. /vol. CO2 for 16 hours. Plates were then centrifuged at 
300g for 5 minutes and 50pl of supernatant transferred from each well to 
scintillation sample plates (Wallac-0y). 150pt of Ultima Gold LLT scintillant fluid 
(Perkin-Elmer, Monza, Italy) was further added to each well of the sample plates 
and the sample plates were sealed with Top Seal film (Perkin-Elmer), before 
vortexing at low speed for 5 minutes. Sample plates were transferred to cassettes 
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and scintillation recorded using a 1450- Microbeta liquid scintillation counter with 
Microbeta for Windows 2.7 (Wallac-0y). Data was analysed and graphs plotted 
using Graphpad Prism. 
2.11 FACS staining 
2.11.1 Cell surface staining 
Phenotypic FACS analyses of murine lymphocyte cell suspensions generated from 
IEL, IHL, LPL, PerLN, PLN, MLN or spleens was carried out using fluorescently- 
labelled antibodies. Cell suspensions were counted using a haemocytometer 
(Sigma-Aldrich), and then centrifuged at 400g for 5 minutes. The cell pellets were 
resuspended in staining buffer (SB) and adjusted to between 1x 106 and 1x 107 
cells/200µl. 200 µl of cells were placed in each required welt of a 96 welt plate; 
cells were centrifuged to pellet at 500g for 3 minutes at 4°C. Supernatants were 
removed and anti-CD16/32 mAb (24G2) was added to each welt to block Fc1III/II 
receptors. After 8 minutes in the dark, fluorochrome-conjugated mAbs or 
biotinylated mAbs were added in 50 µl SB. The plate was then incubated at 4°C in 
the dark for 15 minutes, before two washes with SB to remove unbound mAbs. In 
the first wash 150 µt SB was added to each welt before centrifuging at 500g for 3 
minutes at 4°C, supernatants were discarded and plates gently vortexed to loosen 
cells. 200 µl SB was added to each well and the plates centrifuged again at 500g 
for 3 minutes at 4°C, before discarding supernatants and vortexing. 
In the case of biotin-conjugated anti-mouse antibodies, secondary staining with 
fluorochrome-conjugated SA was necessary, and the washes were repeated. The 
cells were finally resuspended in 200 µl of FACSFlow" (BD Cytometry systems) 
before transfer into 1.2 ml titre tubes (Greiner Bio One). The cell concentration 
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was then adjusted with FACSFlowTM to give a cell concentration of approximately 1 
x 107/ml. 
2.11.2 Intracellular cytokine staining 
Examination of the ability of lymphocytes isolated from various tissues to produce 
IFN-y when stimulated by KdHA peptide was carried out as follows. Freshly 
purified lymphocytes were incubated in a humidified incubator at 37° C, 5% 
vol. /vol. CO2 for three hours in complete media supplemented with 1 µl/ml 
GolgiPlug (BD Pharmingen) and 1 µM KdHA peptide. This incubation was-carried 
out in 200 µl/well in 96-welt plates (BD Falcon) at a cell concentration of 2x 106 
cells/mt. Celts were then washed by centrifugation at 400g for 5 minutes at 4°C 
then discarding supernatants, followed by two further washes with 200 µl/welt SB, 
centrifuging at 400g for 5 minutes at 4°C and removing supernatants between 
each wash. Staining for cell surface markers was then carried out as described 
above. 
To examine the intracellular production of proteins, the cell surface stains were 
fixed and the cell membranes permeabilised by incubating suspensions in 100 
µl/well BD Cytofix/CytoPerm (BD Pharmingen) on ice for 15 minutes. Cells were 
then washed twice: in the first wash 100 µl BD Perm/Wash solution (BD 
Pharmingen) was added to each well before centrifuging at 500g for 3 minutes at 
4°C, supernatants were discarded and plates gently vortexed to loosen cells. 200 
[tl BD Perm/Wash solution was then added to each welt and the plates centrifuged 
again at 500g for 3 minutes at 4°C, before discarding supernatants and vortexing. 
Intracellular staining was then carried out using APC-conjugated anti-IFN-y 
antibody in 50 µl BD Perm/Wash solution for 15 minutes at 4°C. Then cells were 
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washed twice, as before, in BD Perm/Wash solution and resuspended in 200 
µl/well SB and stored at 4°C in the dark prior to acquisition. 
2.11.3 FACS acquisition and analyses 
Antibody-stained cells were acquired using a FACScalibur® flow cytometer, with 
CELLQuest software (BD Cytometry systems). All subsequent analysis of data was 
carried out using FlowJo" software (Tree Star Inc, San Carlos, CA, USA). 
2.12 Cytokine quantification by Enzyme-Linked ImmunoSorbant Assay 
Supernatants (100 pl/well) were removed from co-cultures and stored at -20°C 
until analysis by Enzyme-Linked ImmunoSorbant Assay (ELISA). 96 well 
ImmunoSorb plates (Nunc) were incubated with 50 pt carbonate coating buffer (15 
mM Na2CO3,35 mM NaHCO3 in ddH2O) containing anti-cytokine capture antibody 
(Appendix 3) for 16 hours at 4°C. Plates were then washed by aspirating 
remaining buffer then flooding each well with ELISA wash buffer (PBS 
supplemented with 0.05% vol. /vol. Tween 20; Sigma-Aldrich) and removing this 
wash buffer. The washing steps were repeated twice. Plates were then 
incubated with 200 Nl/well ELISA blocking buffer (PBS with 1% wt. /vol. BSA; 
Sigma-Aldrich) in a humidified incubator for 1 hour at 37°C. Plates were then 
washed three times, as above. 100 µl/well of sample or ELISA blocking buffer 
containing the cytokine standard (appendix 3) were added per well. All wells 
were set up in duplicate. Plates were incubated in a humidified incubator for 4 
hours at 37°C, before washing three times. 100 p1 secondary anti-cytokine 
antibody (appendix 3) diluted in ELISA blocking buffer was added to each well and 
plates were then incubated for 1 hour at room temperature. After a further three 
washes, 100 pt ELISA blocking buffer containing 0.5% vol. /vol. ExtrAvidin 
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peroxidase (Sigma-Aldrich) was added to each well and plates were incubated for 
30 minutes at room temperature. Plates were then washed three times and 
developed by adding 100 pl/well substrate solution (100 ng/ml 
33'58'tetramethylbenzidine, 0.03% vol. /vol. H202,0.05M Na2HPO4,0.025M citric 
acid (all from Sigma-Aldrich) in ddH2O). After 2-5 minutes, reactions were 
stopped by adding 100 pl/well 2M H2SO4- Plates were analysed using a model 3550 
microplate reader (BioRad, CA, USA) with Microplate Manager software (BioRad) at 
a wavelength of 450nm, with reference to 590nm. Data was analysed and graphs 
plotted using Graphpad Prism. 
2.13 Analysis of mRNA production 
2.13.1 Isolation of mRNA from cell suspensions 
RNA was extracted from Clone 4T cells as follows: Cells were harvested from co- 
cultures and CD8' T cells were isolated by MACS enrichement as described in 
chapter 2.5.2. CD8' T cells were lysed by adding 1ml Trizol (Invitrogen) for up to 
5x 107 cells and were transferred to 1.5 ml eppendorf tubes. Samples were 
stored for up to 1 month at -70°C prior to total RNA extraction. 
After thawing, samples were vortexed and incubated at room temperature for 5 
minutes, allowing complete nucleoprotein disassociation. 0.2 ml chloroform 
(Sigma-Aldrich) was then added to each tube. Samples were vortexed and 
allowed to stand for 10 minutes on ice before centrifugation at 12000g for 15 
minutes at 4°C. The upper, aqueous layer, containing RNA, was removed from 
resulting phased mixture and was transferred to sterile 1.5 ml eppendorf tubes. 
RNA was then precipitated by the addition of 500 pl/tube propan-2-ol (Sigma- 
Aldrich), vortexing and incubation for 10 minutes at room temperature. Tubes 
were centrifuged at 12000g for 10 minutes at 4°C and supernantants discarded. 
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The pellets of precipitated RNA were then washed by resuspending in 1 ml 75% 
vol. /vol. Ethanol in dH2O and centrifuged at 7500g for 5 minutes at 4°C. 
Supernatants were discarded and pellets air-dried, before resuspending in 100 pt 
ddH2O. RNA concentration and purity was then determined by spectrophotometry 
using an Ultraspec 3000 Pro (Pharmcia Biotech, Little Chalfont, UK), measuring 
absorbance at 260nm and 240nm. Samples were then standardised by dilution 
with ddH2O to give the same total RNA concentration. RNA samples were 
subsequently stored at -70°C until use. 
2.13.2 Production of cDNA from mRNA 
cDNA was generated from mRNA extracted as above using an Invitrogen 
SuperScript III First-Strand Synthesis kit, according to the manufacturer's 
instructions as follows: 3 pg total RNA was transferred to a 0.2 ml thin wall PCR 
tube (ABGene) containing 2.5 pM Oligo(dT)20i 0.5 mM dNTP mix in ddHZO, total 
volume was then brought up to 10 pl. Tubes were incubated at 65°C for 5 minutes 
followed by 1 minute on ice. Then 10 hl of master mix of reverse transcripase 
enzyme (RT) in buffer was added (200 U RT, 40 U RNaseOUT, 20 mM DTT, 10 mM 
MgCL2,40mM Tris-HCL and 100mM KCl in ddH20) to each tube. Tubes were mixed 
and incubated at 50°C for 50 minutes. Reactions were then terminated by 
incubation at 85°C for 5 minutes. Any remaining RNA was removed by incubation 
at 37°C for 20 minutes with 2U E. coli RNase H. cDNA was stored- at -20°C until 
required. 
2.13.3 Amplification of DNA by polymerase chain reaction 
In order to ascertain the presence of specific mRNA, cDNA, transcribed from mRNA 
as above, was subjected to polymerase chain reactions (PCR) in order to amplify 
genes of interest. For each gene examined, primer pairs, reaction contents and 
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PCR programs employed are detailed in appendix 4. Reactions products were 
obtained in 0.2 ml thin wall PCR tubes in a PTC-200 DNA engine Peltier thermal 
cycler (MJ Research, Waltham, USA). PCR products were stored at 4°C, until 
required. 
2.13.4 Visualisation of PCR products by gel electrophoresis 
10 pt of PCR product were mixed with 6x Orange G loading buffer (15% wt. /vol. 
Ficoll (Sigma) with 2mg/ml Orange G (Sigma) in ddHZO) and loaded onto a 1% 
wt. /vol. agrose (Sigma-Aldrich) gel in TBE buffer containing 0.5 lag/ml ethidium 
bromide (Sigma-Aldrich). Gets were subject to electrophoresis at 100V in a 
horizontal gel tank (FisherBrand) for 1 hour in TBE running buffer. Gets were then 
visualised on a UV transilluminator (Uvitec Ltd, Cambridge, UK) and photographed 
using a Uvisave digital get documenter (Uvitec). Images were prepared using 
Photoshop CS (Adobe, CA, USA) 
2.14 Generation of bone marrow chimeras 
Mice were lethally irradiated with 1000 RADS using a Gamma Irradiation unit 
RX30/55 (Gravatom Projects) and rested for 24 hours before bone marrow 
reconstitution. Bone marrow cells were prepared as above and resuspended at 2x 
108/ml in HBSS + 10% vol. /vol. FCS and 5 µl/ml purified Thyl antibodies anti- 
Thyl. 1 and anti-Thyl. 2 produced by HO. 22.1 and J1. J20 hybridoma cell lines 
respectively) were added as appropriate to the congenic background of donor 
cells. Cells were incubated on ice for 1 hour, so that the antibody bound to any 
mature T cells. Cells were then washed in HBSS and centrifuged for 5 minutes at 
500g. Cells were resuspended in 5x 107 cells/ml low-tox-M rabbit complement 
(Cedarlane, Ontario, Canada), reconstituted with 90% vot, /vol. HBSS, 10% 
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vol. /vol. ddH2O. After incubation at 37°C for 1 hour, cells were washed three 
times in PBS and finally resuspended at 1x 108/ml. 200 d of bone marrow cell 
suspension was injected into each irradiated mouse. Mice were rested for at least 
12 weeks to allow bone marrow reconstitution and analysed by FACS staining of 
peripheral blood lymphocytes for CD4,, CD8 and B220. 
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3.1 Introduction 
CD8' T cells encountering the same cognate antigen can mount opposing 
responses. For example, when CL4 CD8' T cells, which have high avidity for the 
dominant HA epitope presented by the MHC class I molecule Kd, interact with BM- 
APCs presenting self-epitopes in InsHA PLN, they undergo an abortive activation 
which leads to the induction of peripheral tolerance (Morgan et at., 1999a). 
However, when CL4 CD8' T cells respond to the same epitope seen as non-self in 
PR8-immunised mice, they undergo productive activation and the formation of 
effector CTL (Lo et at., 1992). A previous study has already defined some of the 
phenotypic differences between abortive and productive activation (Hernandez et 
at., 2001). However, in this study productive activation was examined amongst 
CL4 CD8+ T cells in the PLN of PR8-immunised InsHA mice; under such 
circumstances, the expression of HA as both a self-antigen and as a viral antigen 
in the same host could confound characterisation of productive activation. Thus, 
in this chapter we have carried out a more detailed comparison of the phenotype 
and function of CL4 CD8' T cells proliferating in PLN of InsHA mice (abortive 
activation) with CL4 CD8' T cells in the PLN of PR8-immunised non-transgenic 
BALB/c mice (productive activation). Such data will allow us to evaluate in vitro, 
as well as in vivo, whether a response by CL4 CD8' T cells is abortive or 
productive. Importantly, we utilise the set of parameters for abortive versus 
productive activation we define in this chapter to examine the consequences of 
CL4 CD8' T cell interactions with DCs in vitro and in vivo in chapter 5b. 
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3.2 Preparation of naive CL4 CD8` T cells 
A high proportion of the peripheral T cell repertoire of CL4 TcR transgenic mice 
express the Val0 Vß8.2 CL4 TcR (Morgan et at., 1996). However, as such mice are 
recombinase activation gene (RAG) sufficient, there is not complete allelic 
exclusion of other TcR a and ß chains during intrathymic T cell maturation 
(Morgan et at., 1999a). Therefore, T cells from CL4 transgenic mice must be 
enriched prior to experimentation to remove unwanted CD4` T cells, B cells and 
innate immune cells. 
Many methods of T cell purification from lymphoid cells suspensions have been 
described: T cells may be selected by non-adherence to nylon wool (Eisen et at., 
1972), or by negative selection. Negative selection removes unwanted cells 
identified by antibodies against markers present on the surface of unwanted cells, 
leaving enriched T cell, populations. Negative selection can be achieved by 
complement depletion (Usinger and Splitter, 1980), flow cytometric cell sorting 
using ftuorochrome-conjugated antibodies (Herzenberg et at., 1976), density 
centrifugation using antibodies conjugated to dense particles or excluding cells 
bound to antibody-coated ferrous beads with strong magnetic fields (Kemshead et 
at., 1986). A major drawback with negative selection methods is that to deplete 
all unwanted cells, antibodies must be selected that identify all unwanted cells, 
but not those cells that are required. It is unlikely that all unwanted can be 
removed by negative selection. Also, as these techniques tend to involve the loss 
of many of the required cells, it is possible that the composition of the enriched 
population may be altered. Antibody-mediated purification techniques can also 
be carried out to positively select cells of choice (Gaudernack et al., 1986). 
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Positive enrichment of CD8` T cells using ferrous bead-conjugated antibodies 
(Magnetic activated cell sorting; MACS) was chosen to enrich CL4 CD8+ T cells as it 
gives greater purity. This protocol relies on incubating lymphoid cell suspensions 
from CL4 mice with magnetic beads conjugated to anti-CD8 antibodies, before 
they are passed through columns containing a ferrous matrix held in a strong 
magnetic field. In this way all CD8" cells, which would not be bound by antibody, 
pass through the column. CD8+ T cells are retained in the column and can be 
eluted after removal of the magnetic field. Positive MACS enrichment typically 
gave lymphocyte populations that were greater than 95% Vß8+ CL4 CD8+ T cells 
(Fig. 3.1A). Individual TcR transgenic CL4 mice yielded 1.5-2.5 x 107 Vß8' CL4 
CD8+ T cells using this method (data not shown). 
It is possible that any anti-CD8 antibodies remaining bound after positive 
enrichment may affect the activity of CL4 CD8' T cells. Reports have 
demonstrated that ligation of T cell co-receptors with antibodies can result in T 
cell proliferation (Campbell et at., 2000; Milia et at., 1997). As we wished to 
study the responses of naive CD8' T cells, it was important to test whether or not 
positive enrichment by this method affects the ability of CL4 CD8+ T cells to 
become activated and proliferate in vitro following interaction with cognate 
peptide as compared with naive CL4 CD8' T cells. Enriched CL4 CD8' T cells were 
labelled with the intracellular dye CFSE, to allow any division by the CL4 CD8' T 
cells to be tracked using flow cytometry (Morgan et at., 1999a). CFSE-labelled 
CL4 CD8' T cells were co-cultured with syngeneic irradiated splenocytes for 72 
hours and were then harvested and examined for proliferation. Following co- 
I 
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Figure 3.1: Enrichment by CD8 positive MACS selection does not activate CL4 
CD8` T cells 
Lymph node cells were prepared from CL4 mice. Red blood cells were lysed with 
deionised water. Unpurified cell samples were taken for flow cytometric analysis. 
The remaining cells were purified using positive MACS enrichment with anti-CD8 
antibody conjugated magnetic beads. To test CL4 CD8` T cell purity, these cells 
were stained with anti-CD8a and anti-Vß8 antibodies and were analysed by Flow 
cytometry. 10,000 events were collected for each sample. 
Panel A depicts CD8 and V08 expression by unpurified CL4 LN cells (left) and 
MACS-enriched CL4 cells (right). These plots are representative of at least four 
independent experiments. 
Enriched CL4 CD8`T cells were labelled with CFSE and a sample was taken for flow 
cytometric analysis. 1x 106 CFSE-labelled cells were then mixed with either 6x 
106 irradiated splenocytes that were either unpulsed or pulsed with KdHA peptide. 
After 72 hours cells were stained with anti-Thyl. 1 antibodies harvested analysed 
by FACS. 
Panel B shows flow cytometric analysis of Thy. 1.1' gated cells: naive CL4 CD8' T 
cells (top), similar cells co-cultured with unpulsed splenocytes for 72 hours 
(centre) and CL4 CD8' T cells co-cultured with KdHA-pulsed splenocytes for 72 
hours (bottom). Plots on the left side, show FSc/SSc properties of such cells. 
Gates indicate the proportions of small (naive) and larger (activated) 
lymphocytes. The right hand side demonstrates the level of CFSE amongst Thyl. 1' 
cells. 
These plots are representative of three independent experiments. 
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culture, a reduction in CFSE fluorescence was observed amongst CL4 CD8' T cells 
when compared to the initial CFSE labelling level (Fig. 3.1 B). It has been 
previously reported that a gradual diminishment of CFSE fluorescence occurs 
during co-culture due to photobleaching (Weston and Parish, 1990). Standard 
assays using thymidine incorporation to measure proliferation demonstrated such 
co-cultured CL4 CD8+ T cells did not proliferate (data not shown). Importantly, 
positively selected CL4 CD8' T cells co-cultured with unpulsed splenocytes do not 
increase in size (Fig. 3.1 B). 
To determine whether or not positive MACS selection altered the responses of CL4 
CD8+ T cells, enriched cell populations were CFSE-labelled and co-cultured with 
syngeneic irradiated splenocytes that had been pulsed with KdHA peptide, the 
cognate peptide for the CL4 TcR. All enriched CL-4 CD8' T cells underwent many 
rounds of division (Fig. 3.1B) and increased in both size and granularity, as 
evidenced by increases in both FSc and SSc (Fig. 3.1 B). These data suggested that 
positive enrichment did not appear to alter CL4 CD8' T cell responses. 
3.3 Expression of activation markers by abortively activated CL4 CD8' T 
cells 
The activation status of CD8' T cells may be determined by examining of the 
expression of certain cell surface molecules (Cerwenka et al., 1998; Croft et al., 
1994). It has been shown that the expression of many different molecules are 
associated with T cell activation and effector function for both CD4' and CD8' T 
cells (Hernandez et al., 2001; Lefrancois, 1991; Linton et al., 1997; Sprent and 
Webb, 1987; Yamanouchi et al., 1998). Abortively activated CL4 CD8' T cells 
differ in their effector function from productively activated CL4 CD8' T cells, 
therefore it is likely these differences correlate with differences in cell surface 
-80- 
Chapter 3: Abortive versus productive activation of CL4 CD8' T cells 
phenotype. The importance of such activation molecules varies from strain to 
strain and for different activation conditions (Budd et at., 1987). In order to 
determine activation molecules associated with CL4 CD8' T cell activation, CFSE- 
labelled purified CL4 CD8` T cells were co-cultured with syngenic irradiated 
splenocytes, either unpulsed or pulsed with KdHA peptide as APCs. After 72 hours 
the expression of activation molecules amongst both populations were examined 
by flow cytometry. 
CL4 CD8` T cells co-cultured with unpulsed splenocytes did not divide, as shown by 
the maintenance of CFSE fluorescence (Fig. 3.2). Plots depicting selected 
activation molecules are shown in Figure 3.2 and the expression profile of other 
cell surface markers is summarised in Table 3.1. Our findings correlate with the 
previous cell surface characterisation carried out by Sherman and co-workers of in 
vivo activated CL4 CD8` T cells (Hernandez et at., 2001) and provide a more 
comprehensive study examining further molecules associated with activation, 
adhesion and migration of T cells. CL4 CD8+ T cells co-cultured with unpulsed 
splenocytes do not express CD25, or CD69 (Fig. 3.2 and Table 3.1). Expression of 
CD62L, an adhesion molecule 'involved in nave T cell recirculation, was 
maintained at high levels. In comparison with freshly isolated CL4 CD8' T cells, 
CL4 CD8+ T cells co-cultured with unpulsed splenocytes did not upregulate the 
adhesion molecules CD44, CD49d (a4 integrin), CD103 (a, EL integrin), or ßi integrin, 
which are associated with effector T cell function. These data suggest that naive 
cell surface phenotype was maintained. However, there was high background 
expression of CD44 and CD49d in both freshly isolated CL4 CD8+ T cells and CL4 
CD8+ T cells co-cultured with unpulsed splenocytes. In contrast, CL4 CD8+ T cells 
co-cultured with KdHA-pulsed splenocytes had increased expression of CD25, CD44, 
and CD69 and lower expression of CD62L as compared with both 
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Figure 3.2: Phenotypic characterisation of cell surface molecules expressed by 
CL4 CD8` T cells 
1x 106 CFSE-labelled naive CL4 CD8' T cells were purified by MACS as described 
(giving a purity of at least 95%) then co-cultured with 6x 106 irradiated syngeneic 
splenocytes either KdHA-pulsed or left unpulsed in 200 µl complete media in 96- 
well U bottom plates. After 24 or 72 hours, cells were stained with anti-Thyl. 1 
antibodies and antibodies against cell surface activation markers. Expression of 
cell surface molecules were analysed by flow cytometry and 10,000 Thyl. 1' 
events were acquired. 
Plots show surface marker expression versus CFSE amongst Thyl. 1' cells. 
These Data are representative of at least three experiments. 
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Table 3.1: Cell surface phenotype of CL4 CD8' T cells following co-culture 
1x 106 CFSE-labelled nave CL4 CD8` T cells were purified by MACS as described 
(giving a purity of at least 95%) then co-cultured with 6x 106 irradiated syngeneic 
splenocytes either K°HA-pulsed or left unpulsed in 200 µl complete media in 96- 
well U bottom plates. After 24 or 72 hours, cells were stained with anti-Thyl. 1 
antibodies and antibodies against cell surface activation markers. Expression of 
cell surface molecules were analysed by flow cytometry and 10,000 Thyl. 1' 
events were acquired. 
This table details the expression profile of surface markers by CL4 CD8' T cells. 
Data are representative of at least three separate experiments. 
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Surface 
Marker 






CD8 +ve +ve (-) +ve (-) 
CD25 -ve -Ve(-) +ve (TT) 
CD44 Int Int (-) Hi (+ ) 
CD49d Int Int (-) Hi (+) 
CD62L Hi Hi (-) Lo (4040) 
CD69 -ve -ve (-) +ve (TT) 
CD95L -ve -ve(-) +ve (-) 
CD103 Lo Lo (-) Lo (-) 
P7 integrin Int ant (-) Hi (T) 
V08 +ve +Ve (-) +Ve (-) 
Table 3.1: Cell surface phenotype of CL4 CD8' T cells following co-culture 
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freshly isolated CL4 CD8' T cells and CL4 CD8+ T cells co-cultured with unpulsed 
splenocytes (Fig. 3.2 and Table 3.1). Upregulation of CD49d and ß, integrin was 
observed amongst CL4 CD8` T cells co-cultured with KdHA-pulsed splenocytes, 
whilst CD103 (a, EL integrin) was expressed at the same level as that expressed by 
CL4 CD8' T cells co-cultured with unpulsed splenocytes. Additionally, co-culture 
with KdHA-pulsed splenocytes had no effect on the expression of TcR(3, CD95L 
(FasL) and CD8 by CL4 CD8` T cells. 
A phenotypic profile of CL4 CD8+ T cells undergoing abortive versus productive 
activation has been previously carried out by Sherman and co-workers (Hernandez 
et al., 2001). However in this study, productive activation was characterised in 
PR8-immunised InsHA mice, where the presence of HA both as a self and non-self 
antigen may confound discrimination of productive activation. As we wished to 
establish the features of abortive and productive activation of CL4 CD8' T cells in 
vivo, we carried out further characterisation of productive activation in mice 
where HA was only present as a non-self antigen. Furthermore, a more extensive 
range of cell surface markers was examined. CFSE-labelled CL4 CD8` T cells were 
transferred into InsHA mice (InsHA; abortive activation) and groups of non- 
transgenic BALB/c mice (BALB/c; unstimulated), further groups of BALB/c 
recipients were immunised with PR8 at the time of CL4 CD8+ T cells transfer 
(BALB/c + PR8; productive activation). PLN, the lymph nodes that drain the site 
of HA expression in InsHA mice, were harvested from each group 72 hours after 
transfer and examined by flow cytometry. Adoptively transferred CL4 CD8' T cells 
were discriminated from host cells based on expression of congenic form of Thyl 
(Thyl. 1) compared with host T cells which express Thyl. 2. 
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CL4 CD8' T cells transferred into unimmunised BALB/c mice as a negative controls, 
expressed similar cell surface phenotypes to those expressed by freshly purified 
naive CL4 CD8' T cells (CD25'CD44'"t, CD49d'"t, CD62Lhi, CD69', and CD95L'; Fig. 3.3 
and Table 3.2). CL4 CD8+ T cells transferred into BALB/c + PR8 mice expressed an 
activation cell surface phenotype similar to CL4 CD8+ T cells co-cultured with 
KdHA-pulsed splenocytes (CD25+, CD44hi, CD49dht, CD62Ltnt/", and CD69'; Fig. 3.3 
and Table 3.2). Interestingly, in contrast to activation in vitro, upregutation of 
CD95L was observed amongst CL4 CD8' T cells activated in BALB + PR8. 
CL4 CD8' T cells activated in InsHA PLN expressed a partially activated cell surface 
phenotype (CD25', CD44hi, CD49dh', CD62L'"t, CD69', and CD95L'; Fig. 3.3 and Table 
3.2). However, most notable is that such abortively activated CL-4 CD8` T cells did 
not express CD25 or CD95L and had only partially downregulated CD62L. 
Additionally, only a low proportion of CL4 CD8` T cells underwent division in InsHA 
PLN. Of those cells that did divide, the number of rounds of division they 
underwent was limited. Whereas the majority of CL4 CD8+ T cells productively 
activated in PR8-immunised mice underwent division generating populations of 
highly divided cells. 
3.4 Proliferation by CL4 CD8+ T cells in response to KdHA expressed as 
either a self or foreign antigen 
Previous studies in vivo have shown that there are differences between the 
proliferative response of CL4 CD8` T cells to KdHA epitopes expressed either as a 
self-epitope in InsHA mice or as a foreign epitope following PR8 immunisation 
(Hernandez et at., 2001). CL4 CD8' T cells abortively activated by self-HA 
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Figure 3.3: Flow cytometric analyses of CL4 CD8'T cells following abortive 
activation in InsHA PLN 
Groups of unimmunised BALB/c mice, PR8-immunised BALB/c mice (BALB/c + PR8) 
and unimmunised InsHA mice, were injected i. v. with 5x 106 CFSE-labelled 
Thy1.1` CL4 CD8' T cells (enriched by MACS selection to give a purity of at least 
95%). After 72 hours, PLN cells from each group were stained with anti-Thyl. 1 
antibodies and antibodies against cell surface markers and analysed by flow 
cytometry. 10,000 Thy1.1' events were aquired. 
Plots show surface marker expression versus CFSE amongst Thy1.1' CL4 CD8' T 
cells recovered from PLN from BALB/c (left), BALB/c + PR8 (centre) and InsHA 
(right). 
These Data are representative of at least five experiments. 
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Table 3.2: Cell surface phenotype of in vivo activated CL4 CD8' T cells 
Groups of unimmunised BALB/c mice, PR8-immunised BALB/c mice (BALB/c + PR8) 
and unimmunised InsHA mice, were injected i. v. with 5x 106 CFSE-labelled 
Thy1.1* CL4 CD8+ T cells (at least 95% pure). After 72 hours, PLN cells from each 
group were stained with anti-Thyl. 1 antibodies and antibodies against cell surface 
markers and analysed by flow cytometry. 
Table lists the expression profile of the surface markers examined amongst 
Thyl. 1 ` cells. 
These data are representative of at least five separate experiments. 
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Surface Marker BALB/c PLN BALB/c + PR8 PLN InsHA PLN 
CD8 +ve +ve +ve 
CD25 -ve Hi -ve 
CD44 Int Hi Hi 
CD49d Int Hi Hi 
CD62L Hi Int/Lo Int/Hi 
CD69 -ve +ve +ve 
CD95L -ve Lo -ve 
CD103 Lo Lo Lo 
P7 integrin Int Hi Int 
V08 +ve +ve +ve 
Table 3.2: Celt surface phenotype of in vivo activated CL4 CD8' T cells 
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epitopes in InsHA mice undergo a limited proliferation: fewer cells divide and 
those cells that divide undergo fewer rounds of division. Further studies 
demonstrated that the time taken to tolerise CL4 CD8` T cells transferred into 
InsHA mice is proportional to the number of CL4 CD8` T cells transferred (Morgan 
et at., 1999a). It is possible that abortive rather than productive activation of CL4 
CD8' T cells occurs because of the large difference in the amount of cognate 
peptide available. To determine whether or-)not the amount of KdHA epitopes 
available limits activation of CL4 CD8' T cells in InsHA PLN, the site of cross- 
presentation of KdHA epitopes, decreasing numbers of CFSE-labelled CL4 CD8' T 
cells were transferred into groups of InsHA mice and groups of BALB/c + PR8. 
After 72 hours, the division of donor CL4 CD8` T cells isolated from PLN was 
evaluated by flow cytometry. 
The percentage of undivided donor CL4 CD8' T cells in the PLN of BALB + PR8 
recipients was approximately the same regardless of the number of CL4 CD8+ T 
cells transferred (Fig. 3.4). However, when 1x 106 CL4 CD8+ T cells were 
transferred into InsHA mice, there was a reduction in the percentage of undivided 
donor cells, as compared to transfer of 5x 106 cells (Fig. 3.4). The percentage of 
undivided cells was even less when 5x 105 CL4 CD8+ T cells were transferred (Fig. 
3.4). These data suggest that the number of dividing cells in the PLN of InsHA 
mice were similar. This indicates that the level of available cross-presented 
antigen, rather than the size of the responder pool, is the limiting factor in 
proliferation of CL4, CD8+ T cells during abortive activation. An alternative 
explanation of the limited number of CL4 CD8+ T cells undergoing abortive 
activation is that the number of naive HA-specific T cells trafficking though the 
PLN that encounter cross-presented epitopes. is limited. If this were indeed the 
case, then it would be expected that altering the number of transferred cells 
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Figure 3.4: CL4 CD8` T cell proliferation in PLN of InsHA is independent of 
number of cells transferred 
Groups of PR8-immunised BALB/c mice (BALB/c + PR8) and unimmunised InsHA 
mice, were injected i. v. with 5x 106,1 x 106 or 5x 105 MACS-enriched CFSE 
labelled Thy1.1` CL4 CD8` T cells. After 3 days cell suspensions from PLN of alt 
groups were prepared surface stained with anti-Thyl. 1 antibodies and anti-CD3 
antibodies. 
Using flow cytometry, 10,000 CD3' cells were collected from each sample. Plots 
show CFSE histograms for Thy1.1`, CD3' cells recovered from the PLN of BALB/c + 
PR8 (left) and InsHA (right) for each of the different numbers of CL4 CD8' T cells 
transferred. Statistics show percentage of undivided cells. 
These Data are representative of two experiments. 
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would affect not affect percentage of abortively activated cells, instead altering 
the absolute numbers of activated cells. 
Using algorithms from FlowJo software ((Thompson and Mitchell, 2004), the 
absolute number of responders and proliferative index of CL4 CD8' T cells in PLN 
was determined for each group of mice (Table 3.3). Histograms depicting the 
level of CFSE fluorescence amongst dividing cells skew data towards divided cells, 
as histograms do not take into account that the percentage of divided cells does 
not equate to percentage of the starting population of cells that undergo division. 
For example, when a cell divides three times, its daughter cells will account for 8 
cells in the divided population. Thus, the divided cells appear to make up a more 
significant percentage of the actual number of responding cells. By 
mathematically dividing the number of divided cells at each round of division, by 
the number of daughter cells produced from that number of divisions, the 
percentage of the starting cells that have undergone cell division can be 
calculated. Using this percentage, the total number of responding cells can be 
calculated. The proliferative index was also calculated; this value indicates the 
average amount of rounds of divisions that each cell that divides undergoes. The 
proliferative index of donor CL4 CD8' T cells in the PLN of InsHA mice does not 
vary with the number of input donor cells (Table 3.3). This implies that an 
individual cell that is activated to divide underwent the same level of 
proliferation, independently of the numbers of cells dividing. The proliferative 
index of CL4 CD8` T cells dividing in response to PR8 immunisation varied more 
when numbers of donor cells were decreased. The total numbers of cells dividing 
did not increase in InsHA PLN when lower numbers of donor cells were 
transferred. Indeed, it appears that similar numbers of cells will divide in 
response to self-KdHA epitopes independently of the initial number of cells. In 
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contrast, a great reduction in absolute numbers of cells that undergo some 
division was observed amongst CL4 CD8' T cells responding in PR8-immunised mice 
(Table 3.3). This suggests that in InsHA PLN there is enough cross-presented HA 
epitopes to abortively activate a particular number of extravasating CL4 CD8; T 
cells. Thus, an increase in the number of input cells, and therefore increasing the 
number of CL4 CD8+ T cells trafficking through the PLN, does not increase the 
absolute number of abortively activated cells. Unlike the situation during a PR8 
infection, activation in the PLN is limited by amount of available K°HA epitopes. 
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Table 3.3: CL4 CD8' T cell proliferation in vivo 
Groups of PR8-immunised BALB/c mice (BALB/c + PR8) and unimmunised InsHA 
mice, were injected i. v. with 5x 106,1 x 106 or 5x 105 MACS-enriched CFSE 
labelled Thyl. 1` CL4 CD8' T cells (at least 95% pure). After 3 days, cell 
suspensions from PLN of all groups were prepared surface stained with anti-Thyl. 1 
antibodies and anti-CD3 antibodies. 
Using flow cytometry, 10,000 CD3` cells were 
plots for Thy1.1 `, CD3' CL4 CD8` T cells were 
determine proliferative index and divided cell 
divided cells was calculated from the divided 
cells originally transferred. 
collected from each sample. CFSE 
analysed using FlowJo software to 
percentage. The total number of 
cell percentage of the number of 
Data is given from two separate experiments. 
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InsHA PLN 




Total number of 
divided cells 
6 
1.53 67.0 x 106 
5x10 
1.49 24.2 x 106 
6 
1.62 19.5 x 106 
1x 10 




1.69 11.6 x 106 
BALB/c + PR8 




Total number of 
divided cells 
6 
3.43 125 x 106 
5x 10 
3.09 106 x 106 
6 
2.81 28.2 x 106 
1x10 
2.98 34.3 x 106 
5 
2.70 18.4 x 106 
5x10 
2.32 11.2 x 106 
Table 3.3: CL4 CD8+ T cell proliferation in vivo 
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3.5 Measurement of effector functions amongst activated CL4 CD8+ T 
cells 
The responses of CL4 CD8+ T cells differ depending upon whether HA-epitopes are 
expressed as a self-antigen or as a non-self-antigen (PR8). When CL4 CD8' T cells 
undergo productive activation on encounter with HA following PR8 immunisation 
of recipient BALB/c mice, they proliferate vigorously (Chapter 3.4), express cell 
surface molecules typical of activated effector CTL (Chapter 3.3) and are 
diabetogenic in InsHA mice (Hernandez et at., 2001). Whereas, when CL4 CD8' T 
cells undergo abortive activation following encounter with 0 cell-derived KdHA 
epitopes in the PLN of InsHA recipient mice, they go through only a few rounds of 
proliferation (Chapter 3.4), express a partially activated cell surface phenotype 
(Chapter 3.3) and do not cause autoimmune diabetes in InsHA mice (Hernandez et 
at., 2001). It is possible that abortively activated CL4 CD8+ T cells do not 
differentiate into effector CTL or alternatively, although they possess cytotoxic 
function, they are unable to gain access to the pancreas. CL4 CD8' T cells 
undergoing abortive activation sorted from InsHA PLN and rested in BALB/c mice 
can be later activated to generate effector CTL (Kreuwel et at., 2002). Thus once 
initiated, the process of tolerance induction can be reversed, suggesting that 
repeated exposure to self-antigens may be required to fully tolerise-self -reactive 
T cells. In vitro methods of assessing effector function were performed on CL4 
CD8+ T cells undergoing abortive or productive activation in vivo, to look at 
indicators of effector function. 
Production of the cytokine IFN-y has been previously associated with the induction 
of cytotoxicity amongst CD8' T cells (Fong and Mosmann, 1990). CL4 CD8+ T cells 
abortively or productively activated in vivo were isolated and tested for their 
ability to produce IFN-y. As a control, CL4 CD8' T cells from peripheral LN of 
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recipient InsHA mice were also tested. T cells were restimulated in vitro with 
KdHA peptide in the presence of monensin, before intracellular staining with 
antibodies against IFN-y and analysis by flow cytometry. Productively activated 
CL4 CD8' T cells from BALB/c mice co-injected with PR8 expressed intracellular 
IFN-y, whilst despite undergoing cell division in the PLN of InsHA mice, abortively 
activated CL4 CD8' T cells did not produce IFN-y (Fig 3.5). 
Due to the lack of IFN-y production, abortively activated CL4 CD8` T cells were 
tested in vitro for potential cytotoxicity. Effector CTL release cytotoxic enzymes 
such as perforins and granzymes from intracellular granules (Masson and Tschopp, 
1985; Masson et at., 1986). Fusion of these granules with the cell surface 
membrane leads to the temporary presence of membrane components from 
lysosomes in the plasma membranes (Chen et at., 1985). One such protein is 
lysosome-associated membrane protein 1 (CD107a); accumulation of CD107a on 
the cell surface of CD8' T cells indicates that degranulation and thus cytotoxic 
activity is occurring (Betts et at., 2003; Betts and Koup, 2004). CFSE-labelled CL4 
CD8' T cells isolated from LN and PLN of recipient mice were restimulated ex vivo 
with KdHA peptides in the presence of fluorochrome-conjugated anti-CD107a 
antibodies, to trap and detect this lysosome membrane component. The relative 
CD107a recruitment was evaluated by flow cytometry. CD107a was detected in 
vitro amongst CL4 CD8' T cells from PR8-immunised mice (Fig. 3.6). Greater 
levels of this protein were recruited by the highly divided CL4 CD8' T cells, 
indicating greater cytotoxic potency. In contrast, CD107a surface recruitment was 
not detected amongst abortively activated CL4 CD8' T cells (Fig. 3.6). These data 
suggest that activation by self-pepides in InsHA PLN does not lead to the formation 
of anti-HA CTL. Furthermore, restimulation by high doses of K°HA peptide in vitro 
of these cells does not induce cytotoxicity. 
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Figure 3.5: IFNy production by activated CL4 CD8` T cells 
Groups of unimmunised InsHA mice and PR8-immunised BALB/c mice (BALB/c + 
PR8), were injected i. v. with 5x 106 MACS-enriched CFSE [abetted Thyl. 11 CL4 
CD8` T cells (at least 95% pure). After 72 hours, cell suspensions from PLN of 
InsHA and BALB/c + PR8 as well as LN cells from InsHA were restimulated with 
KdHA peptide in the presence of Monensin and cells for 4 hours. Cells were then 
surface stained with anti-Thyl. 1 antibodies before permeabilisation and 
intracellular staining with anti-IFNy antibodies. Samples were analysed by flow 
cytometry, collecting 10,000 events for each sample. 
Plots show intracellular IFNy versus CFSE amongst Thy1.1` CL4 CD8' T cells 
recovered from BALB/c + PR8 PLN (top), InsHA LN (centre) and InsHA PLN 
(bottom). 
These Data are representative of at least three separate experiments. 
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Figure 3.5: IFNy production by activated CL4 CD8' T cells 
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Figure 3.6: Cell surface recruitment of CD107a by activated CL-4 CD8' T cells 
Groups of unimmunised InsHA mice and PR8-immunised BALB/c mice (BALB/c + 
PR8), were injected i. v. with 5x 106 MACS-enriched CFSE labelled Thy1.1' CL4 
CD8' T cells (at least 95% pure). After 72 hours, cell suspensions from PLN of 
InsHA and BALB/c + PR8, as well as LN cells from InsHA, were restimulated in 
complete media in 96 U-bottom plates with KdHA peptide in the presence APC- 
conjugated anti-CD107a antibodies. Monensin was added after 30 minutes and 
cells were then harvested after a further 4 hours. Samples were analysed by flow 
cytometry. 10,000 Thyl. 1*events were acquired. 
Plots show CD107a recruitment versus CFSE amongst Thy1.1` CL4 CD8' T cells 
recovered from BALB/c + PR8 PLN (top), InsHA LN (centre) and InsHA PLN 
(bottom). 
Data are representative of at least three separate experiments 
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Figure 3.6: Cell surface recruitment of CD107a by activated CL4 CD8+ T cells 
-99- 
Chapter 3: Abortive versus productive activation of CL4 CD8' T cells 
3.6 Discussion 
CL4 CD8' T cells were successfully enriched using anti-CD8 positive MACS selection 
from the secondary lymphoid tissue of CL4 mice. These cells expressed the 
following nave T cell surface phenotype: CD25', CD44mnt, CD49d'"`, CD54', CD62Lhi, 
CD69', CD95', and Ly6C'Ve. This profile of molecule expression is similar to that 
seen amongst unmanipulated naive CD8' T cells analysed after harvest from CL4 
mice. Additionally, CL4 CD8' T cells enriched by MACS did not divide 
spontaneously, but were able to proliferate when co-cultured with KdHA-pulsed 
splenocytes. Thus, following MACS enrichment, CL4 CD8' T cells remain in a naive 
and show no signs of activation. 
Following transfer into conventional BALB/c hosts, CL-4 CD8' T cells retained their 
naive phenotype and failed to divide. The high levels of CD44 observed amongst 
these CL4 CD8' T cells are consistent with other studies which have shown that 
CD44 may be constitutively expressed amongst T cells obtained from mice of a 
BALB/c background (Budd et al., 1987). Both the lack of proliferation and the cell 
surface phenotype of CL4 CD8' T cells transferred into BALB/c mice implies that 
adoptive transfer of CL4 CD8' T cells does not result in CL4 CD8+ T cell activation. 
CL4 CD8` T cells productively activated in PR8-immunised recipient mice 
upregulated surface expression of CD25, CD49d, CD69, Ly6C, and CD95L; while 
expression of CD62L was reduced. This phenotype is consistent with published cell 
surface phenotypes of productively activated CD8' T cells (Oehen and Brduscha- 
Riem, 1998) as well as the phenotype of CL4 CD8' T cells co-cultured with KdHA- 
pulsed splenocytes. However, CL4 CD8` T cells harvested from PR8-immunised 
mice did not upregulate CD95L (FasL) expression. CD95L expression has been 
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observed amongst activated effector CTL, (Kojima et at., 1994) and CD95L allows 
CD8' T cells to mediate cytotoxicity through Fas on target cells (Nagata, 1997). 
Expression of CD95L is observed amongst CL4 CD8` T cells productively activated 
in vivo, but not amongst CL4 CD8' T cells co-cultured with KdHA pulsed 
splenocytes, indicating in vitro activation may not be able to fully differentiate 
CL4 CD8' T cells. In other studies, CD95L expression was also downregulated by 
CD8+ T cells in vitro (Walker et at., 2000). However, experiments, utilising 
populations of transgenic CL4 CD8` T cells deficient in either perforin or CD95L 
expression, have indicated that whilst perforins appear to be essential for CL4 
CD8' T cell effector function, CD95L interactions are less important in cytotoxicity 
mediated by CL4 CD8` T cells (Kreuwel et at., 1999). Thus, differences in CD95L 
expression in vivo and in vitro are unlikely to translate to differences in effector 
function. 
CL4 CD8` T cells undergoing abortive activation in the PLN of InsHA mice 
expressed a partially activated cell surface phenotype (CD25', CD44hi, CD49dni, 
CD62Ltht, CD69', Ly6Ch1 , and CD95L'). CD25 is the a-chain of the high affinity IL-2 
receptor, and expression of this allows an efficient IL-2 feedback loop to be 
initiated, which enhances T cell activation and differentiation to effector cells 
(Farrar et at., 1986). Thus, the fact that abortively activated CL4 CD8+ T cells do 
not upregulate CD25 implies that such T cells may be unable to carry out effector 
activity. If abortive activation of CL4 CD8` T cells involves the induction of anergy 
resulting from TcR ligation without co-stimulation, the lack of CD25 may aid this 
process as anergy amongst T cells activated in the absence of co-stimulation can 
be reversed by the addition of exogenous IL-2 (Beverly et at., 1992). However, 
the effect of IL-2 was not tested in this thesis. 
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CD62L is an adhesion molecule that allows the recirculation of naive T cells 
though secondary lymphoid tissue , but inhibits the migration of T cells into non- 
lymphoid tissue (Mobley et at., 1994). Previous, examination of pancreta from 
InsHA mice that have received CL-4 CD8' T cells indicated, that although activated 
to divide in the PLN, CL4 CD8' T cells fail to migrate into the pancreas (Morgan et 
at., 1996). Thus, it is possible that maintaining expression of CD62L by abortively 
activated CL4 CD8` T cells correlates with their inability to enter intact tissue. 
It is somewhat surprising that Ly6C, a molecule associated with effector function 
(Cerwenka et at., 1998), was more highly expressed by abortively activated CL4 
CD8+ T cells than by productively activated CL4 CD8` T cells. Although, high levels 
Ly6C expression has been observed amongst memory T cells (Walunas et at., 
1995), other reports report suggest that Ly6C may inhibit IL-2 signalling and thus 
prevent T cell activation (Yamanouchi et at., 1998). Perhaps expression of Ly6C 
by abortively activated CL4 CD8' T cells is related to their lack of CD25 
upregulation. Furthermore, Ly6C expression has also been observed amongst 
unconventional T cells in the IEL or LPL of murine small intestine (Wang et at., 
2002). Many of these Ly6C-expressing GALT cells possess TcR's specific for self- 
antigens (Poussier et at., 2002; Rocha et at., 1992), suggesting that Ly6C may be 
associated with tolerised T cells. Additionally, a deficiency in Ly6C expression has 
also been reported in NOD rice, which are high susceptible to spontaneous 
autoimmunity, indicating Ly6C may be involved in preventing ativation of self- 
specific T cells (Philbrick et at., 1990). It is therefore possible that Ly6C in 
addition to acting as a memory T cell marker, with a role in activation, may have 
an alternative function on T cells that have been tolerised to self-antigens; this is 
discussed further in Chapter 5b. A further possibility is that this molecule is 
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utilised by abortively activated CL4 CD8' T cells in order to traffic out of 
secondary lymphoid tissue into tertiary lymphoid sites (see Chapter 4). 
It has been suggested that activation of T cells to express CD25 also requires CD28 
ligation (Cerdan et at., 1992). Therefore, as CD25 is not upregulated by abortively 
activated CL4 CD8+ T cells, it is possible that abortive activation results from CL4 
CD8' T cell encounter with KdHA epitopes in the absence of CD28 co-stimulation. 
Indeed, as described in Chapter 5, abortively activated CL4 CD8+ T cells can be 
produced in vitro by stimulation of nave CL4 CD8' T cells by iDC that lack 
expression of co-stimulatory molecules. Additionally, treatment of InsHA mice 
which had received CL4 CD8+ T cells and PR8, with anti-CD80 and anti-CD86 
antibodies, reduced the productive CL4 CD8' T cell response, both in number and 
effector phenotype whereas division of donor CL4 CD8' T cells in InsHA PLN was 
not effected by such treatment (Hernandez et al., 2001). These data suggest that 
abortive activation of CL4 CD8' T cells may occur as a result of activation in the 
absence of CD28 co-stimulation. 
Effector CTL in vitro can still be produced despite a lack of co-stimulation through 
CD28, when an increased TcR signal is given, through increased antigen doses 
(Motta et at., 1998) or via alternative co-stimulation pathways (Jenkinson et at., 
2005). Also, the limited proliferation of CL4 CD8' T cells in InsHA PLN may be 
explained by a limited level of antigen. Additionally, it has been reported that T 
cell activation by low doses of mitogen or alloantigen can lead to CD62L 
upregutation rather than CD62L downregulation (Hamann et at., 1988). This 
suggests that the reason that CL4 CD8* T cells activated by self-antigen do not 
fully downregulate CD62L may result from a low level of stimulation through the 
TcR. Indeed, abortive activation may result from a balance of both stimulation 
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through the TcR and co-stimulation. Following adoptive transfer of CL4 CD8+ T 
cells into InsHA mice, the PLN contained both dividing and undivided CL4 CD8+ T 
cells, which implies that there are factors limiting cell division. When fewer CL4 
CD8+ T cells were transferred into InsHA mice, similar numbers of CL4 CD8+ T cells 
underwent abortive activation. Therefore, abortive activation is not limited by 
number of responder T cells available. These data may support the hypothesis 
that abortively activated CL4 CD8+ T cells are rapidly cleared from the site of 
activation, either by AICD, death by neglect or migration. Alternatively, the 
number of dividing CL4 CD8+ T cells may be determined by the amount of KdHA- 
epitopes and the fact that a certain number of cells divide at any one time 
regardless of the number of input cells. APCs isolated from InsHA PLN are unable 
to stimulate CL4 CD8+ T cells to divide ex vivo (Fraser and Morgan, unpublished 
data), indicating that the number of available KdHA-epitopes must be fairly low. 
It is possible that it is this low level of epitope availability rather that a lack of co- 
stimulation that may be responsible for the induction of an abortive rather than a 
productive response. Evidence from other laboratories have shown that an 
altered TcR signal can either increase or decrease the functional response 
(Verhoef and Lamb, 2000) and also that reducing peptide doses in vitro to below a 
threshold level can lead to anergy (Cai and Sprent, 1996). This hypothesis 
suggests potential for APC/peptide immunotherapies, as the peptide dose may be 
crucial in tolerance induction. To test whether or not tolerance induction 
depends on the level of available epitopes, chemical or physical treatments could 
be employed to increase the availability of HA-epitopes in InsHA mice. Increasing 
the amount of HA-epitopes may divert tolerance induction to autoimmunity. 
The effector function of abortively activated versus productively activated CL4 
CD8` T cells was also examined in vitro. Previous studies have linked effector CTL 
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function with IFN-y secretion (Betts et at., 2003) and in this study, CL4 CD8" T 
cells productively activated in 13118-immunised mice secrete IFN-y. In contrast, 
CL4 CD8" T cells undergoing abortive activation in the PLN of InsHA mice do not 
produce IFN-y. These data support the hypothesis that measurement of IFN-y 
production by CD8' T cells can be used to determine whether or not activated 
CD8` T cells will mount cytotoxic effector responses. The recruitment of CD107a 
to the cell surface of CL4 CD8" T cells was also measured. CD107a is a membrane 
component of CD8" T cells lytic granules. During an effector response, CD8' T 
cells degranulate to secrete lytic enzymes and CD107a is recruited into the cell 
surface membrane (Betts et al., 2003). Previous studies have associated CD107a 
surface recruitment with CTL activity (Betts and Koup, 2004). When CL4 CD8' T 
cells productively activated in PR8-immunised mice are restimulated in vitro even 
with low levels of KdHA, CD107a surface recruitment was observed. However, 
CD107a was not recruited to the surface of abortively activated CL4 CD8' T cells, 
unless restimulated with high levels of KdHA in vitro. Therefore, measurement of 
CD107a recruitment may be a useful indicator of the in vivo effector function of 
an activated CL4 CD8* T cell. It is interesting to note that restimulation of 
abortively activated CL4 CD8+ T cells with high levels of KdHA may initiate 
productive response, as evidence by increases in CD107a surface recruitment. 
These data support previous experiments demonstrating that abortive activation 
of CL4 CD8* T cells can be reversed in vivo (Kreuwel et at., 2002). We propose 
that IFN-y production and CD107a recruitment can be utilised to determine 
whether CL4 CD8* T cells are activated abortively rather than productively. Such 
parameters will be used later in chapter 5b to examine the outcomes of CL4 CD8* 
T cell interaction with DCs cross-presenting K°HA. 
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The experiments described in this chapter suggested that the features of CL4 CD8` 
T cells undergoing abortive activation in vivo are: a of lack of upregulation of 
CD25, and a failure to initiate complete downregulation of CD62L. Coupled to a 
lack of effector cytotoxic activity, as evidenced by an absence of autoimmune 
diabetes, abortively activated CL4 CD8' T cells fail to produce IFN-y. In addition, 
upon re-encounter with K°HA in vitro, such cells fail to produce cytotoxic granules 
as a lack of CD107a surface recruitment was observed. It is proposed that these 
experiments have provided a set of parameters to evaluate CL4 CD8' T cell 
response in vitro. Moreover, in the absence of a clinical readout in vitro, these 
characteristics can be used to determine whether CL4 CD8' T cell activation is 
abortive or productive. Using the features of abortive activation defined in this 
chapter, the factors that influence whether a CL4 CD8' T cell will be abortively 
rather than productively activated following interactions with KdHA epitopes can 
be investigated in vitro. It is proposed that understanding what controls the 
activation of a high avidity CD8' T cell, such as CL4 CD8' T cells, encountering 
self-antigens may allow the development of therapies to prevent autoimmunity 
and transplant rejection. 
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4.1 Introduction 
The experiments described in chapter 3 detailed the hallmarks of abortive versus 
productive activation of CL4 CD8` T cells in vivo. The experiments described in 
this chapter follow the fate of CL4 CD8` T cells subsequent to abortive activation 
in InsHA PLN compared with the fate of CL4 CD8' T cells productively activated in 
PR8-immunised BALB/c mice. These experiments were performed to determine 
how self-specific CD8' are functionally deleted during the induction of peripheral 
tolerance in InsHA mice compared with deletion of T cells following clonal 
exhaustion. 
InsHA mice are pröfoundly tolerant to the haemaggluttinin (HA) protein expressed 
on their pancreatic islet ß cells (Lo et at., 1992). Studies carried out with bone 
marrow chimeras revealed that such tolerance relies on a mechanism of 
peripheral tolerance. Briefly, lethally irradiated, thymectomised InsHA mice that 
were reconstituted with non-transgenic bone marrow and a non-transgenic thymus 
demonstrated tolerance to ß cell-expressed HA (Lo et al., 1992). Further studies 
also demonstrated that peripheral tolerance induction in InsHA mice is not due to 
ignorance of ß cell expressed HA; instead self-tolerance in InsHA mice is 
accompanied by the functional loss of CD8' T cells with high avidity to the 
dominant KdHA epitope (Morgan et at., 1998). To learn more about how 
peripheral tolerance is induced amongst CD8' T cells, we have utilised CL4 CD8' T 
cells, which express a MHC class I restricted transgenic TcR that is specific for the 
dominant H-2K d restricted epitope of HA from PR8 (KdHA). When naive CL4 CD8+ T 
cells are transferred into InsHA recipients, they become activated, but only in the 
PLN (Lo et at., 1992). However activation does not generate autoimmune 
diabetes in InsHA mice and as such this activation has been termed `abortive 
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CL4 CD8` T cells in vivo 
activation' (Morgan et at., 1999a). Moreover, subsequent to transfer into InsHA 
mice, CL4 CD8' T cells functionally disappear over time from the peripheral T cell 
repertoire (Morgan et al., 1998). In contrast, naive CL4 CD8' T cells transferred 
into PR8-immunised InsHA mice undergo productive activation and generate 
autoimmune diabetes. This chapter describes experiments carried out in order to 
investigate the consequences of CD8' CL4 T cell interaction with KdHA epitopes in 
vivo, following abortive versus productive activation. 
Several mechanisms of peripheral tolerance, which prevent potentially auto- 
reactive T cells that circulate in the periphery from generating autoimmunity, 
have been shown to exist. Many studies have demonstrated that circulating CD4' 
and CD8+ T cells that are specific for self-epitopes exist in the periphery (Kitze et 
at., 1988; Naquet et at., 1988). One way in which activation of these cells is 
prevented by physical or immunological separation from their epitope (Barker and 
Billingham, 1977). Another possibility is that T cells which do not undergo thymic 
tolerance induction are of too low an avidity to generate autoimmunity (Ferber et 
at., 1994; Heath et at., 1998) and as such these self-reactive T cells are ignorant 
of self-epitopes. For example, mice which express both a LCMV epitope and a 
LCMV epitope-specific transgenic TcR have high numbers of circulating self- 
specific T cells, but do not develop autoimmune diabetes (Ohashi et at., 1991; 
Oldstone et at., 1991). However such ignorance can be reversed by immunisation 
of these double transgenic mice with LCMV, leading to autoimmunity (Ohashi et 
al., 1991; Oldstone et al., 1991). 
T cells which encounter cognate epitopes in a non-inflammatory environment are 
partially activated (Jenkins and Schwartz,. 1987; Nossal and Pike, 1980). Such 
partial activation gives rise to anergic rather than effector cells (Schwartz, 1996). 
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It has been suggested that in the steady state, self-specific T cells encounter self- 
epitopes under non-inflammatory conditions in the periphery, resulting in the 
induction of anergy amongst self-specific T cells (Blackman et a!., 1991; Blackman 
et al., 1990; Lechler et al., 2001, Burkly, 1989 #6). Thus, the induction of anergy 
may be a further mechanism of peripheral tolerance induction. There is also 
evidence that T cells, following TcR engagement with their cognate peptide/MHC 
in the absence of co-stimulation may be deleted in the periphery, rather than 
being rendered anergic (Critchfield et a!., 1994; Huang and Crispe, 1993). Such 
deletion has been demonstrated in the RIP-mOVA transgenic mouse following 
transfer of OVA-specific OT-1 CD8` T cells. The loss OT-1 CD8' T cells in RIP-mOVA 
mice was observed after interaction with OVA-epitopes in the pancreatic lymph 
nodes (Kurts et at., 1997b). 
Other laboratories have demonstrated that the state of tolerance can be sustained 
by endogenous regulatory CD25` CD4' T cells, which suppress the activation of 
auto-reactive T cells (Maloy and Powrie, 2001). Also, neonatal thymectomy, 
which prevents the development of regulatory CD4' T cells, leads to widespread 
autoimmunity, suggesting a role for regulation in tolerance induction (Nishizuka, 
1982). Transfer of CD25'CD4' regulatory T cells into neonatally thymectomised 
mice prevents autoimmunity (Asano et at., 1996; Sakaguchi et at., 1995). More 
recently it has been shown that the induction of peripheral tolerance by 
administration of low-doses of self-peptide through an oral or nasal route may be 
accompanied with the generation a population of antigen-specific regulatory T 
cells (O'Neill et al., 2004). 
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4.2 Involvement of CL4 CD8 T cells interactions with InsHA endogenous 
T cells 
To test whether or not populations of regulatory cells are involved in the 
induction of peripheral tolerance in the InsHA mouse, InsHA mice were crossed 
with CD4''' or CD8"" mice. The strains generated expressed HA on pancreatic ß 
cells and lacked either CD4' or CD8' T cells from their peripheral repertoires. 
These CD4''" InsHA and CD8-" InsHA mice thrived and did not develop spontaneous 
autoimmunity. 
It has been shown that there is functional loss of HA-specific activity from the 
peripheral repertoires of InsHA mice, while this may be due to deletion it is 
possible that other populations of T cells can suppress this activity. In this case 
HA-specific T cells may still circulate, but cannot be activated. That CD4'"* InsHA 
and CD8''' InsHA mice appear to be tolerance to p-cell expressed HA does not rule 
out a role for populations CD4' or CD8` regulatory T cells induction or 
maintenance of tolerance to HA in InsHA mice. Tolerance in CD4''' InsHA and CD8' 
'" InsHA mice could be due to ignorance, as nave T cells are unlikely to traffic 
through intact tissues, therefore such strains were further examined to determine 
if a lack of T cells affect tolerance processes. 
If CD4"* InsHA and CD8''' InsHA mice posses T cell repertoires containing cells with 
high avidity for HA, then activation of such cells in a productive manner would 
lead to autoimmune diabetes. To test this groups of CD4'" InsHA and CD8''" InsHA 
mice were immunised with replicating PR8 virus and were tested for diabetes for 6 
weeks. No diabetes was detected in either group (Table 4.1). Although these 
data implied that CD4'"* InsHA and CD8''" InsHA mice are profoundly tolerant to 
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Table 4.1 CD4''" InsHA and CD8'"- InsHA mice are profoundly tolerant to HA 
CD4'" InsHA and CD84' InsHA mice were generated by backcrossing InsHA mice 
with CD4'"* or CD8"'' mice. Mice were immunised i. p. with 200 HAU of PR8. Mice 
were monitored for diabetes urine glucose concentration at bi-weekly intervals. 
Diabetes was confirmed in mice with glycosurea by measuring the glucose 
concentration of venous blood withdrawn from the tail vein. Mice with blood 
glucose levels of greater than 14 mmol/L on consecutive days were confirmed as 
diabetic. Mice were tested observed for a period of 6 weeks post-immunisation. 
Two independent experiments were carried out, each with 4 mice per group. 
Chapter 4: Peripheral tolerance induction amongst ß cell specific CL4 CD8' T cells in vivo 
Diabetes incidence 
Mouse strain 
At 28 days At 42 days 
CD4"' InsHA 0% 0% 
CD8"" InsHA mice 0% 0% 
Table 4.1: CD4"'" InsHA and CD8-'- InsHA mice are profoundly tolerant to HA 
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HA, that these mice lack peripheral anti-HA responses is not the only explanation. 
This result could also be accounted for by a requirement of both CD4` and CD8' T 
cells to generate enough islet destruction to cause pathology. 
To test this, populations of HA-specific CL4 CD8` T cells were adoptively 
transferred into CD4''' InsHA and CD8''' InsHA mice, as well as control InsHA mice. 
These mice were co-immunised with replicating PR8 and monitored for diabetes 
by measurement of urine and blood glucose levels over three weeks. All groups of 
mice were observed to be severely diabetic within 14 days of immunisation (Table 
4.2). These data show that HA-specific T cells are sufficient to generate 
autoimmunity in these mice and so implies that CD4"- InsHA and CD8''" InsHA 
mice, like InsHA mice, remain tolerant to their ß-cell expressed HA due to 
functional deletion of HA-specific T cells from their repertories. 
To further study whether or not similar tolerance induction processes occur 
amongst HA-specific T cells in InsHA mice compared to similar InsHA mice that 
lack endogenous CD4' or CD+ T cells, CFSE-labelled Ly5.2' CL4 CD8' T cells were 
transferred into such mice. After 3 days cell suspension were made from LN and 
PLN of recipient InsHA, CD4"* InsHA and CD8"" InsHA mice which were analysed for 
activation by flow cytometry. - 
Division of Ly5.2' donor cells was not observed in any peripheral LN (data not 
shown). However, in PLN of all groups limited proliferation of a low number of 
cells was detected (Fig. 4.1). This division was analogous to that demonstrated by 
CL4 CD8` T cells undergoing abortive activation which lead to tolerance induction. 
These data suggest that endogenous CD4` or CD8' T cell subsets are not essential 
for abortive activation of HA-specific T cells in the periphery of InsHA mice. 
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Table 4.2 CD44' InsHA and CD8'"* InsHA mice receiving CL4 CD8' T cell remain 
tolerant to HA 
5x 106 CL4 CD8` T cells, enriched by CD8' MACS selection from CL4 B10. D2 mice, 
were adoptively transferred into groups of InsHA, CD4'"* InsHA and CD8"' InsHA 
mice. Half the mice in each group were Immunised with 200 HAU of PR8 i. p. (+ 
PR8), the remaining recipients left unimmunised. Mice were monitored for 
diabetes by measurement of urine glucose concentration at bi-weekly intervals. 
Diabetes was confirmed in mice with glycosurea by measuring the glucose 
concentration of venous blood withdrawn from the tail vein. Mice with blood 
glucose levels of greater than 14 mmol/L on consecutive days were confirmed as 
diabetic. Mice were tested observed for a period of 4 weeks post-transfer. 
4 mice were used per group. 
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Mouse strain 
Diabetes incidence 
At 7 days At 14 days At 28 days 
InsHA + CL4 + PR8 50% 100% 100% 
CD4''" InsHA + CL4 + PR8 0% 100% 100% 
CD8"' InsHA mice + CL4 + PR8 25% 100% 100% 
InsHA + CL4 0% 0% 0% 
CD4''' InsHA + CL4 0% 0% 0% 
CD8"' InsHA mice + CL4 0% 0% 0% 
Table 4.2: CD4''" InsHA and CD8''' InsHA mice receiving CL4 CD8+ T cell 
remain tolerant to HA 
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Figure 4.1: Endogenous CD4` and CD8' T cells are not required for abortive 
activation of CL4 CD8' T cells in InsHA mice. 
5x 106 MACS-enriched CFSE-labelled Ly5.2' CL4 cells were adoptively transferred 
into homologous InsHA, InsHA CD4''' or InsHA CD8''' mice. After 96 hours, PLN 
cells were stained with anti-CD45.1 antibody. Samples were then analysed by 
flow cytometry. 
2,500 CFSE-divided cells were counted. Plots show CFSE histograms for Ly5.2i 
cells. 
These results are representative of three independent experiments. 
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Figure 4.1: Endogenous CD4' and CD8+ T cells are not required for abortive 
activation of CL4 CD8' T cells in InsHA mice 
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4.3 Migration of activated CL4 CD8+ T cells 
The data described in chapter 3 demonstrate that following adoptive transfer only 
a low number donor CL4 CD8' T cells divide in InsHA PLN and no highly divided 
donor cells are detected in any secondary lymphoid tissue. Such abortively 
activated CL4 CD8' T cells are functionally lost from the peripheral repertoire of 
InsHA recipient mice over time (Lo et al., 1992; Morgan et al., 1999b). In 
contrast, highly divided CL4 CD8' T cells are observed following transfer of naive 
CL4 CD8' T cells into PR8-immunised mice. To explain why abortively activated 
CL4 CD8' T cells undergo only a limited number of divisions, it was postulated that 
abortively activated CL4 CD8' T cells die by apoptosis soon after activation. As 
CL4 CD8' T cells productively activated in 13118-immunised mice are deleted from 
the periphery by the induction of apoptosis after clonal exhaustion, as evidenced 
by annexin V binding (Hernandez et al., 2001). However, data examining annexin 
V binding to abortively activated CL4 CD8' T cells in InsHA PLN are unconvincing as 
the majority of annexin V-binding cells were present amongst the undivided CL4 
CD8' T cells (Hernandez et at., 2001). Amongst those CL4 CD8' T cells that had 
divided, the amount of bound annexin V was low. To explain the functional toss of 
CL4 CD8' T cells from the periphery if abortively activated CL4 CD8' T cells do not 
undergo apoptosis in situ, we propose that following abortive activation CL4 CD8' 
T cells may migrate from InsHA PLN to distal sites. It was suggested that such 
cells may traffic to the pancreas; however, no CL4 CD8' T cells were observed 
amongst pancreatic tissue (Morgan et at., 1999b). Other studies have show that 
following clonal exhaustion, T cells may migrate to gut-associated lymphoid tissue 
(GALT), liver or lung (Crispe and Huang, 1994; Sprent and Miller, 1972; Wack et 
at., 1997). As a high proportion of intrahepatic lymphocytes (IHL) are undergoing 
apoptosis (Crispe and Mehal, 1996), it has been suggested that the liver has a 
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major röte in the post-activation disposal of T cells (reviewed in (Crispe et at., 
2000). However, no such apoptosis is seen amongst activated T cells migrating 
into diffuse GALT tissue (Wack et al., 1997). Indeed, within GALT many unusual T 
cells exist which express hallmarks of activated cells, such as low levels of CD62L 
expression and high levels of CD49d and Ly6C (Cebra et al., 1998). Therefore, 
experiments were carried out which examine such tertiary lymphoid sites in InsHA 
mice to determine whether, after abortive activation, CL4 CD8' T cells are 
functionally lost from the periphery of InsHA mice due to migration to distal sites. 
4.3.1 Selective migration of abortively activated CL4 CD8` T cells to LPL 
CFSE-labelled Thy1.1' CL4 CD8+ T cells were transferred into groups of InsHA mice, 
PR8-immunised BALB/c mice (BALB/c + PR8) or, as a control, into unimmunised 
BALB/c mice. Tissues were harvested at 4 or 8 days post transfer and lymphoid 
cell suspensions were prepared from liver, lung, vagina, small intestine and 
secondary lymphoid tissue. Cells obtained from the following secondary and 
tertiary lymphoid sites were studied separately: pancreatic lymph nodes (PLN), 
peripheral lymph nodes (LN), intrahepatic lymphocytes (IHL), lamina propria 
lymphocytes (LPL), intestinal intraepithelial lymphocytes (IEL), respiratory tract 
lymphocytes (RTL) and vaginal lymphocytes (a mixture of both lamina proprial and 
intraepithelial; VL). IHL and GALT have been previously identified as putative T 
cell 'disposal sites' (Wack et at., 1997), IEL contain high proportions of long-lived 
populations of phenotypically-activated cells (Klein, 1986) and activated cells 
have been reported to become trapped in lung tissue (Galkina et at., 2005). VL 
were examined as a control mucosal tissue amongst which only locally activated T 
cells have been identified (Roig de and Burgos, 1968). Cell suspensions were 
analysed with flow cytometry. Donor CL4 CD8' T cells were identified by the 
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binding of anti-Thyl. 1 antibodies and extent of cell division amongst donor cells 
was measured by examining the profile of CFSE fluorescence. 
Importantly, in BALB/c recipients only undivided donor CL4 CD8' T cells were 
detected in lymph node tissue and fewer than 100 Thy1.1` cells were detected in 
the tertiary lymphoid compartments examined. All such donor cells were 
undivided (Fig. 4.2). The secondary lymphoid components of P118-immunised 
BALB/c recipients contained large numbers of highly divided donor CL4 CD8` cells. 
On day 4, large numbers of divided CL4 CD8' T cells were seen amongst the IHL, 
RTL and LPL of BALB/c + PR8 (Fig. 4.2). Fewer donor cells were detected in IHL, 
RTL and LPL of BALB/c + PR8 at day 8 (data not shown). Those donor cells 
recovered from LPL had undergone at least one division more than those homing 
to IHL or RTL (Fig. 4.2). No transferred cells could be recovered from IEL or VL 
compartments of PR8-immunised BALB/c mice at any of the time points examined. 
These data suggest that homing of productively activated CD8' T cells to the LPL 
following clonal exhaustion may involve activation as distinct from activation 
leading to migration to RTL and IHL. Such differences may possibly relate to 
different T cell fates, for example the formation of memory cells or the final 
disposal of T cells. 
As shown in Chapter 3, dividing donor CL4 CD8' T cells were only observed in 
InsHA PLN and not in any other peripheral secondary lymphoid tissue. However, 
figure 4.2 shows that CL4 CD8' T cells were isolated from InsHA LPL on day 4 
which had undergone cell division to the same extent as highly divided CL4 CD8+ T 
cells in 
_BALB/c 
+ PR8 mice. Highly divided Donor CL4 CD8r T cells were not 
detected in any other compartment of InsHA mice. An increase in the number and 
proportions of divided CL4 CD8' T cells were observed amongst LPL of InsHA mice 
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Figure 4.2: CFSE expression amongst CL4 CD8` T cells isolated from secondary 
and tertiary lymphoid tissue 
5x 106 MACS-enriched CFSE-labelled Thy1.1' CL4 CD8' T cells were adoptively 
transferred into homologous InsHA or BALB/c mice co-injected with 200 HAU PR8 
i. p. After 4 days, small intestines, lungs and liver were removed and lymphoid 
cell suspensions of lamina propria lymphocytes (LPL), respiratory tract 
lymphocytes (RTL) and intrahepatic (IHL) were isolated as well as pancreatic 
lymph nodes (PLN). The lymphocytes were stained with anti-Thyl. 1 antibody then 
analysed by flow cytometry. 
2x106 cells were acquired for IHL and 5x106 cells for LPL and RTL, while for PLN 
2.5x103 CFSE-divided cells were counted. Plots show CFSE histograms for Thy1.1' 
cells. 
These results are representative of more than three separate experiments. 
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Figure 4.2: CFSE expression amongst CL4 CD8+ T cells isolated from 
secondary and tertiary lymphoid tissue 
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Figure 4.3: Donor CL4 accumulate in the lamina propria of InsHA recipients 
after undergoing division. 
5x 106 MACS-enriched CFSE-labelled Thyl. 1' CL4 CD8' T cells were adoptively 
transferred into homologous InsHA mice. After 4 or 8 days, small intestines were 
removed and lymphoid cell suspensions of lamina propria lymphocytes (LPL) were 
isolated. The lymphocytes were stained with anti-Thyl. 1 antibody then analysed 
by flow cytometry. In all 5x 106 events were collected. 
A shows the level of CFSE fluorescence amongst Thyl. 1' LPL cells after 4 or 8 days. 
These results are representative of two independent experiments. 
B shows recovered Thyl. 1' cells as a percentage of total ungated lymphocytes 
collected for each time point. 




























Figure 4.3: Donor CL4 CD8'T cells accumulate in the lamina propria of InsHA 
recipients after undergoing division. 
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Day 4 Day 8 
Chapter 4: Peripheral tolerance induction amongst ,6 cell-specific 
CL4 CD8' T cells in vivo 
8 days after transfer and of the divided cells, all had undergone many rounds of 
division (Fig. 4.3). The fact that in InsHA recipients, donor CL4 CD8' T cells found 
amongst the LPL had divided more times than in those isolated from PLN, suggests 
that after a few divisions in the PLN of InsHA mice, abortively activated CL4 CD8` 
T cells may traffic to the LPL. Also, this trafficking is specific, as highly divided 
CL4 CD8' T cells were not observed in any peripheral tissue other than LPL 
following abortive activation in InsHA mice. 
In contrast to LPL from InsHA recipients, LPL from BALB/c + PR8 recipients 
contained donor CL4 CD8' T cells across the whole range of CFSE fluorescence 
(Fig. 4.2). It is possible that this finding is due to division of donor cells in the LPL 
or that migration of donor cells occurs at all stages of division. Homing of 
activated CL4 CD8' T cells in PR8-immunised hosts could result from the fact that 
PR8 administered i. p. and therefore may trigger a local CD8' T cell response in 
GALT. To test whether or not the detection such activated donor CL4 CD8' T cells 
is due to in situ activation, CFSE-labelled CL4 CD8' T cells were adoptively 
transferred into groups of BALB/c mice, which were immunised with PR8 by either 
i. p or s. c. at the base of the tail. After 4 days, lymphoid cell suspensions of LN, 
IHL and LPL were isolated for each group. These cells were stained with anti- 
Thyl. 1 antibodies and analysed by flow cytometry. The CFSE division profiles of 
donor CL4 CD8' T cells activated by PR8 were similar whether the PR8 
administered i. p. or s. c. in LN, IHL and LPL (Fig. 4.4). More division of CL4 CD8' T 
cells was observed in the LN of s. c. -immunised mice as compared to i. p. 
immunised mice, possibly due to PR8 infection being more systemic in s. c. - 
immunised mice. These data indicate that the presence of divided donor cells in 
the LPL is not influenced by the site of PR8 administration. 
-121 - 
Figure 4.4: Does the route of administration of PR8 influence CL4 CD8; T cells 
migration to tertiary lymphoid tissues? 
5x 106 MACS-enriched CFSE-labelled Thyl. 1` CL4 CD8` T cells were adoptively 
transferred into homologous BALB/c mice. Mice were injected i. p. or s. c with 200 
HAU PRB. After 8 days, small intestines and liver were removed and lymphoid cell 
suspensions of lamina propria lymphocytes (LPL) and intrahepatic lymphocytes 
(IHL) were isolated as well as PLN. The lymphocytes were stained with anti- 
Thyl. 1 antibody then analysed by flow cytometry. 
In all analyses 5x 106 lymphocytes were acquired for LPL, 2x 106 lymphocytes for 
IHL and 1x 105 lymphocytes for LN. Plots show CFSE histograms for Thy1.1' cells. 
These results are representative of two independent experiments. 
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Figure 4.4: Does the route of administration of PR8 influence CL4 CD8' T 
cell migration to tertiary lymphoid tissues? 
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Nave CL4 CD8+ T cells adoptively transferred into 13118-immunised BALB/c mice 
divided and migrated to the IHL, RTL and LPL lymphoid compartments. Whereas, 
CL4 CD8+ T cells encountering self-antigen in InsHA mice migrated only to the 
small intestine LPL. Donor CL4 CD8+ T cells were not found amongst the small 
intestinal IEL of PR8-immunised mice or InsHA recipients. It has been previously 
shown that many T cells within the epithelium of the small intestine lack 
expression of the Thyl T cell marker (Lefrancois, 1991). It is possible that that T 
cells migrating to the gut from other lymphoid sites downregulate expression of 
Thyl. If IEL-homing involves Thyl downregulation, donor CL4 CD8+ T cells could 
not be discriminated from host cells based on Thyl. 1 expression. To solve this 
potential problem, we utilised the Ly5 (CD45) congenic marker which is expressed 
at high levels on all mature T cells including IEL (Raveney, BJ and Pullen, AM, in 
press). Ly5.2" CL4 CD8' T cells were detected using anti-Ly5.2 antibodies 
following adoptive transfer into Ly5.1` hosts. As the congenic marker was only 
available on the H-2d B10. D2 background, InsHA B10. D2 mice and PR8-immunised 
non-transgenic B10. D2 mice were used as hosts. Using these mice, adoptive 
transfer experiments were performed to compare the migration to tertiary 
lymphoid sites of CL4 CD8' T cells following productive or abortive activation. 
8 days after transfer of Ly5.2+ CL4 CD8' T cells into PR8-immunised B10. D2 mice, 
secondary lymphoid tissue contained mainly-highly divided donor cells (Fig. 4.5). 
All donor cells isolated from the LPL of the small intestine of such mice were 
highly divided (Fig. 4.5). Ly5.2+ CL4 CD8' T cells in IEL of PR8-immunised mice had 
undergone similar numbers of rounds of division as activated CL4 CD8+ T cells 
observed amongst the IHL and RTL, but fewer divisions than those late stage cells 
detected in the PLN and LPL (Fig. 4.5). The presence of Ly5.2' CL4 CD8' T cells in 
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Figure 4.5: Is the failure to detect CL4 CD8` T cells amongst IEL due to down 
regulation of Thyl? 
5x 106 MACS-enriched CFSE-labelled Ly5.2' CL4 CD8' T cells were adoptively 
transferred into homologous Ly5.1 InsHAor into Ly5.1 B10. D2 mice immunised i. p. 
with 200 HAU PR8. After 8 days, PLN, LPL and IEL cells were stained with PE- 
conjugated anti-Ly5.2 antibody and analysed by flow cytometry. 5,000 Ly5.2', 
divided CFSE positive lymphocytes were counted for each sample. 
Plots show CFSE histograms Ly5.2' cells. 
These results are representative of three independent experiments. 
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Figure 4.5: Examination of IEL from recipient mice following adoptive 
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the IEL compartment of PR8-immunised mice is in contrast to the original 
experiments using Thy1.1+ CL-4 CD8' T cells. Ly5.2' CL4 CD8' T cells encountering 
KdHA as a self-epitope in the PLN of InsHA mice underwent limited proliferation 
(Fig. 4.5) and divided CL4 CD8' T cells were not observed in any other secondary 
lymphoid tissue (data not shown). Highly divided Ly5.2` CL4 CD8' T cells were 
only found amongst LPL of InsHA recipient mice. As in experiments transferring 
Thy1.1` CL-4 CD8' T cells, no donor CL4 CD8' T cells were detected in InsHA IEL 
(Fig. 4.5). These data suggested that productively activated CL4 CD8' T cells 
downregulate Thyl and migrate into the IEL compartment, whereas abortively 
activated CL-4 CD8' T cells do not and appear only to home to the LPL 
compartment. 
4.3.2 Accumulation of CL4 CD8' T cells over time 
Data suggest that the process of peripheral tolerance induction by abortive 
activation in InsHA PLN is also associated with the appearance of highly divided 
self-specific CD8+ T cells amongst the LPL. Only few highly divided donor CL4 
CD8+T cells can be isolated from the LPL of InsHA recipients. To generate mice in 
which greater numbers of CL4 CD8'T cells emerging from the thymus for tolerance 
induction in the periphery we made mixed bone-marrow chimeric mice. Lethally 
irradiated InsHA mice were reconstituted with 10% CL4 bone marrow (Thy1.1') 
mixed with 90% bone marrow from non-transgenic BALB/c mice (Thy1.2'). These 
10%CL4 BM4InsHA mice have increased numbers of high avidity KdHA-specific 
thymic emigrants as compared to InsHA mice. In order to examine the effect of ß 
cell-expressed HA on the peripheral T cells, control 10%CL4 BM4BALB/c chimeras 
were also generated. By comparing the circulating T cell repertoire and LPL of 
10%CL4 BM4InsHA chimeras with 10%CL4 BM3BALB/c chimeras, it would be 
possible to determine whether or not migration to the LPL by abortively activated 
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cells is a part of the natural peripheral tolerance induction process or if migration 
to the LPL is simply an artefact of clearing high numbers of adoptively transferred 
cells. Examination of chimeric mice may also indicate whether or not self-specific 
CD8'T cells are long-lived in the periphery/LPL following abortive activation. 
In previous studies, we demonstrated that CL4 CD8' T cells are not deleted in the 
thymus of CL4 X InsHA F, hybrids (Morgan et at., 2004). To examine the effect of 
peripheral expression of the HA transgene, the thymic output of CL4 CD8+ single 
positive cells amongst both the 10%CL4 BM4InsHA and the 10%CL4 BM-)BALB/c 
chimeras must be approximately equal. 
Flow cytometric analyses revealed that there were similar proportions of CD4"CD8' 
, CD4'CD8`, and CD4'CD8+ thymocytes in 
both 10%CL4 BM4InsHA and 10%CL4 
BM4BALB/c groups (Fig. 4.6A). Importantly, the percentage of CD8'CD4' single 
positive thymocytes expressing Thyl. 1 in 10%CL4 BM-4InsHA mice was similar to 
10%CL4 BM-)BALB/c single positive thymocytes (Fig. 4.6B). Therefore, any 
differences observed between the T cell populations in peripheral lymphoid 
compartments (LN and LPL) of 10%CL4 BM4InsHA chimeras and control 10%CL4 
BM-)BALB/c chimeras would be due to peripheral expression of the InsHA 
transgene. 
Examination of LN from 10%CL4 BM4InsHA chimeras revealed many fewer Thyl. 1` 
cells amongst CD3' LN cells as compared with Thy1.1' cells amongst CD3+ LN cells 
from 10%CL4 BM4BALB/c chimeras (Fig. 4.7A). Although, equal numbers of 
Thy1.1`, CD4', CD8` thymocytes were observed in 10%CL4 BM4InsHA and 10%CL4 
BM4BALB/c chimeras and 10%CL4 BM4InsHA LN contained at least four fold 
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Figure 4.6: Flow cytometric analyses of thymocytes from 10%CL4 BM4InsHA 
chimeric mice 
Non-transgenic BALB/c and InsHA mice were lethally y-irradiated (950 rads) and 
rested for 24 hours. Mice were then injected with mixed bone marrow: 90% 
Thy1.2' BALB/c BM and 10% Thy1.1' CL4 BM. Mice were then rested for 10-16 
weeks to allow for reconstitution. 
Thymocytes were harvested from both 10%CL4 BM4BALB/c and 10%CL4 
BM4InsHA mice and stained with a panel of antibodies of antibodies before flow 
cytometric analyses. 
Panel A shows the expression of CD8a versus CD4 by thymocytes from 10%CL4 
BM-4InsHA and 10%CL4 BM-4BALB/c mice. 
Panel B shows the expression of Thyl. 1 by CD8'CD4' thymocytes from 10%CL4 
BM4InsHA and 10%CL4 BM9BALB/c mice. 
These results are representative of at least three independent experiments. 
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Figure, 4.6: Flow cytometric analyses of thymocytes from 1O%CL4 BM4InsHA 
chimeric mice 
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Figure 4.7: Analyses of CL4 CD8` T cells from 10%CL4 BM4 InsHA chimeric 
mice 
Non-transgenic BALB/c and InsHA mice were lethally y-irradiated (950 rads) and 
rested for 24 hours. Mice were then injected with mixed bone marrow: 90% 
Thy1.2' BALB/c BM and 10% Thyl. 1' CL4 BM. Mice were then rested for 10-16 
weeks to allow for reconstitution. 
LN an LPL cell suspensions were prepared from both 10%CL4 BM-4BALB/c and 
10%CL4 BM4InsHA mice and stained with a panel of antibodies of antibodies 
before flow cytometric analyses. 
Panel A shows the expression of Thyl. 1 versus TcR-Vß8 by CD3' LN (upper) or CD3' 
LPL (lower) from 10%CL4 BM)InsHA and 10%CL4 BM4BALB/c mice. 
These results are representative of at least three independent experiments 
LN cell suspensions were prepared from both 10%CL4 BM3BALB/c and 10%CL4 
BM4InsHA mice. The percentage of Thyl. 1' cells was measured for each 
suspension. Irradiated syngeneic 'filler' splenocytes were added to LN cells 
suspensions from 10%CL4 BM )BALB/c mice to reduce the percentage of Thyl. 1+ 
cells to that of the LN cell suspensions from 10%CL4 BM4InsHA mice. LN cell 
suspensions were then seeded at 1,000 unpurified Thyl. 1` cells per well and co- 
cultured with irradiated KdHA-pulsed splenocytes for 48 hours. Proliferation was 
measured as incorporation of 3H-thymidine during the final 8 hours. 
Panel B depicts the proliferation of LN cells from 10%CL4 BM4InsHA and 10%CL4 
BM4BALB/c mice in response to increasing amounts of KdHA. LN cells from InsHA 
and BALB/c cell were also tested as controls. 
These results are representative of at least three independent experiments. 
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fewer Thyl. 1' than 10%CL4 BM4BALB/c LN, the percentage of Thy1.1' cells 
amongst 10%CL4 BM)InsHA LPL T cells was always observed to be at least two 
fold greater than Thy1.1' amongst 10%CL4 BM4BALB/c LPL T cells (Fig. 4.7A). 
These data imply that the toss of Thy1.1' CL-4 CD8' T cells from the periphery of 
10%CL4 BM4InsHA mice is accompanied by accumulation of Thy1.1` cells in the 
LPL. 
Although, reduced numbers of Thy1.1' cells were isolated from 10%CL4 BM-4InsHA 
LN cells, some potentially auto-reactive Thy1.1` remained. To ascertain if such 
cells were capable of mounting HA-specific responses, the ability of LN cells from 
chimeric mice to proliferate in response to KdHA-epitopes was tested in vitro. 
10%CL4 BM4BALB/c LN cells proliferated at low concentrations of KdHA, 
demonstrating a high avidity response (data not shown). 10%CL4 BM-4InsHA LN 
cells did not proliferate in the presence of KdHA (data not shown). It is possible 
that the lack of proliferation by 10%CL4 BM+InsHA LN in response to KdHA- 
epitopes may be due to too low a number of CL4 CD8' T cells, as in such mice 
fewer Thy1.1' LN cells are present as compared with 10%CL4 BM4BALB/c mice. 
To determine whether or not circulating Thy1.1` T cells 10%CL4 BM)InsHA 
chimeras were able to respond to KdHA with similar avidity to those Thy1.1' T cells 
from 10%CL4 BM-)BALB/c chimeras, in vitro proliferation assays were performed 
with equal numbers of Thy1.1` cells from each group as responders. The 
percentage of Thy1.1` cells in LN suspensions from 10%CL4 BM3InsHA and 10%CL4 
BM)BALB/c chimeras was determined by flow cytometry. The percentage of 
Thyl. 1+ cells was equalised between the two groups by the addition of irradiated 
splenocytes as "filler" cells to 10%CL4 BM4BALB/c LN cells, which decreased the 
proportion of Thy1.1' cells. Responder cells were seeded, such that each well 
contained 1,000 Thy1.1` cells and then co-cultured with KdHA-pulsed irradiated 
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sptenocytes for 48 hours. LN cells from 10%CL4 BM4InsHA did not proliferate in 
response to KdHA-epitopes (Fig. 4.7B). LN cells from 10%CL4 BM4BALB/c mice 
proliferated in response to KdHA, even when co-cultured with splenocytes that had 
been pulsed with a low concentration of KdHA (Fig. 4.7B). These data imply that 
loss of Thy1.1` T cells from the repertoire of 10%CL4 BM4InsHA mice is 
accompanied by toss HA-specific responses by peripheral T cells and any remaining 
Thy1.1+ cells are non-responsive to KdHA. 
4.4 Discussion 
The mechanism in which CL4 CD8' T cells are functionally deleted through 
peripheral tolerance induction following encounter with self-K°HA epitopes was 
investigated. It is proposed that abortive activation does not lead to deletion at 
the site of activation, but that CL4 CD8' T cells are functionally deleted by 
migration from the periphery into the tertiary lymphoid tissue of the small 
intestine lamina propria. 
As already stated, previous studies by Sherman and co-workers indicated that 
deletion occurs of CL4 CD8+ T cells from InsHA mice occurs through mechanisms of 
apoptosis (Hernandez et al., 2001), as has been reported in other transgenic 
mouse models of peripheral tolerance induction (Critchfield et al., 1994; Huang 
and Crispe, 1993; Kurts et al., 1998; Kurts et al., 1997b). However, as annexin V 
binding data measuring of apoptosis amongst CL4 CD8' T cells undergoing abortive 
activation in InsHA PLN is unconvincing, we investigated alternative mechanisms 
to explain the functional loss of CL4 CD8' T cells from the periphery of InsHA 
mice. 
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One possible mechanism of peripheral tolerance induction is the action of 
naturally occurring CD4'CD25' regulatory T cells to prevent the activation of 
potentially auto-reactive T cells (Sakaguchi et at., 1995; Taguchi and Nishizuka, 
1987). Using transgenic murine models, other studies have also demonstrated the 
production of CD4` regulatory T cells subsequent to the induction of peripheral 
tolerance (O'Neill et at., 2004; Weiner, 1997). A few studies have also shown that 
subpopulations of CD8' T cells may also be able to act in a regulatory manner 
(Mukasa et at., 1994). Although the role of regulatory T cells has not been 
previously addressed in the induction of tolerance to peripherally-expressed HA in 
InsHA mice, this mechanism is an attractive explanation for how autoimmunity is 
prevented in InsHA mice. CD4'CD25' regulatory T cells do not exit the thymus for 
some time in neonatal mice (Asano et at., 1996). Interestingly, also during this 
time period F, InsHA X CL4 double transgenic mice are susceptible to developing 
spontaneous diabetes neonatally (Morgan et at., 1996). It has been suggested that 
autoimmunity resulted from the fact that peripheral tolerance mechanisms were 
overwhelmed by such high numbers of potentially auto-reactive cells exiting the 
thymus needing to be tolerised. However, when high numbers of CL4 CD8' T cells 
were adoptively transferred into older InsHA mice, these cells underwent 
peripheral tolerance induction. Furthermore, the immunisation of neonatal InsHA 
mice up to 2 weeks of age with PR8 induces autoimmune diabetes (Morgan et at., 
1999b). It is possible that the diabetes observed in neonatal mice may result from 
the fact that at this stage too few thymic regulatory cells circulate to prevent 
activation of such a high numbers of CL4 CD8+ T cells. Another explanation is 
that, as tolerance induction coincides with the appearance of dendritic cells in 
lymphoid tissue, it is cross-presentation of self-epitopes by DCs, rather than the 
influence of regulatory T cells, that induces peripheral tolerance neonatally 
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(Fraser and Morgan, unpublished data). This possibility is further discussed in 
Chapter 5a. 
We carried out experiments to determine whether or not regulatory T cell play a 
role in the induction of peripheral tolerance in InsHA mice. CD4''" InsHA and CD8''" 
InsHA mice were profoundly tolerant to HA and CL4 CD8+ T cells transferred into 
such mice are toterised by abortive activation (Chapter 4.2). These data indicate 
that induction of peripheral tolerance by abortive activation in InsHA mice is 
unlikely therefore unlikely to rely on endogenous populations of regulatory T cells. 
An alternative explanation for the lack effector function amongst abortively 
activated CL-4 CD8' T cells is that such cells are rapidly transported from the site 
activation to distal tissues. After abortive activation of CL4 CD8` T cells in InsHA 
recipients, highly divided donor cells could be detected amongst the LPL of the 
small intestine and there was an accumulation of these cells in the LPL over time. 
Whereas, such highly divided cells were not detected in RTL and IHL, the other 
sites previously associated with the disposal of activated T cells (Galkina et al., 
2005; Wack et al., 1997), nor in IEL, MLN, PP and the lamina propria of other 
mucosal tissues (VL). Therefore, it appears that the migration of divided CL4 CD8+ 
T cells in the LPL was specific. Highly divided CL4 CD8' T cells were found 
amongst IHL, RTL, and IEL, the other putative T cell 'disposal sites', subsequent 
to productive activation in response to PR8, indicating that the techniques 
employed could successfully isolated T cells from tertiary lymphoid tissue. It is 
possible that the presence of highly divided CL4 CD8` T cells amongst the LPL of 
InsHA mice could be explained by activation of these cells in this location, rather 
than activation in the PLN and their subsequent migration. -. CFSE peaks showing 
intermediate division were not detected in the LPL at any time point, which 
-132- 
Chapter 4: Peripheral tolerance induction amongst ß cell-specific CL4 CD8` T cells in vivo 
implies that in situ activation is unlikely. Other laboratories have implied that 
homing into GALT tissue requires attachment to the mucosal associated cell 
adhesion molecules (MadCAM; (Picker, 1994). Naive CL4 CD8' T cells do not 
express the ligand for MadCAM, a47 (CD49d; Chapter 3), and upregulation of this 
integrin by CL4 CD8' T cells occurs after both abortive and productive activation. 
This upregulation may allow the migration of CL4 CD8' T cells into the LPL of 
InsHA recipient mice subsequent to their activation. This hypothesis could be 
tested by examining the effect of administering anti-MadCAM blocking antibodies 
to InsHA mice prior to CL4 CD8' T cells transfer on homing to the LPL cross- 
breeding CL4 mice with 07"" mice. Expression of HA protein in intestinal tissue 
could explain the presence of highly divided CL4 CD8' T cells amongst the LPL. 
Therefore, it is proposed that western blots could be used to detect HA protein or 
RT-PCR utilised to examine HA mRNA production, in order to determine whether 
or not HA is expressed by InsHA intestinal tissue. 
It was found that CL4 CD8+ T cells present in the LPL compartment of PR8- 
immunised BALB/c recipients undergo more rounds of division than those CL4 CD8' 
T cells isolated from secondary lymphoid tissue, IHL or RTL. The increased 
division of CL4 CD8' T cells in LPL as compared to other tissues was not as a result 
of the fact that PR8 was delivered into this tissue (i. p. ), as administration of PR8 
s. c also generated LPL-resident CL4 CD8' T cells, which had divided more times 
than activated CL4 CD8' T cells in other tissues. Highly divided CL4 CD8' T cells 
isolated from InsHA LPL had also undergone the same number of divisions as those 
in the LPL of BALB/c + PR8, implying that post-activation migration of T cells to 
the LPL may have an altered function to those migrating to other tertiary 
lymphoid sites. The liver contains a high percentage of T cells undergoing 
apoptosis and this has been suggested as the main site of deletion of activated T 
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cells (Crispe et at., 2000). The lung has also been linked with deletion of T cells 
which have undergone clonal exhaustion (Maxwell et al., 2004). Early studies 
indicated that the gut was aT cell 'graveyard' (Sprent, 1976). However, more 
recent studies put forward hypotheses stating that T cells in the small intestine 
are self-specific and are involved in tolerance (Poussier et al., 2002) or 
responsible for the prevention of responses to environmental antigens (Cheroutre, 
2005; Nagler-Anderson and Shi, 2001). GALT T cells are long-lived (Wang et al., 
2003), therefore it is suggested that following productive activation some CL4 
CD8' T cells selectively home to LPL and such cells are responding in an altered 
manner to that of CL4 CD8' T cells, which are cleared in the lungs, liver or at the 
site of activation. 
Accumulation of CL4 CD8' T cells amongst small intestine LPL was also observed in 
10%CL4 BM4InsHA mice. As mixed bone-marrow chimeras do not involve the 
transfer of naive great numbers CL4 CD8+ T cells, but instead involve the 
emergence of CL4 CD8' T cells after developing in the thymus over time, 10%CL4 
BM4InsHA may model peripheral tolerance induction amongst CD8' T cells more 
accurately. 10%CL4 BM-)InsHA mice exhibited a loss of HA-specific CD8' T cells 
over time, as compared to 10%CL4 BM4BALB/c control mice, accompanied by a 
functional loss of peripheral anti-HA response. Tolerance induction in 10%CL4 
BM4InsHA did not appear to have a thymic component as 10%CL4 BM41nsHA mice 
had similar proportions of CL4 transgenic thymocytes to 10%CL4 BM4BALB/c 
control mice. 10%CL4 BM4InsHA mice had higher numbers of CL4 CD8' T cells 
amongst their LPL than 10%CL4 BM4BALB/c littermate controls. The association 
in 10%CL4 BM)InsHA between the loss of peripheral self-specific T cells and the 
accumulation of such cells in the LPL suggests that migration to LPL is likely to be 
linked to peripheral tolerance induction. Experiments with 10%CL4 BM4InsHA 
-134- 
Chapter 4: Peripheral tolerance induction amongst ß cell-specific CL4 CD8` T cells in vivo 
chimeras negate the possibly that the similar migration observed amongst 
transferred CL4 CD8` T cells is an phenomenon generated because of the non- 
physiological experimental conditions rather than natural peripheral tolerance 
induction. Additionally, the fact that increased numbers of CL4 CD8` T cells were 
isolated from the LPL of 10%CL4 BM4InsHA at later time intervals following 
reconstition, implies that tolerised T cells may be retained long-term in this 
tissue. CL4 transgenic cells in the LPL of 10%CL4 BM4InsHA mice do not express 
CD8 and have reduced TcR expression. TcR down regulation. has been reported 
amongst anergised T cells (Benson et al., 2000). There are also reports 
demonstrating altered co-receptor expression amongst T cells found in the GALT 
(Lefrancois, 1991) and many T cells found in the GALT appear to have been 
previously activated (Wang et at., 2002). For example, in a double transgenic 
system, where mice have only peripheral CD8` T cells which are specific for a gut 
epithelial-expressed self-antigen, an accumulation of CD8aa' T cells and T cells 
which lack co-receptor expression can be observed in the IEL (Personal 
communication with A. Herman, University of Bristol). It is suggested that these 
cells were activated by self-antigen and down regulate expression of 08aß and 
are retained long-term in GALT tissue. It is possible that similar mechanisms 
occur amongst CL4 CD8+ T cells adoptively transferred into InsHA recipients. In 
such mice partially activated CL4 CD8` T cells may traffic from the PLN to LPL 
were they are retained in a non-auto-reactive state for an, as yet, undetermined 
purpose. 
Although, it has been hypothesised that the induction of peripheral tolerance 
amongst CL4 CD8+ T cells involves their migration and accumulation in the LPL of 
the small intestine, it is possible that LPL migration could be generated by the co- 
expression of an alternative TcR by CL4 CD8+ T cells. Evidence from several 
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studies demonstrate that T cells can express more than one TcR (Bluthmann et 
at., 1988; Malissen et al., 1988) and this may be true of CL4 CD8` T cells as it is 
known that allelic a chain exclusion is incomplete (Casanova et al., 1991; Lo et 
at., 1992; Wallace et at., 1995). It is crucial to determine whether or not LPL 
homing essential part of the tolerising process of CD8+ T cells in InsHA mice or if 
such migration is mediated by the expression of a second TcR. To answer this 
question, CL4 RAG''' mice could be generated and experiments where RAG''' CL4 
CD8` T cells are transferred into InsHA mice could be performed. Any migration of 
RAG'"* CL4 CD8' T cells to InsHA LPL following abortive activation must be due to 
tolerance induction and not expression of second TcRs by CL4 CD8' T cells. 
Examination of the abortive activation of CL4 CD8+ T cells in InsHA mice 
demonstrates that tolerance in the InsHA mouse is unlikely to involve peripheral 
deletion of potentially auto-reactive T cells at the site of activation. As these 
cells undergo a partial activation, maintenance of tolerance to ß cell expressed 
HA cannot be due to ignorance of the self-antigen. Additionally, tolerance 
induction can occur in the absence of population of regulatory T cells. Lack of 
evidence for these mechanisms of peripheral tolerance has led to investigation of 
an alternative pathway: that CL4 CD8' T cells undergoing tolerance are 
transported to a distal site where deletion or retention occurs. The data 
described in this chapter support the hypothesis that T cells subsequent to the 
induction of peripheral tolerance migrate to the lamina propria of the small 
intestine. Such cells may survive in this location for an as yet unknown purpose. 
It is hoped that further study and possible isolation of this novel population of 
cells may provide clues as to how tolerance of CD8' T cells can be maintained. It 
is possible that such cells will a reveal potent pathway to prevent autoimmunity. 
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5a. 1 Introduction 
The röte of the DC as an antigen presenting cell (APC) in the initiation of immunity 
to pathogens is well described (Inaba et at., 1993; Inaba et at., 1990; Schuler and 
Steinman, 1985). DCs also prevent autoimmunity though the process of central 
tolerance induction, in which any developing thymocyte which responds with high 
avidity to self-epitopes presented by DCs is deleted (Hengartner et at., 1988; 
Nossal, 1994). Recent evidence suggests that in the absence of inflammatory 
signals naive DCs (immature dendritic cells; iDC) may also participate in the 
induction and maintenance of peripheral self-tolerance (Bonifaz et at., 2002; 
Ferguson et at., 2002; Hawiger et at., 2001; Heath and Carbone, 2001; Legge et 
at., 2002). It is known that DCs capture both microbial antigens and self-peptides 
by endocytosis in vivo for presentation (Huang et at., 2000; Scheinecker et at., 
2002), yet in the steady state DCs only initiate T cell immunity to foreign 
antigens. Additionally, co-culture of CD4+ T cells with allogeneic iDCs can lead to 
the generation of anergic IL-10-secreting regulatory CD4' T cells (Jonuleit et at., 
2000), suggesting that similar regulatory cells generated by iDC stimulation in vivo 
may help suppress autoimmunity. There is also evidence that DCs play a role in 
the peripheral deletion of T cells.. Murine studies have indicated that BM-APCs are 
required for the induction of peripheral tolarance amongst naive CD4' and CD8' T 
cells (Betz et at., 2002a; Burkly et at., 1989; Kurts et at., 1996) and as well as 
memory CD8+ T cells (Kreuwel et at., 2002). 
It has been suggested that during the early stages of type 1 diabetes mellitus, 
tissue damage, infiltration and inflammation is produced by CD8' T cells which 
thereby sets up the conditions for further activation and auto-reactivity by other 
immune cell populations (Herrera et at., 1994; Jorns et at., 2005). Therefore 
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controlling the activation of CD8' T cells to induce tolerance rather than 
productive activation, may be crucial in prevention of autoimmunity. Thus, we 
examined interactions between CD8' T cells and DCs to determine whether or not 
CD8` T cell activation could be controlled by DCs. 
It is hypothesised that peripheral tolerance induction amongst KdHA-specific T 
cells in InsHA mice results from interaction with self-epitopes in the periphery. 
However, it is unclear how -and where nave CD8' T cells encounter such KdHA- 
epitopes. Following transfer into InsHA mice, activated donor CL4 CD8` T cells are 
only observed in the pancreatic lymph nodes that drain the site of HA expression 
(PLN). As proliferation is limited to PLN, it is unlikely that HA proteins are shed 
by pancreatic islet ß cells in InsHA mice. Also naive CL4 CD8' T cells do not 
express adhesion molecules that allow trafficking through non-lymphoid tissue, 
and are therefore unlikely to encounter ß cell antigens in situ. Thus, direct 
presentation of K°HA-eptiopes from ß cells to CL4 CD8' T cells may not occur. 
Other models of peripheral tolerance induction have demonstrated that there is a 
requirement for bone marrow-derived APCs in the induction of peripheral 
tolerance amongst auto-reactive transgenic CD8' T cells (Kurts et al., 1996). We 
hypothesise that ß cell-derived KdHA epitopes are cross-presented to CL4 CD8' T 
cells by APCs. To determine whether or not bone marrow-derived APCs are 
required to induce tolerance amongst CL4 CD8' T cells transferred into InsHA 
mice, experiments were performed using H-2kBM 4InsHA bone marrow chimeras. 
InsHA mice were lethally irradiated and reconstituted with H-2k bone marrow. In 
H-2kBM 4InsHA BM chimeras, host cells, such as pancreatic ß cells, are able to 
present epitopes on the MHC class I molecule Kd, but BM-APCs, derived from H-2k 
bone marrow, are deficient in Kd presentation. Control H-2dBM-+InsHA chimeras 
were also generated: in which lethally-irradiated InsHA mice were reconstituted 
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with H-2d bone marrow. H-2dBM. InsHA chimeras have Kd-restricted presentation 
by host cells and BM-APC. CL4 CD8+ T cells only recognise the dominant HA- 
epitope presented by the MHC class I molecules Kd. CL4 CD8' T cells adoptively 
transferred into H-2dBM4InsHA chimeras proliferated in the PLN, similar to CL4 
CD8' T cell proliferation following transfer into InsHA mice. However, CL4 CD8' T 
cells did not proliferate when transferred into H-2kBM4InsHA. These data suggest 
that the abortive activation of CL4 CD8+ T cells in the PLN InsHA mice does not 
rely on direct presentation by ß cells, but requires a BM-APC sufficient in Kd 
(Fraser and Morgan, unpublished data). Other studies have demonstrated a röte 
for DCs in peripheral tolerance to f cell-derived auto-antigens (Betz et at., 
2002a). Therefore, it is likely that DCs also induce tolerance amongst ß cell- 
specific CD8' T cells in the InsHA mouse. 
The nature of CL4 CD8' T cell activation depends upon whether KdHA is 
encountered as a self-antigen (InsHA) or as a foreign antigen (BALB/c + PR8). CL4 
CD8+ T cells undergo abortive activation following encounter with KdHA epitopes in 
the PLN of InsHA mice and as a result are tolerised. Whereas, activation of CL4 
CD8+ T cells in PR8-immunised conventional mice is referred to as productive 
(Chapter 3). It is possible that these opposing responses may result' from KdHA 
being presented presentation by different cell types. One suggestion is that the 
phenotype and functional qualities of the BMDC dictates whether abortive or 
productive T cell activation is induced. Possibly DCs encountering antigen in a 
non-inflammatory environment are not activated. Therefore immature DCs 
presenting antigen to T cells without a `danger signal', leads to abortive 
activation and the induction of peripheral tolerance. Experiments were carried 
out to answer the following questions: can DCs cross-present ß cell-derived HA- 
epitopes to CL4 CD8+ T cells? Do iDCs and mDCs activate CL4 CD8+ T cells to 
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produce different responses? How do DCs acquire HA-epitopes? Can iDCs acquire 
HA-epitopes from ß cells by a separate mechanism to acquisition by mDCs thus 
remain immature? 
5a. 2 Generation and isolation of APCs 
We suggest that it is likely that DCs are responsible for cross-presentation of ß 
cell-derived antigens resulting in abortive activation of CL4 CD8' T cells in InsHA 
PLN leading to tolerance induction. We investigated CL4 CD8` T cell interactions 
with DCs, and examined whether DCs can cross-present KdHA to CL4 CD8+ T cells. 
Therefore, we established protocols to produce purified populations of BMDCs for 
use in such assays. 
Many protocols have been previously described for the generation of purified 
population of DCs (Bartz et at., 2003; Inaba et at., 1992a; Lopez et at., 2003; Lutz 
et at., 1999). Circulating DCs are routinely enriched from the secondary lymphoid 
tissue or blood of mice, rats and humans (Inaba et at., 1992b; Thomas et at., 
1993; Thomas and Lipsky, 1994; Vremec et at., 1992). Murine DCs found amongst 
peripheral tissues, such as the lung, the small intestine or ear have also been 
studied (Austyn et at., 1994; Calder et at., 2004; Macpherson and Uhr, 2004; 
Ortner et at., 1996). It is predicted that DCs from these peripheral sources will 
have encountered many antigens prior to their isolation. Therefore, it is likely 
that these isolation protocols would yield populations of DCs with a broad range of 
maturities. Previous studies in other laboratories have used murine DCs generated 
ex vivo from bone marrow progenitor cells (Inaba et at., 1992a; Scheicher et at., 
1992; Yamaguchi et at., 1997). Unlike DCs isolated from the periphery, the 
maturation status of ex vivo generated BMDCs can be controlled, yielding iDCs. 
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In the following set of experiments we have utilised a method for generation of 
BMDCs ex vivo adapted from a protocol devised by Lutz and co-workers (Lutz et 
at., 1999). Bone marrow progenitor cells were isolated from the tong bones of the 
hind limbs and pelvis of conventional unmanipulated BALB/c mice and 
macrophages were depleted by adherence to tissue-culture plastic. These non- 
adherent cells were cultured in the presence of GM-CSF for 10 days, during this 
_ 
time media was replaced at intervals with fresh GM-CSF containing media. Care 
was taken to limit manual manipulation as it has been suggested that such activity 
can cause spontaneous DC activation. This protocol yielded immature DCs (iDCs); 
matured DCs (mDCs) were generated using similar protocols with the addition of 
LPS for the final 24 hours of culture. 
Bone-marrow progenitor cells can differentiate into several cell types, depending 
upon the culture conditions (Lutz et at., 1999). It is therefore essential to ensure 
that all the cultures used in this study generate pure population of DCs. Samples 
were taken from DC growth cultures and tested by flow cytometry to determine 
their purity, phenotype and state of activation. As myloid DCs express CD11c and 
CD11b (Buckley, 1991), the binding of antibodies against these surface markers 
was tested. In addition, antibodies against markers of non-DC BM cells were used, 
such as the granulocyte marker GR-1 and the B cell marker B220. 
Figure 5a. 1 shows representative flow cytometric analyses of iDCs and mDCs 
generated by culture of BM progenitor cells. Greater than 90% of cultured BM 
cells expressed the DC marker CD11c, indicating DCs had been generated (Fig. 
5a. 1 B1-2). These CD11 c` cells also expressed CD11b, a marker of myeloid DCs 
(Fig. 5a. 1C1-2). Lack of expression B220 (CD45R), CD19, NK1.1 and DX220 
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iDCs were prepared from BM cells from BALB/c mice, by culture in complete 
media containing GM-CSF for ten days. mDCs were prepared by a similar method 
except that LPS was added to cultures for the final 24 hours. DCs were harvested 
and stained with a panel of antibodies against DC markers, co-stimulatory 
molecules, adhesion molecules, MHC molecules together with appropriate isotype 
controls. The expression of these markers was assayed by flow cytometry. 
Forward and Side scatter properties are shown for both mDCs and iDCs (Al and A2 
respectively). Dot plots B1 and B2 show the expression of both CD11c and Gr-1 by 
mDCs and iDCs, while histograms C1 and C2 show CD11 b expression. In panel D 
histograms depict the expression of selected co-stimulatory molecules, MHC 
molecules and adhesion molecules by mDCs (black lines) and iDCs (grey tines). 
The control refers to relevant isotype staining of mDCs (light grey filled). All plots 
show ungated cells. These results are representative of more than forty 
experiments. 
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indicated that the cultures did not contain any B cells or NK cells (data not 
shown). Furthermore, it was noted that the amount of Gr-1 expressing 
granulocytes was consistently less than 5%. 
DCs exist in a range of maturation states (Banchereau et at., 2000), which define 
their activity. iDCs are described as optimised for antigen uptake and processing 
(Inaba et at., 1992a; Inaba et at., 1992b), while mDCs function as effective 
antigen presenting cells (Ruedl and Hubele, 1997). Importantly, it has been 
suggested that DCs in an immature state could act as tolegenic APCs (Steinman et 
at., 2003). Therefore, it was crucial to determine the maturation of BMDCs 
utilised. To this end, flow cytometric examination of the cell surface expression 
of MHC class I and II molecules, co-stimulatory molecules and adhesion molecules 
was carried out to examine the DC maturation state. 
Increases in both forward and side scatter were observed amongst mDCs compared 
to iDCs by flow cytometry (Fig. 5a. 1A1-2). iDCs expressed low amounts of CD40 
and the majority of these cells also lacked CD80 expression, while iDCs expressed 
CD86 (Fig. 5a. 11)). iDCs did not express 4-1 BBL, a co-stimulatory molecule 
demonstrated in other studies to be of particular importance in the activation of 
CD8' T cells (Fig. 5a. 1 D). Addition of LPS to BM cultures resulted in expression of 
CD40 and higher levels of expression of CD80 and CD86 as compared with 
expression by iDCs (Fig. 5a. 11)). Interestingly, no expression of 4-1 BBL was 
observed in mDCs (Fig. 5a. 11)). 
Most studies which- characterise the maturation status of BMDCs by flow cytometry 
rely upon the level of MHC class II as a measure of DC maturity, as MHC class II is 
expressed at high levels by mDCs (Amrani et al., 2002). The focus of this thesis is 
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the response made by CD8' T cells, thus levels of MHC class I molecules were also 
tested. iDCs expressed high levels of both MHC class I and class II molecules. 
mDCs had increased in MHC class II expression compared to that by iDCs, however 
mDCs and iDCs had a similar level of MHC class I expression (Fig. 5a. 1 D). 
DCs also require adhesion molecules to carry out their function as APCs. They 
interact with surface molecules expressed by T cells and this may increase the 
strength of the immunological synapse (Grakoui et at., 1999). In addition to the 
fact that adhesion molecules are also involved in binding of DCs to target cells, it 
has been recently shown that in the absence of B7-CD28 co-stimulation, CD54 
(ICAM-1) interaction with CD11a on naive CD8' T cells can provide sufficient co- 
stimulation to induce effector CTL (Jenkinson et at., 2005). It is possible that this 
adhesion molecule allows close association between APCs and T cells leading to 
activation. Thus, the expression of adhesion molecules was examined amongst 
iDCs and mDCs. Both iDCs and mDCs expressed CD54 but in mDCs the level of 
CD54 expression was increased. The expression of CD36 and CD51, two adhesion 
molecules associated with activation of T cells by DCs was also measured. Both 
iDCs and mDCs expressed CD36 at similar levels (Fig. 5a. 11)). Whereas, CD51 was 
expressed only by iDCs (Fig. 5a. 1 D). _ 
To ensure that robust repeatable results were obtained from experiments and that 
co-culture variations were not due to DC generation variations, BMDCs were 
routinely tested for expression of maturation markers. Occasionally iDCs 
demonstrated a mature cell surface and as a result were discarded and not 
utilised in any assays. 
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5a. 3 BMDCs can cross-present ß cell-derived KdHA peptides to naive CL4 
CD8+ T cells 
5a. 3.1 Activation of naive CL4 CD8' T cells in response to lnsHA ß cells 
Previous studies have shown that H-2kBM4 H-2d InsHA chimeric mice which are 
deficient in Kd-expressing BM-APC, were unable support abortive activation of 
transferred CL4 CD8' T cells in the PLN (Fraser and Morgan, unpublished data). 
This demonstrated that there is an absolute requirement for BM-APCs to induce 
abortive activation of CL4 CD8' T cells. However, the identity of the BM-APC 
required to induce peripheral tolerance in InsHA mice remains elusive. 
Experiments by Betz and co-workers suggest that CD8a+ DCs are involved the 
cross-presentation of self-antigens to tolerise CD8` T cells (Beiz et at., 2002a). 
Therefore, we wish to study the interactions of cross-presenting BMDCs with CL4 
CD8' T cells to learn more about how DCs may control the activation of self- 
specific T cells. Firstly, it was important to determine whether or not DCs are 
capable of cross-presenting pancreatic islet ß cell-derived epitopes to activate 
CL4 CD8* T cells. To this end, the ability of BMDCs to cross-present epitopes 
derived from InsHA ß cells to CL4 CD8' T cells was examined in vitro. As a 
control, cross-presentation by another BM-APC, B cells, was also tested. APCs 
were co-cultured with CL4 CD8' T cells and ß cells purified from InsHA mice 
pancreata. For the final 8 hours of culture, 3H-thymidine' was added to the co- 
cultures and the proliferative response was measured by thymidine incorporation. 
Islet ß cells and APCs were irradiated prior to the assay to prevent division. 3H- 
thymidine incorporation was less than 100 cpm amongst co-cultures in the absence 
of APCs and this was approximately the same as observed in wells containing only 
islets (Fig. 5a. 2A). This suggests that InsHA ß cells are unable to directly present 
KdHA to activate a CL4 CD8' T cells response. 
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CL4 CD8* T cells co-cultured with B cells and InsHA ß cells did not proliferate (Fig. 
5a. 2A), suggesting B cells do not cross-present KdHA to CL4 CD8` T cells. However, 
CL4 CD8* T cells co-cultured with iDCs proliferated in the presence of InsHA ß cells 
(Fig. 5a. 2A) to the same extent as CL4 CD8* T cells in the presence of mDCs and 
InsHA p cells (Fig. 5a. 2A). CL4 CD8* T cells co-cultured of with either iDCs or 
mDCs in the presence ß cells from non-transgenic BALB/c mice did not proliferate 
(Fig. 5a. 2A). Therefore, both iDC and mDCs were to cross-present KdHA epitopes 
from InsHA p cells to activate naive CL4 CD8* T cells. 
Previous studies have demonstrated that when CL4 CD8r T cells are transferred 
into InsHA''' mice, more cells are proliferating in PLN and as a result tolerance 
induction occurs faster than in InsHA'" recipients. This difference is due to the 
increase in the amount of KdHA epitopes which are available in InsHA`'+ mice as 
compared with InsHA''" mice (Morgan et at., 1999a). CL4 CD8' T cells that 
undergo productive activation in PR8-immunised mice encounter much greater 
amounts of KdHA and in InsHA mice generate autoimmunity. It is possible that the 
amount of available KdHA is key in determining whether or not the subsequent 
response is abortive or productive. For example, perhaps stimulation by high 
amounts of KdHA can overcome a lack of co-stimulation by DCs or uptake of large 
amounts of protein initiates DC maturation. To investigate how the availability of 
epitope influences the ability of iDCs versus mDCs to activate naive CL4 CD8+ T 
cells, CL4 CD8' T cells were co-cultured with DCs and different numbers of InsHA ß 
cells. The level of proliferation of CL4 CD8' T cells was similar when co-cultured 
with 1x 104 InsHA ß cells in the presence either iDCs or mDCs (Fig. 5a. 2A). 
Moreover, proliferation was maximal as, CL4 CD8' T cells co-cultured with greater 
than 1x 104 InsHA ß cells in the presence of iDCs or mDCs did not increase 
proliferation (data not shown). CL4 CD8' T cells co-cultured with 1x 103 InsHA ß 
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Figure 5a. 2: Cross-presentation of ß cell-derived KdHA epitopes to naive CL4 
CD8' T cells in vitro 
10,000 naive MACS-enriched CL4 CD8' T cells per well were added in complete 
media in 96 well U-bottom plates and then were co-cultured for 72 hours with 
irradiated pancreatic islet ß cells from InsHA mice in the presence of 10,000 iDCs, 
mDCs or B cells. 3H-thymidine was added in excess for the final 8 hours of 
culture. Graph A shows the proliferation of co-cultures containing InsHA ß cells 
with iDCs, mDCs or B cells as measured by incorporation of 3H in counts per 
minute (CPM). 
Naive CL4 CD8' T cells were co-cultured for 72 hours with irradiated InsHA ß cells 
or BALB/c ß cells in the presence of iDCs or mDCs. Graph B shows the 
proliferation of CL4 CD8` T cells co-cultured with InsHA ß cells (black bars) or 
BALB/c ß cells (unfilled bars) as measured by incorporation of 3H in CPM. 
These results are representative of more than three independent experiments. 
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Figure 5a. 2: Cross-presentation of ß cell-derived KdHA epitopes to nave CL4 
CD8' T cells in vitro 
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cells proliferated in the presence of mDCs, but not iDCs (Fig 5a. 3). CL4 CD8' T 
cells did not proliferate in response to 1x 102 InsHA ß cells with either DC type 
(Fig. 5a. 3). Therefore, iDCs require greater numbers of InsHA ß cells and hence 
greater amounts of. HA-epitopes, as compared with mDCs, in order to induce CL4 
CD8' T cell proliferation. Since iDCs and mDCs express the same level of MHC 
class I, a difference in antigen processing by iDCs and mDCs, rather than MHC I 
loading, may be key in determining the amount of HA protein required to 
stimulate CL4 CD8' T cells. An alternative explanation is that iDCs require greater 
amounts of KdHA to induce similar CL4 CD8' T cell responses as compared with 
mDCs due to the lower amounts of co-stimulation provided by iDCs. 
5a. 3.2 Cross-presentation is required for BMDC-mediated activation 
It is most likely that proliferation of naive CL4 CD8' T cells co-cultured with InsHA 
pancreatic ß cells in presence of iDCs or mDCs is due to cross-presentation of KdHA 
by DCs. However, it is also possible that InsHA ß cells could shed HA-epitopes or 
following apoptosis in cell culture, InsHA ß cells release HA-epitopes. Exogenous 
HA-epitopes could then be directly loaded onto surface MHC I molecules on DCs 
and therefore no antigen processing occurred. If this were indeed the case, direct 
presentation of KdHA by DCs would occur, rather than cross-presentation. 
MHC class I-restricted epitopes must be internalised before processing and cross- 
presentation by APCs can occur (Schutz and Reis e Sousa, 2002). Phagocytosis 
requires the rearrangement of actin filaments and this can be disrupted using the 
chemical agent cytochalasin D (CCD) (Urbanik and Ware, 1989; Wodnicka et at., 
1992). Thus, CCD was used to test whether or not DCs cross-present InsHA ß cell 
derived proteins to stimulate CL4 CD8' T cells. iDCS "-and mDCs were pre- 
incubated with CCD before co-culturing with CL4 CD8+ T cells and InsHA ß cells. 
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Figure 5a. 3: CL4 CD8' T cell proliferation induced by iDC is dependent on the 
level of HA available for cross-presentation 
10,000 naive MACS-enriched CL4 CD8` T cells per well were added in complete 
media to 96 well U-bottom plates and then were co-cultured for 72 hours with 
irradiated pancreatic islet I3 cells from InsHA mice in the presence of 10,000 iDCs 
or mDCs. 3H-thymidine was added in excess for the final 8 hours of culture. As 
indicated a range of numbers of InsHA 11 cells were used. 
These results are representative of more than three independent experiments. 







+1x 10 4 BALB/c islet cells 
D+1x 102 InsHA islet cells 
D+1x 103 InsHA islet cells 
+1x 104 InsHA islet cells 
Figure 5a. 3: The level of HA available for cross-presentation by DC 
influences CL4 CD8' T cell proliferation 
-150- 
MC mDC 
Chapter 5a: Cross-presentation of ß cell-derived antigens by dendritic cells 
CCD-treated iDCs failed to stimulate CL4 CD8` T cells to proliferate (Fig. 5a. 4A). 
CCD treatment of mDCs reduced CL4 CD8' T cell proliferation in response to InsHA 
P cells as compared with untreated mDCs (Fig. 5a. 4A). The CCD treatment did not 
affect the ability of DCs to present KdHA, as DCs pulsed with high concentrations 
of KdHA stimulated CL4 CD8' T cell proliferation (Fig. 5a. 4B). These data imply 
that CCD is able to inhibit internalisation of HA-epitopes, but not the ability to 
load MHC class I. Thus, the proliferation of CL4 CD8' T cells co-cultured with iDCs 
and InsHA ß cells, is due to cross-presentation of KdHA epitopes processed from 
internalised HA protein by iDCs. Whereas mDC-mediated CL4 CD8+ T cell 
proliferation may only be partially dependent on phagocytosis. 
5a. 4 Requirements for activation by cross-presentation 
As already stated, it has been suggested that iDCs induce tolerance amongst 
potentially auto-reactive T cells whereas whilst mDCs presenting foreign antigens 
generate T cell immunity (Inaba et at., 1990). This difference may be due to the 
high level of expression of co-stimulatory molecules and production of 
inflammatory cytokines by mDCs (Inaba et at., 1993). Based on the fact that in 
InsHA mice, cross-presentation of ß cell-derived KdHA to CL4 CD8+ T cells leads to 
the induction of tolerance, we hypothesise that cross-presentation is most likely 
carried out by iDCs rather than mDCs. On the other hand, CL4 CD8' T cells are 
productively activated in P118-immunised mice; it is possible that such activation is 
initiated amongst nave CL4 CD8+ T cells by cross-presentation of KdHA epitopes by 
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Figure 5a. 4: Activation of CL4 CD8' T cells by BMDCs is due to cross- 
presentation of ß cell antigens 
iDCs and mDCs were pre-incubated with CCD or PBS for one hour. DCs were then 
irradiated and co-cultured with 10,000 MACS-enriched CL4 CD8' T cells at a ratio 
of 1: 1 and 10,000 irradiated InsHA ji cells for 72 hours. 3H-thymidine was added in 
excess for the final 8 hours of culture. Graph A shows the proliferation of CL4 CD8' 
T cells responding to InsHA-epitopes presented by CCD-treated or untreated iDCs 
or mDCs as measured by incorporation of thymidine in CPM. 
iDCs and mDCs were pre-incubated with CCD or PBS for one hour and pulsed with 1 
µg/ml KdHA peptide. 10,000 DCs were then irradiated and co-cultured with 10, 
000 CL4 CD8` T cells for 72 hours. 3H-thymidine was added in excess for the final 8 
hours of culture. Graph B shows CL4 CD8' T cell proliferation stimulated by KdHA- 
pulsed iDCs or mDCs. 
These results are representative of more than three independent experiments. 
Statistical analyses were carried out with two-tailed t-tests (paired). 
* significantly different to untreated controls (p <0.005) 
** significantly different to untreated controls (p <0.05) 
$ not significantly different to untreated controls (p >0.2) 






























Figure 5a. 4: Activation of CL4 CD8' T cells by BMDCs is due to cross- 
presentation of f3 cell antigens 
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mDCs, followed by direct presentation by P118-infected cells. Therefore, the 
mechanism by which DC acquires epitopes may be crucial to determine whether or 
not DCs mature or remain immature yet still cross-present antigen. If the 
maturation state of the cross-presenting DC determines the outcome of CL4 CD8` 
T cell activation, then mechanisms of epitope acquisition may control T cell 
activation. 
BrdU labelling experiments have demonstrated that there was very little turnover 
of pancreatic ß cells in the InsHA mouse (Morgan, unpublished data). 
Furthermore, it is unlikely that soluble HA epitopes ares shed by ß cells. Thus, it 
is unclear how HA-epitopes traffic to the PLN. One possibility for the mechanism 
by which DCs acquire HA-epitopes from InsHA ß cells is the 'nibbling' of epitopes 
from intact cells by DCs as they migrate through tissues. DCs may then carry 
epitopes to PLN for cross-presentation. It has been suggested that this acts as a 
mechanism for the induction and maintenance of peripheral self-tolerance 
(Harshyne et at., 2001). 
If DCs acquire antigen from ß cells by 'nibbling' epitopes from live p cells, 
cell/cell contact between DC and ß cell would be required. Whereas,, uptake of 
epitopes shed by live ß cells or released by ß cells undergoing apoptosis would not 
require direct DC/p cell contact. To test whether cross-presentation by DCs relies 
on upon contact with ß cells, co-cultures were set up where CL4 CD8' T cells and 
iDCs or mDCs were physically separated from InsHA ß cells by transwells. 
Proliferation of CL4 CD8' T cells co-cultured with iDCs or mDCs in the presence of 
InsHA ß cells was prevented by transwells (Fig. 5a. 5). This indicates that cell/cell 
contact is required between DCs and InsHA ß cells in order to cross-present KdHA 
epitopes and stimulate CL4 CD8` T cells. 
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Figure 5a. 5: DC-InsHA ß cell-cell contact is required for cross-presentation of 
HA antigens to CL4 CD8' T cells 
10,000 MACS-enriched CL4 CD8' T cells were co-cultured for 72 hours with 10,000 
InsHA (3 cells in the presence of either 10,000 iDCs or 10,000 mDCs. InsHA (3 cells 
were either added directly to wells or were separated from CL4 CD8` T cells/DCs 
by transwell inserts. Triturated thymidine was added in excess for the final 8 
hours of culture. This figure shows CL4 CD8' T cell proliferation in the presence of 
iDCs or mDCS and InsHA (i cells, either separated by a transwell or not. 
These results are representative of three independent experiments. 
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Figure 5a. 5: DC /ß cell contact is required for cross-presentation of KdHA 
epitopes to CL4 CD8' T cells 
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Previous studies have demonstrated that DCs express several molecules which may 
be involved in mediating the uptake of exogenous epitopes, including Fcy 
receptors (CD16/CD32, (Regnault et at., 1999), DEC-205 (Swiggard et at., 1995) 
CD36 (Betz et at., 2002c), and CD51 (Albert et at., 1998a). It has been suggested 
that CD51 and CD36 play an important role in the initiation of internalisation of 
exogenous epitopes by iDCs (Albert et at., 1998a). Furthermore, CD36 may be 
required in order for DCs to directly `nibble' epitopes from live cells (Harshyne et 
at., 2001). iDCs express both CD36 and CD51, whereas mDCs only express CD36 
(Fig. 5a. 11)). It is possible that iDCs and mDCs acquire epitopes using different 
receptors and the use of these receptors may account for the difference in 
outcome of T cell activation by iDCs versus mDCs. Experiments were carried out 
to determine whether or not CD36 or CD51 function in the acquisition of KdHA 
from InsHA (3 cells by iDC or mDCs. Therefore, CL4 CD8' T cells plus InsHA ß cells 
with were co-cultured with DCs that had been pre-incubated with blocking 
antibodies against CD36 or CD51 or with a combination of both antibodies as 
described (Finnemann and Silverstein, 2001) and proliferation of CL4 CD8+ T cells 
was assessed. 
Pre-incubation with anti-CD51 antibody had no statistically significant effect on 
the ability of DCs to stimulate CL4 CD8` T cell proliferation (Fig. 5a. 6). However, 
CL4 CD8` T cells do not proliferate when co-cultured with mDCs that had been 
pre-incubated with anti-CD36 blocking antibodies in the presence of InsHA ß cells. 
This reduction in proliferation was highly statistically significant. In contrast, 
anti-CD36 antibodies increased the CL4 CD8` T cell proliferation mediated by iDCs 
(Fig. 5a. 6). Pre-incubation of iDCs or mDCs with both anti-CD36 and anti-CD51, 
prior to co-culture with CL4 CD8' T cells and InsHA ß cells, prevented proliferative 
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Figure 5a. 6: mDCs and iDCs have distinct adhesion molecule requirements to 
cross-present ß-cell antigens 
iDCs and mDCs were pre-incubated with 10 «g/ml anti-CD36 antibody, with 10 
[&g/ml anti-CD51, with a combination of both antibodies (both 10 Etg/ml), or with 
PBS for one hour. To wells containing 10,000 of these pre-incubated DCs, 10,000 
MACS-enriched CL4 CD8' T cells and 10,000 irradiated InsHA li cells were added. 
Cells were co-cultured for 72 hours, with triturated thymidine added in excess for 
the final 8 hours of co-culture. This figure shows the effect of blocking antibodies 
on iDCs or mDCs ability to bring about CL4 CD8' T cell proliferation. 
These results are representative of three independent experiments. 
Statistical analyses were carried out with two-tailed t-tests (paired). 
* significantly different to untreated controls (p <0.001) 
** significantly different to untreated controls (p <0.01) 
O significantly different to untreated controls (p <0.05) 
$ not significantly different to untreated controls (p >0.1) 
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Figure 5a. 6: Requirements for CD51 and CD36 by mDCs and iDCs during 
cross-presentation of 13 cell-derived antigen in vitro 
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responses by CL4 CD8' T cells (Fig. 5a. 6). These data imply that the activity of 
CD36 is essential for mDCs to acquire antigen from ß cells. Whereas, in iDCs 
either CD51 or CD36 may be utilised in adhesion to (3 cells in order to internalise 
antigen. Although, it is possible that in these blocking studies anti-CD36 or anti- 
CD51 antibodies may generate an effect via non-specific binding of Fc receptors 
expressed by dendritic cells. This caveat could be negated by further experiments 
utilising isotype-matched irrelevant antibodies as controls. 
5a. 5 Discussion 
Previous studies demonstrated that BM-APCs induce peripheral tolerance amongst 
CL4 CD8' T cells in vivo (Fraser, JM and Morgan DJ, unpublished data), most likely 
DCs (Betz et al., 2002a). We have compared the ability of iDCs and mDCs to 
activate CL4 CD8' T cells by cross-presenting InsHA ß cell-derived antigen. 
Initially, protocols were developed to generate iDCs and mDCs from murine bone- 
marrow. 
Flow cytometric examination of non-adherent cells generated by a 10 day culture 
of macrophage-depleted bone marrow cells in the presence of GM-CSF 
demonstrated that these protocols yield a pure populations of myeloid DCs 
expressing high levels of CD11c and CD11b (Lutz et al., 1999). Analysis of 
expression of other cell surface molecules was also carried to determine the 
maturity of BMDCs obtained using this protocol. Consistent with other studies, 
iDCs expressed low levels of CD80, CD40, CD54 and MHC class II (Thomas et at., 
1993). iDCs also expressed CD86 and MHC class I. Upon stimulation with LPS, 
both FSC and SSC properties of the DCs increased. Although LPS stimulation did 
not increase the expression of MHC class I by DCs, there was an increase in both 
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the level of expression of CD40, CD54, CD80, CD86 and MHC class II by DCs 
increased. These phenotypic changes are consistent with differentiation from iDC 
to mDC (Gallucci et al., 1999). Although other co-stimulatory molecules were 
examined, the key indicators of BMDC maturation were increases in the `classical' 
co-stimulatory molecules CD40, CD80, and CD86. 
It has been suggested spontaneous maturation of iDCs can occur due to stress 
(possibly by fluctuations in culture conditions or from mechanical manipulation), 
or by inflammatory stimuli from necrotic cells in DCs cultures (Sauter et al., 
2000). Therefore, samples from each batch of DCs were tested and any iDC 
cultures containing high proportions of mDC-phenotype cells were rejected. 
Experiments were also performed which demonstrated that harvesting of iDCs and 
their subsequent culture in assay did not induce maturation. 
Experiments demonstrated that CL4 CD8+ T cells proliferated when co-cultured 
with InsHA ß cells, only when iDCs or mDCs were present as an APC. These data 
indicate that in vitro pancreatic ß cells are unable to directly present MHC class I 
restricted HA antigens to CL4 CD8' T cells and that DCs can mediate the primary 
activation of these T cells. Furthermore, experiments blocking DC internalisation 
by incubation with CCD, prevented presentation of KdHA epitopes from InsHA ß 
cell by iDCs. This suggests that that iDCs actively acquire and cross-present InsHA 
ß cell epitopes to CD8+ T cells, therefore we investigated the mechanism by which 
iDCs take up ß cell antigens. 
CL4 CD8+ T cells were also cultured with DCs, but were separated from their 
antigenic source, InsHA ß cells, by a transwell which would allow the circulation 
of secreted proteins, but not ß cell: DC contact. These studies showed that 
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contact with ß cells was required for the uptake of antigen by DCs for 
presentation to CL4 cells. Previous experiments have also demonstrated that 
there is no detectable pancreatic islet cell death in naturally tolerant InsHA mice, 
and that apoptosis and islet regeneration is extremely low (Morgan, unpublished 
data). Therefore, in InsHA mice it is unlikely that soluble HA is acquired by BM- 
APCs as a result of (3 cell death. A more likely hypothesis is that iDCs, circulating 
through intact islet tissues, acquire antigen by direct DC: p cell contact 
(Banchereau et at., 2000). Many surface molecules expressed by DCs have been 
shown to play a röte in endocytosis of cellular antigens, such as Dec-2005 
(Regnault et at., 1999; Swiggard et at., 1995). It has been demonstrated that 
both CD36 and CD51 have a key function for in interacting with cellular to acquire 
antigens has been demonstrated (Albert et al., 1998a). However, potentially 
auto-reactive T cells are tolerised in CD36 and CD51 knock-out mice, suggesting 
that neither CD36, nor CD51 are absolutely required for the induction of 
peripheral self-tolerance (Betz et at., 2002c; Schutz et at., 2002). Physical 
interaction between DCs and InsHA p cells is required for cross-presentation of ß 
cell-derived antigens and as CD51 was expressed only by iDCs, but CD51 by both 
iDCs and mDCs, the röte of these molecules in acquisition of antigen was 
investigated. Activation of CL4 CD8' T cells by mDCs in the presence of InsHA ß 
cells requires CD36 activity on the mDCs; yet activation by iDCs ddn occur in the 
absence of CD36 or CD51 availability, but not in the absence of both. This 
suggests that at least one of these molecules must be present on DCs to allow 
interaction between DCs and p cells. These close interactions may then allow the 
`nibbling' of HA antigens from intact cells, prior to their cross-presentation to T 
cells. As mDCs lack CD51 expression, CD36 is essential for these DCs to acquire 
antigens from self-tissue. Whereas iDCs, which co-express CD36 and CD51, can 
cross-present antigens from ß cells even when CD36 activity is blocked. As it has 
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been previously suggested that iDCs can act as APCs which induce peripheral T cell 
tolerance (Steinman et at., 2003), while mDCs drive immunity to foreign insult or 
autoimmunity to self-tissues (Schuler and Steinman, 1985), the selective blocking 
of cross-presentation by mDCs could be a significant therapeutic tool. Blocking 
with anti-CD36 blocking antibodies would determine whether or not a normally 
auto-reactive response could be tuned into a tolerant one. In designing such 
experiments it must be noted that the use of PR8 immunisation of InsHA recipient 
mice given CL4 CD8' T cells, which normally induces autoimmune diabetes, may 
not provide an appropriate test. Administration of a HA antigens in the context of 
foreign virus epitopes will also activate other leukocyte populations, which may 
create an inflammatory environment and potentially drive DC maturation. Under 
these conditions autoimmunity would be enhanced. Previously, diabetes in the 
InsHA mouse has been induced by increasing the availability of HA proteins by 
creating some ß cell destruction by sub-lethal irradiation (Morgan, unpublished 
data) or by administering streptozotocin (data not shown), a chemical agent that 
is selectively toxic to pancreatic islet cells (Like and Rossini, 1976). Experiments 
utilising such models to test the efficacy of blocking CD36 to generate immune 
deviation are currently in progress. 
The data presented in this chapter also support the hypothesis iDCs could be 
involved the cross-presentation KdHA from ß cells to CL-4 CD8' T cells and thereby 
induce peripheral tolerance. Further in vitro study of factors that control 
whether or not productive CL4 CD8' T cell responses are initiated by DCs 
presenting KdHA. These studies may indicate molecules that are important to 
determine the-effector function of CL4 CD8` T cells and may explain how the 
outcome of activation is controlled. To this end, experiments detailed in chapter 
5b examine the role of antigen amount, co-stimulatory molecules and cytokines on 
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interactions between CL4 CD8' T cells and DCs and suggests how by altering these 
factors the CL4 CD8+ T cell response may be diverted. 
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5b. 1 Introduction 
The ability of DCs to induce productive activation of naive T cells to form effector 
and memory T cells is well described (Inaba et at., 1993; Inaba et at., 1990; 
Schuler and Steinman, 1985). The potential tolerising capability of DCs is also 
well understood in the induction of central tolerance (Nossal, 1994). Also, certain 
subsets of DCs have been shown to promote the differentiation of regulatory T 
cells as well as generate peripheral tolerance induction by deletion (Jonuteit et 
at., 2000). The fact that both productive activation and tolerance induction can 
result from CD8` T cell interactions with antigens presented by DCs, suggests that 
DC may determine how self-specific CD8' T cells will respond. For example, 
without DC maturation, antigen presentation does not induce effector T cell 
responses (Steinman et at., 2003). Therefore the maturation state of the DC may 
be key in controlling how CD8' T cells respond (Banchereau et at., 2000). 
It is clear that, in addition to those signals produced by TcR interaction with 
peptide/MHC complexes, T cells require co-stimulation to form full effector 
responses (Harding and Allison, 1993; Miceli and Parnes, 1993). Many co- 
stimulatory molecules, which enhance T cell stimulation by APCs, have been 
identified. For example, the B7 family of co-stimulatory molecules, which 
interact with CD28 on T cells, include CD80 (Yokochi et at., 1982), and CD86 
(Freeman et at., 1993). However, co-stimulation via the CD28 pathway is not 
essential, as CD4' and CD8` T cells from CD28 knock-out mice can be activated as 
to the same degree as those from CD28-sufficient mice (Green et at., 1994; 
Shahinian et at., 1993). Another co-stimulatory molecule expressed by mDCs is 4- 
1BBL (DeBenedette et at., 1997), which preferentially acts on CD8' T cells 
(Shuford et at., 1997). Ligands expressed by DC can also inhibit T cell activation, 
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such as PD-1L (Freeman et at., 2000). Secreted factors can also modulate T cell 
activation: for example IL-2 maintains and enhances T cell proliferation (Mize[ and 
Farrar, 1979) and is essential in prolonged activation (Watson, 1979), while IL-12 
and IFN-y drive activation of T cells and polarisation of CD4' T cells to Thl 
phenotypes (Macatonia et at., 1993). The factors governing CD8` T cell activation 
are less understood. The effect of antigen dose on T cell activation has also been 
investigated and findings indicate that for CD8' T cell proliferation the 
requirement for co-stimulation can be superseded by high antigen concentrations 
(Cai and Sprent, 1996). 
Adoptive transfers of naive CL4 CD8' T cells into InsHA mice results in abortive 
activation in response to KdHA epitopes presented by BM-APCS in the PLN. As a 
consequence CL4 CD8` T cells are functionally tolerised (Morgan et at., 1999a). 
However, CL4 CD8' T cells encountering KdHA epitopes in mice which have been 
immunised with PR8 virus undergo productive activation throughout all secondary 
lymphoid tissues (Hernandez et at., 2001). In the InsHA mouse, tolerance 
induction to pancreatic 0 cell-expressed HA requires cross-presentation by a bone 
marrow-derived APC (Fraser and Morgan, Unpublished data). We propose that the 
investigation of CL4 CD8` T cells interactions with iDCs and mDCs in vitro may 
further our understanding of how the balance between abortive and productive 
responses is controlled. Experiments described in chapter 5a demonstrate that in 
vitro BMDCs are capable of cross-presenting antigens from InsHA mice to CL4 CD8+ 
T cells. 
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5b. 2 CL4 CD8+ T cell functional responses following interactions with 
DCs 
5b. 2.1 Proliferation of CL4 CD8' T cells subsequent to activation 
Naive CL4 CD8' T cells are activated in PLN of InsHA mice; this activation is 
termed 'abortive' as no autoimmunity develops. From studies described in 
chapter 3, the characteristics of abortive activation are that proliferation is 
limited, both in terms of numbers of dividing cells and number of divisions, with 
no CL4 CD8` T undergoing more than 5 divisions. Thus, highly divided effector CTL 
are not observed during peripheral tolerance induction in the draining lymph 
nodes of the pancreas: the site of antigen expression (Hernandez et al., 2001). 
Although, both iDCS and mDCs can mediate CL4 CD8` T cell activation by InsHA ß 
cell-derived antigens in vitro (Chapter 5a. 3), does such activation lead to 
productive or abortive responses? Is division of CL4 CD8+ T cells stimulated by 
iDCs and mDCs limited, as in peripheral tolerance induction in the InsHA mouse, or 
do CL4 CD8+ T cells divide many times to generate a productive response? To 
learn more about the consequences of CL4 CD8+ T cell interactions with DCs, the 
proliferation of CL4 CD8+ T cells co-cultured with DCs in the presence of KdHA 
peptide was measured. As the way in which the level of antigen influences 
tolerance induction is unclear, the effects of a range of peptide doses were 
examined. Briefly, irradiated iDCs or mDCs were co-cultured with equal numbers 
of purified CL4 CD8+ T cells in 96-well plates into which various concentrations of 
KdHA were added. For the final 8 hours of culture 3H-thymidine was added in 
excess. CL4 CD8+ T cell activation was measured using the relative incorporation 
of 3H-thymidine as a measure of proliferation. 
At high concentrations of KdHA peptide (>1 x 10'' µg/ml) both iDCs and mDCs 
induced similar level of proliferation amongst naive CL4 CD8' T cells (Fig. 5b. 1A). 
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Figure 5b. 1: iDC are less efficient than mDCs at presenting cognate peptide to 
CL4 CD8` T cells 
10,000 MACS-enriched CL4 CD8' T cells co-cultured with 10,000 iDCs or mDCs in 
the presence of KdHA at a range of different concentrations. 3H-thymidine was 
added in excess for the final 8 hours of culture. Cultures were harvested and cells 
were assayed for incorporation of 3H. All plots depict proliferation as 3H 
incorporation in counts per minute (CPM). Plots A-D show CPM over time at the 
peptide concentration shown. Plot E demonstrates CPM of CL4 CD8` T cells 
culture for 72 hours across a range of peptide concentrations. 
These results are representative of more than three independent experiments. 
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Figure 5b. 1: Proliferation of naive CL4 CD8' T cells following interaction 
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Responses reached a maximum at 72 hours, before declining over the rest of the 
time course (Fig. 5b. 1A). CL4 CD8' T cell responses to both iDCs and mDCs were 
similar at early time points. At these high concentrations of KdHA, iDC-driven CL-4 
CD8` T cell proliferation was less sustained and had decreased by 96 hours (Fig. 
5b. 1B and C). At a KdHA concentration of 1x 10-5 µg/ml, proliferation of CL4 CD8' 
T cells stimulated with iDC was approximately 7 fold less at all time points. On 
the other hand, the magnitude of CL4 CD8' T cell proliferation over time was 
more or less the same in response to mDC at all peptide concentrations (Fig. 
5b. 1 D). 
The peak proliferation of CL-4 CD8' T cells occurs between 48 and 72 hours. At 72 
hours, although proliferative responses of CL-4 CD8' T cells to both iDC and mDC 
were similar at the highest KdHA peptide level, iDCs barely induced proliferation 
amongst CL-4 CD8+ T cells at lower KdHA peptide doses, <1x 10-4 µg/ml, mDCs 
induced detectable CL4 CD8' T cells proliferation with just 1x 10'9 µg/ml KdHA 
(Fig. 5b. 1 E). 
Measuring 3H-thymidine incorporation cannot determine what proportion of CL4 
CD8' T cells proliferated and how many times each cell divided. However, lower 
levels of 3H-thymidine incorporation could relate either to fewer cells responding 
or that individual cells are proliferating less. Also measuring 3H-thymidine 
incorporation only represents single point in time and does not show the total 
amount of cell division. Our in vivo observations have shown that high numbers of 
rounds of cell division indicate productive responses whereas a limited number of 
rounds of division is associated with abortive responses. To determine whether 
proliferation in vitro relates to productive or abortive activation, the division of 
" CL4 CD8' T cells must be evaluated on an individual cell basis. The low level 
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proliferation, as indicated by 3H-thymidine incorporation by CL4 CD8' T cells 
responding to iDCs, may correspond to the generation of a few highly divided 
productively activated CL4 CD8' T cells. Thus, such a response may be productive 
in vivo as only low numbers of highly divided cells are required to generate a 
productive autoimmune response (Morgan et at., 1999a). 
CFSE-labelled CL4 CD8` T cells were co-cultured with DCs and hi (1 µg/ml KdHA), 
int (1x10'2 µg/ml KdHA) or to (1x10'5 µg/ml KdHA) concentrations of KdHA peptides 
and the number of divisions were measured amongst Thy1.1 ` CL4 CD8' T cells by 
examining the loss of CFSE fluorescence by flow cytometry. These concentrations 
were chosen as the 3H-thymidine incorporation data showed that CL4 CD8` T cell 
proliferation generated by the hi level of KdHA was similar with both iDCs and 
mDCs. Whilst with the int level of KdHA there was a difference between 
proliferation stimulated by iDCs and mDCs, and at the to KdHA concentration there 
was little CL-4 CD8+ T cell proliferation with iDCs. As a control it was determined 
that there was no difference in 3H-thymidine incorporation between CFSE-labelled 
CL4 CD8` T cells and unlabelled CL4 CD8' T cells following stimulation with KdHA- 
pulsed APCs (data not shown). 
After 48 hours of culture, CL4 CD84 T cells underwent no more than 4 rounds of 
division when stimulated by mDCs at all peptide concentrations tested (Fig. 5b. 2). 
At hi and int KdHA concentrations, more of the CL4 CD84 T cells analysed had 
undergone 4 divisions; while at the to peptide concentration, there were more 
undivided cells. The fluorescence intensity profile of CFSE was similar amongst 
CL4 CD8` T cells responding to iDCs in the presence of hi/int KdHA concentrations 
to those responding to mDCs. In the presence of to KdHA concentrations, few CL4 
CD8` T cells stimulated with iDC divided, and this division was limited. 
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Figure 5b. 2: In vitro cell division of CL4 CD8` T cells 
10,000 Thyl. 1' CFSE-labelled CL4 CD8` T cells were co-cultured with 10,000 iDCs 
or mDCs in the presence of KdHA at a range of different concentrations. Cells were 
harvested after various time points, stained with anti-Thyl. 1 antibodies and 
assayed using flow cytometry. Histogram plots depict CFSE fluorescence of 
Thyl. 1` cells versus cell frequency. Data is shown for both iDCs and mDCs at 48, 
72 and 96 hours, and at 3 separate peptide concentrations. 
Dotted grey lines indicate the numbers of rounds of cell division, based on CFSE 
algorithms in FlowJo software. 
These results are representative of more than three independent experiments. 
KdHA concentrations 
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After 72 and 96 hours some of the CL-4 CD8` T cells stimulated by either mDCs or 
iDCs had divided >4-5 times with hi and int peptides concentrations (Fig. 5b. 2). At 
to KdHA concentration, when stimulated by mDCs most CL-4 CD8+ T cells underwent 
at least 4 rounds of division, leaving few undivided cells. In contrast, CL-4 CD8+ T 
cells co-cultured with iDCs and to KdHA, underwent little proliferation and most 
CL4 CD8+ T cells remained undivided (Fig. 5a. 2). This supports data from 
thymidine incorporation assays, demonstrating that at low peptide concentrations 
CL4 CD8+ T cell proliferation can be induced by mDCs but not iDCs. CFSE 
fluorescence intensity analysis shows that at low peptide concentrations any CL4 
CD8+ T cell proliferation stimulated by iDCs is due to few T cells undergoing 
limited division (Fig 5a. 2). 
In theory all naive CL4 CD8' T cells express the same TcR and thus have the same 
specificity for KdHA. Therefore, it is likely that differences in the response by CL4 
CD8' T cells to low doses of cognate peptide presented by iDCs versus mDCs are 
due to a difference in DCs. It is unlikely that these differences are due to any 
inherent failure in the ability of iDCs to present KdHA epitopes as iDCs and mDCs 
express similar levels of MHC class I molecules and at high peptide concentrations 
stimulation of cell division by iDC is similar to that by mDC.. It is possible that the 
difference in proliferation at low peptide concentrations stimulated by iDCs versus 
mDCs, is due to lower level of expression of co-stimulatory molecules by iDCs. It 
has been previously shown that T cells activated in the absence of co-stimulation 
become anergic, rather than full effector T cells (Mueller et at., 1989). However, 
as some division of CL4 CD8' T cells stimulated by iDCs is observed, some T cell 
activation must be mediated under these conditions, rather than a failure to 
exceed an activation threshold. However, iDCs do not generate populations of 
highly divided CL4 CD8` T cells. Is this difference merely quantitative due to 
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lower co-stimulation by iDC or do iDCs with low peptide doses induce a 
functionally different T cell activation? Experiments were performed to 
determine whether or not those few CL4 CD8' T cells activated by iDCs at low 
peptide doses differentiate into mature effector CTL. 
Upon activation, signalling events lead to an altered cell surface protein 
expression that allow T cells to carry out their specific functions. Assessing the 
expression by CL4 CD8` T cell of surface markers subsequent to activation may 
indicate whether T cells activation is productive or abortive. CSFE-labelled nave 
CL4 CD8' T cells were co-cultured with mDC or iDC in the presence of a range of 
concentrations of K°HA. At various time points cells were harvested and pooled. 
Cell suspensions were assessed for expression of a panel of surface molecules by 
staining with antibodies and examining by flow cytometry. 
CD25 (IL-211a), a key marker of productive CL4 CD8+ T cell activation in vivo 
(Chapter 3), was upregulated by CL4 CD8' T cells following co-culture with mDC 
and high concentrations of peptide (Fig. 5b. 3a). Under these conditions, CD25 
was expressed at high levels by 48 hours and expression at 72 and 96 hours 
maintained. At lower peptide concentrations (1 x 10'5 µg/ml KdHA) mDCs 
stimulated CD25 upregulation by CL4 CD8+ T cells to a lesser extent, despite 
similar levels of division. The CD25 expression induced by iDC at early time points 
was similar to CD25 expression induced by mDCs. There was a more rapid 
decrease in CD25 expression over time by CL4 CD8` T cells responding to iDCs 
compared with CL4 CD8' T cells responding to mDCs (Fig. 5b. 3a). Importantly, it 
appeared that decreasing the concentration of KdHA had a greater reduction in 
CL4 CD8` T cells CD25 upregulation in response to iDC than mDC. 
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Figure 5b. 3a: iDC stimulated CL4 CD8+ T cells express a partially activated cell 
surface phenotype in vitro 
10,000 Thyl. 1' CFSE-labelled CL4 CD8' T cells co-cultured with 10,000 iDCs or 
mDCs in the presence of KdHA at a range of different concentrations. Cells were 
harvested after various time points, stained with anti-Thyl. 1 antibodies and 
antibodies against a number of different cell surface markers before analysis with 
flow cytometry. Dot plots shows the expression of CD25, Ly6C and CD69 by 
Thyl. 1' cells stimulated with either iDCs or mDCs in the presence of KdHA. Data 
for 48 hours is shown in red, 72 hours in blue and 96 hours in green. 
These results are representative of more than three independent experiments. 
KdHA concentrations 
Hi 1 µg/ml KdHA 
Int 1x10-2 µg/ml KdHA 
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Figure 5b. 3a: Flow cytometric analyses of cell surface phenotypes of CL4 
CD8' T cells following co-culture with KdHA peptide-pulsed iDCs or mDCs 
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Figure 5b. 3b: iDC stimulated CL4 CD8' T cells express a partially activated cell 
surface phenotype in vitro 
10,000 Thy1.1` CFSE-labelled CL4 CD8` T cells co-cultured with 10,000 iDCs or 
mDCs in the presence of 1 µg/ml KdHA. Cells were harvested after 72 hours, 
stained with anti-Thyl. 1 antibodies and antibodies against a number of different 
cell surface markers before analysis with flow cytometry. Dot plots shows the 
expression of CD62L, and CD95L by Thy1.1' cells stimulated with either iDCs or 
mDCs in the presence of KdHA compared with expression by nave freshly isolated 
CL4 CD8' T cells. 
These results are representative of more than three independent experiments. 
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Figure 5b. 3b: Flow cytometric analyses of cell surface phenotypes of CL4 
CD8`T cells following co-culture with KdHA peptide-pulsed iDCs or mDCs 
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Table 5b. 1: Cell surface phenotype of in vitro activated CL4 CD8' T cells 
10,000 Thy1.1' CFSE-labelled CL4 CD8{ T cells co-cultured with 10,000 iDCs or 
mDCs in the presence of KdHA at a range of concentrations. Cells were harvested 
after 72 hours, stained with anti-Thyl. 1 antibodies and antibodies against cell 
surface markers before analyses with flow cytometry. This Table summarises 
expression of cell surface markers by Thyl. 1' cells. 
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Surface Marker mDC iDC 
CD25 T hi Tint 
Ly6C Lo T hi 
CD62L y to Int/to 
CD95L T -ve 
is INFy Hi Int 
Vß8 Hi Hi 
Table 5b. 1: Cell surface phenotype of in vitro activated CL4 CD8` T cells 
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Expression of Ly6C, a surface molecule associated with both activated and 
memory T cells, by CL4 CD8' T cells responding to mDCs only increased slightly 
(Fig. 5b. 3a). In contrast, CL4 CD8' T cells responding to iDC expressed high levels 
Ly6C even when cultured with low peptide concentrations. It did not appear that 
such Ly6C expression decreased over time (Fig. 5b. 3a). 
The level of CD69 expression, an early indicator of activation, increased at 48 
hours in all co-cultures. CD69 expression was also observed amongst CL4 CD8' T 
cells stimulated by iDCs in the presence of to concentrations of KdHA (Fig. 5b. 3a). 
CD69 was expressed for a shorter period by CL4 CD8' T cells activated by iDC as 
compared with mDC activation, some decrease in CD69 expression was observed 
at 72 hours and no CD69 expression at 96 hours. In contrast, the expression of 
CD69 by CL4 CD8+ T cells at 96 hours was still at high levels following activation by 
mDCs (Fig. 5b. 3a). Additionally, iDC stimulated CL4 CD8' T cells only partially 
downregulated CD62L, did not express CD95L (Fas ligand) and produced only low 
levels of IFN-y (Fig. 5b. 3b). These data suggest that despite the fact that CL4 
CD8` T cells were both activated and underwent divisions in response to KdHA 
presented by iDC, they may not be maturing into effector CTL. 
5b. 2.2 Do iDC stimulated CL4 CD8' T cells differentiate into effector CTL? 
The data described in chapter 5b. 2.1 suggest that there are both quantitative and 
qualitative differences in the proliferative responses of CL4 CD8` T cells following 
their encounter with iDCs or mDCs presenting KdHA. Stimulation of CL4 CD8` T 
cells was less effective by iDCs than by mDCs. iDCs could only induce CL4 CD8' T 
cell proliferation at relatively high peptide concentrations. Examination of the 
cell surface phenotype of CL4 CD8' T cells following co-culture with DCs and KdHA 
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also showed altered activation and effector marker expression between cells co- 
cultured with iDCs and those co-cultured with mDCs. It is possible that such 
differences in activation correspond to different downstream activities; possibly 
productive and abortive activations. Therefore, we tested whether or not iDC 
activated CL4 CD8' T cells produced effector responses associated with productive 
activation. 
Production of IFNy and other Thl-associated cytokines by CD8+ T cells in response 
to antigen has been associated with the acquisition of effector function (Fong and 
Mosmann, 1990). Activated CD8' T cells which exhibit a Thl-like cytokine 
secretion profile have been termed Tcl cells (Mosmann et at., 1986). Also, it has 
been shown that activated CD8' T cells can also differentiate to Tc2 cells, which 
exhibit a Th2-like cytokine secretion profile (Croft et at., 1994). Tc2 cells have 
reduced secretion of IFN-y, but secrete IL-4 (Cronin et at., 1995) and have an 
impaired cytotoxic function (Maggi et at., 1994; Sad et at., 1995). Tc2 cells have 
also been identified which produce IL-10 (Cerwenka et at., 1998). CL4 CD8` T 
cells are productively activated following PR8 encounter in vivo and form Tcl 
cells, secreting IFN-y (chapter 3). While, abortive activation of CL4 CD8' T cells in 
the PLN of InsHA mice does not appear to lead to Tcl differentiation. It is 
possible that iDC activation of CL4 CD8' T cells also does not lead to 
differentiation to normal Tcl effector CTL. To investigate this possibility the 
cytokine secretion profile of CL4 CD8' T cells was measured from co-cultures of 
CL4 CD8' T cells with either iDCs or mDCs KdHA peptide. Supernatants were ` 
harvested from these cultures and concentration of cytokines in these 
supernatants was assayed using antibody capture cytokine ELISA assays. 
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CL4 CD8' T cells cultured with mDCs in the presence of high KdHA concentrations 
produced high concentrations of supernatant IFN-y (Fig. 5b. 4A). IFN-y was 
detected in co-cultures of CL4 CD8' T cells with mDC in the presence of KdHA 
concentrations as low as 1x 10.3 µg/ml (Fig 5b. 4A). In contrast, very little IFN-y 
was detected at 72 hours in co-cultures with iDCs at all concentrations of KdHA 
tested (Fig. 5b. 4A). To ensure that the failure to detect IFN-y production by iDC- 
stimulated CL4 CD8+ T cells was not due to degradation of this cytokine or a delay 
in secretion, IFN-y production was analysed over time. At a hi concentration of 
KdHA, CL4 CD8' T cells did not produce IFN-y when co-cultured with iDCs for 24-96 
hours (Fig. 5b. 4B). 
The cytokine IL-2 enhances both CD4' and CD8' T cell proliferation (Mookerjee et 
at., 1989). During productive activation CD8' T cells secrete IL-2 as well as 
upregulating the high affinity receptor for this cytokine (CD25) (Sereti et at., 
2000). As described in chapter 5b. 2.1, CL-4 CD8' T cells co-cultured with mDCs 
and KdHA upregulate CD25; less CD25 upregulation occurs in co-cultures with iDCs. 
Therefore, IL-2 may be involved in CL-4 CD8' T cell activation by DCs, so IL-2 
concentration in DC-CL4 co-cultures was measured. 
Despite high levels of proliferation occurring, no IL-2 was detected in supernatants 
from co-cultures of CL4 CD8' T cells with iDCs at any KdHA concentration tested 
after 72 hours (Fig. 5b. 4C). In contrast, supernatants from co-cultures of CL4 
CD8` T cells with mDCs contained high concentrations of IL-2 (Fig. 5b. 4C). This 
difference in IL-2 secretion was also seen at 48 and 96 hours (data not shown). 
The concentrations of Tc2-associated cytokines were also measured, but no IL-4 or 
IL-10 were detected by ELISA assay in supernatants from CL4 CD8' T cell co- 
- 177 - 
Figure 5b. 4: Profiles of cytokine production by CL4 CD8' T co-cultured with 
DCs and KdHA 
10,000 MACS-enriched CL4 CD8' T cells were co-cultured with 10,000 iDCs or 
mDCs in the presence of KdHA at a range of concentrations. Supernatants were 
removed from co-cultures after 24,48,72 and 96 hours and the concentration of 
cytokines in these supernatants was determined by standard ELISA. Graph A 
shows the production of IFN-y over time in the presence of 1x 101 [tg/ml KdHA. 
Graph B shows the production of IFN-; at 72 hours over wide range of peptides. 
Graph C shows similar data for the concentration of IL-2 at 72 hours over the 
peptide range. 
These results are representative of more than three independent experiments. 
Cells from co-cultures were also harvested at 8 and 24 hours and from these 
suspensions, CL4 CD8` T cells were enriched by CD8' MACS selection . mRNA was 
isolated from these cells and cDNA was reverse transcribed. The production of 
mRNA specific for cytokines was deterimed by PCR and amplified products were 
visualised on agrose Gels containing Ethidium Bromide. Panel D represents the 
results from these PCRs. Data is shown from CL4 CD8' T cells stimulated by wither 
iDCs or mDCs for 8 or 24 hours with the following peptide concentrations: 
1) Hi -1 jig/ ml KdHA 
2) Int -1 x 10-3 tg/ml KdHA 
3) Lo -1x 10-5 tt8/ml KdHA 
4) No KdHA 
These results are representative of two separate experiments. 
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cultures (data not shown). It is possible cytokines are short-lived in supernatant 
or may be secreted at levels below the threshold of detection by this assay. To 
solve this potential problem, the production of messenger RNA (mRNA) for these 
cytokines was measured. CL4 CD8' T cells were harvested and purified by positive 
MACS selection of CD8' cells from DC/T cell co-cultures, set up as before, then 
mRNA was isolated from these cells. mRNA for IL-4 and IL-10 was amplified by 
reverse transcriptase PCR (RT-PCR) using specific primers and identified by gel 
electrophoresis. As a control for IL-4 and IL-10 mRNA, a CD4' T cell clone, which 
produces Th2 cytokines (a kind gift from Dr F. S. Wong, University of Bristol), was 
stimulated and mRNA isolated and analysed as for test cells. 
As cytokine mRNA production is an early event in T cell activation, the production 
of IL-4 and IL-10 mRNA was examined after 8 and 24 hours of co-culture. IL-10 
mRNA was isolated from Th2 control cells, indicating that PCR reactions for this 
cytokine were effective (Fig. 5b. 4D). However, mRNA isolated from CL4 CD8' T 
cells co-culture with either iDCs or mDCs did not contain any IL-10 mRNA. IL-4 
mRNA was not isolated from CL4 CD8' T cells taken from co-cultures with mDC at 
any concentration of KdHA (Fig. 5b. 4D). IL-4 mRNA was detected in RNA isolated 
from CL4 CD8` T cells which had been stimulated by iDCs with high concentrations 
of KdHA for 8 or 24 hours or with moderate concentrations of KdHA 24 hours. The 
level of the expression of IL-4 mRNA by such CL4 CD8' T cells was lower than that 
detected in control RNA. RT-PCRs were also performed to measure IFN-y mRNA 
and HPRT mRNA, as controls. Production of IFN-y mRNA was detected amongst 
CL4 CD8' T cells stimulated with mDCs, but not from similar cells stimulated with 
iDCs (Fig. 5b. 4D). As the cells analysed for mRNA production were isolated by 
CD8' MACS selection, it is conceivable that that the IL-4 mRNA detected may be 
produced by populations of CD8a' DCs from co-cultures. However, this is unlikely 
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due to the fact that IL-4 mRNA production is dependent on the presence of K°HA 
peptide. To confirm that the IL-4 is produced by CL4 CD8' T cells, further studies 
could utilise Thyl. 1 MACS selection to purify CL4 CD8' T cells from co-cultures. 
The cytokine production profile of CL4 CD8' T cells activated by iDC is similar to 
that described for Tc2 cells. Therefore, following co-culture with iDCs and KdHA, 
those CL4 CD8' T cells that divide may differentiate into productively activated 
CTL. To determine whether or not CL4 CD8' T cells form effector CTL following 
encounter with iDCs, chromium release assays were used to measure the 
cytotoxicity of activated CL4 CD8' T cells (Brunner et at., 1968). Effector cells 
were prepared by stimulating naive CL4 CD8' T cells with 1x 101 µg/ml KdHA in 
the presence of either mDCs or iDCs for 72 hours. Target cells were then 
prepared by radio-labelling the H-2° Mastoma line cell P815 with "Chromium and 
pulsing with KdHA peptide. A range of peptide concentrations were used in an 
attempt to reveal the functional avidity of the effector CD8' T cells for the 
peptide-pulsed target cells. The labelled target cells were incubated with 
effector cells for 16 hours. Supernatants were then harvested and levels of 
51chromium release measured by -y-scintillation counts. Counts for effector cells 
were compared to spontaneous as well as maximum target cell acid induced lysis, 
in order to generate a value for percentage specific lysis. 
When target cells were pulsed with the highest level of K°HA, similar killing by 
effector CL4 CD8` T cells stimulated by either iDCs or mDCs was observed (Fig. 
5b. 5A). At lower KdHA concentrations, killing by iDC stimulated CL4 CD8' T cells 
was less than killing by CL4 CD8` T cells stimulated by mDCs. No detectable killing 
of target cells pulsed with 1x 10.2 µg/ml KdHA was seen when incubated with iDC 
stimulated CL4 CD8` T cells, whereas a high level of lysis of similar target cells 
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Figure 5b. 5: CTL response by CL4 CD8' T cells following co-culture with DCs 
and KdHA 
1x 106 CL4 CD8` T cells were co-cultured with iDCs or mDCs at a ratio of 1: 1 in the 
presence of 1x 10-' µg/ml KdHA for 72 hours. CL4 CD8' T cells were enriched from 
these cultures using CD8' MACS selection and cell concentrations were adjusted to 
give similar numbers of activated T cells per sample. 1x 106 CL4 CD8' T cells were 
incubated at a ratio of 10 effector cells to 1 target cell with KdHA-pulsed P815 
target cells that had been labelled with 51Cr. After 16 hours supernatant was 
harvested and assayed for the amount of 51Cr released using a I3 scintillation 
counter. Graph A shows P815 cell lysis generated by effector cells relative to 
spontaneous lysis and maximum lysis by acid. 
These results are representative of more than three independent experiments. 
CFSE-labelled CL4 CD8' T cells were co-cultured with iDCs or mDCs in the presence 
of KdHA at a range of concentrations. After 72 hours cultures were incubated with 
KdHA and anti-CD107a antibodies for 30 minutes. Monensin was added and cells 
were incubated for a further 4 hours. The increase in MFI in the APC channel for 
CFSE-divided CL4 CD8' T cells relative to unstained controls was determined by 
flow cytometry. Plots B and C show % MFI increase in response to restimulation by 
a range of KdHA peptide concentrations for CL4 CD8' T cells activated by iDCs or 
mDCs in the presence of 1x 10-1 [tg/ml (graph B) or 1x 10 3 «g/ml (graph C) KdHA 
peptide. Panel D shows histograms of the anti-CD107a antibody binding for CL4 
CD8' T cells restimulated by high levels of peptide after initial activation in the 
presence of a range of peptide concentrations. 
These results are representative of three independent experiments. 
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Figure 5b. 5: CTL response by CL4 CD8' T cells following co-culture with DCs 
and KdHA peptide 
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was detected by CL4 CD8' T cells incubated with mDC (Fig. 5b. 5). The difference 
between the cytotoxic functional avidity for peptide-pulsed target cells of CL4 
CD8` T cells co-cultured with iDC was between 0.5/1 log less than for those co- 
cultured with mDCs. 
These data were generated from CL4 CD8' T cells initially activated in the 
presence of a relatively high concentration of K°HA peptide (1 x 101 µg/ml). At 
this peptide concentration CL4 CD8' T cell proliferation induced by iDCs was 
similar to that induced by mDCs activation (Chapter 5b. 2.1). At physiological 
peptide concentrations CL4 CD8' T cell responses stimulated by iDCs were 
quantitatively and qualitatively different from responses to mDCs (Chapter 
5b. 2.2). Experiments were therefore designed to test the effect on generation of 
effector CL4 CD8' T cells from a range of initial KdHA stimulation. 
We utilised another method to assess CD8+ effector function, a flow cytometric 
measurement of degranulation (Kane and Mescher, 1993), which requires fewer 
effector CTL and thus facilitates the study of CL4 CD8` T cells activated by low 
concentrations of KdHA. When CTL release lytic granules, lysosome membranes 
fuse to the cell surface membrane where lysosome-associated membrane proteins 
(LAMPs) become transiently incorporated (Betts et al., 2003). Fluorochrome- 
conjugated antibodies against LAMPs can be utilised to trap intracellular 
membrane proteins at the cell surface and visualise by flow cytometry (Betts and 
Koup, 2004). P815 target cells were pulsed with KdHA peptide and were used to 
restimulate CL4 CD8` T cells that had been co-cultured for 72 hours. 
Fluorochrome-conjugated anti-CD107a (LAMP-1) antibodies were also added. 
Mean fluorescence intensities of anti-CD107a antibodies were measured by flow 
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cytometry to indicate how much degranulation had occurred during this 
restimulation. 
There were measurable increases in CD107a surface expression by CL4 CD8' T cells 
activated by iDCs or mDCs upon restimulation by target cells (Fig. 5b. 5B). The 
increase in surface CD107a corresponds to functional degranutation which 
correlates with effector function (Betts and Koup, 2004) as degranulation was 
detected for the same target peptide range as CL4 CD8' T cell cytotoxicity was 
observed by chromium release assay. CL4 CD8` T cells stimulated by iDC had 
much lower CD107a recruitment in response to high concentrations of KdHA than 
CL4 CD8+ T cells stimulated by mDC (Fig. 5b. 5B). CL4 CD8' T cells stimulated 
initially with a lower KdHA concentration had similar CD107a recruitment (Fig. 
5b. 5C). 
When CL4 CD8' T cells activated in the presence of high concentrations of peptide 
encountered pulsed target cells they had an increased CD107a surface expression; 
this expression was greater in those CL4 CD8' T cells stimulated by mDCs versus 
iDCs (Fig. 5b. 4E). With lower concentrations of peptide in the initial stimulation, 
those CL4 CD8+ T cells pre-activated by iDCs had little CD107a recruitment upon 
restimulation, whilst high levels of CD107a was still observed in mDC stimulated 
CL4 CD8' T cells (Fig. 5b. 4E). These data support the hypothesis that CL4 CD8` T 
cells stimulated with more physiological levels of peptide presented by iDC do not 
form productively activated effector CTL. 
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5b. 3 Factors influencing CL4 CD8+ T cell activation 
5b. 3.1 The role of cytokines in controlling CL4 CD8` T cell activation 
Data presented in chapter 5b. 2.2 revealed that CL4 CD8+ T cells stimulated by 
iDCs do not produce IFN-y. Secretion of IFN-y by CD8+ T cells can be induced by IL- 
12 produced by an APC (Manetti et al., 1993; Wu et al., 1993). IFN-y production 
by T cells in response to LPS or other microbial stimuli is greatly impaired in 
transgenic mice that are unable to produce active IL-12 (Maltram et al., 1996). 
Also, IL-12-mediated response\s are disrupted in transgenic mice that lack a IFN-y 
signalling pathway component (Darnell, 1998; Thierfelder et al., 1996). The 
activation of CL4 CD8+ T cells by iDCs did not appear to lead to secretion of IFN-y, 
it is possible this might be due to deficiency in the ability of iDCs to produce IL- 
12. Co-cultures of CL4 CD8+ T cells with DCs were examined by supernatant ELISA 
for the production of IL-12. High levels of IL-12 were detected in mDC cultures at 
all peptide concentrations (Fig. 5b. 6A); similar amounts of IL-12 were observed in 
mDC/CL4 CD8+ T cell co-cultures in the absence of KdHA peptide. IL-12 was not 
detected in co-cultures with iDCs (Fig 5b. 6A). The fact that the level of IL-12 was 
independent of the amount of peptide added supports the idea that this cytokine 
is produced by mDCs rather than by the CL4 CD8+ T cells. This was also confirmed 
by the fact that in the absence of CL4 CD8+ T cells high concentrations of IL-12 
were detected in freshly harvested mDC cultures but not iDC in similar cultures 
(Fig. 5b. 6B). 
The difference in cytokine production between iDCs and mDCs may determine 
whether DC induce productive or abortive responses. CL4 CD8+ T cells were co- 
cultured with iDCs or mDCs and KdHA peptide as before. Duplicate co-cultures of 
CL4 CD8` T cells with DCs and KdHA peptide were set up and to these wells 
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Figure 5b. 6: Production of IL-12 by iDCs versus mDCs 
10,000 iDCs or mDCs were co-cultured with 10,000 MACS-enriched CL4 CD8` T 
cells in the presence of KdHA at a range of concentrations. Supernatants were 
removed and the level of IL-12 in these supernatants was determined by standard 
ELISA. Graph A shows the IL-12 concentration under different co-culture 
conditions. 
Supernatants were also harvested from BMDC growth cultures and the level of IL- 
12 in these supernatants were determined by ELISA. Graph B shows the IL-12 
concentrations from iDC or mDCs generation cultures 
These results are representative of two independent experiments. 
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recombinant IL-12 was added. Standard proliferation assays were performed after 
72 hours and culture supernatants were assayed by ELISA for cytokines to 
ascertain the effect IL-12 on CL4 CD8* T cell activation. The addition of IL-12 did 
not alter the proliferation profile of CL4 CD8* T cells responding to iDCs (Fig. 
5b. 7A). IL-12 also had no effect on CL4 CD8+ T cells stimulated in the presence of 
mDCs at low peptide concentrations (<1 x 10.3 g/ml KdHA). Although, at high 
concentrations of KdHA, proliferation amongst CL4 CD8~ T cells co-cultured with 
mDCs was reduced by addition of IL-12 (Fig. 5b. 7A). However, the addition of IL- 
12 to co-cultures of CL4 CD8' T cells with iDCs resulted in increases in the level of 
IFN-y in co-culture supernatants after 72 hours. This amount was similar to the 
amount of IFN-y detected in co-cultures of CL-4 CD8* T cells and mDCs (Fig. 5b. 7B). 
The addition of IL-12 did not result in IL-2 in co-cultures of CL-4 CD8* T cells and 
iDCs (Fig. 5b. 7 C). However, the addition of IL-12 also increased IFN-y and IL-2 
production by CL4 CD8' T cells stimulated by mDCs, but the concentration of KdHA 
needed to elicit cytokine production remained unchanged (Fig. 5b. 7B and C). 
Taken together these data suggest that although, the addition of IL-12 restored 
IFN-y production by CL4 CD8' T cells stimulated by iDCs to that by CL4 CD8+ T cells 
stimulated by mDCs, full effector response was not restored, as evidenced by a 
lack of IL-2. 
5b. 3.2 The role of co-stimulation on DC-induced CL4 CD8' T cell activation 
It is possible that the response of CL4 CD8' T cells to DCs is only partially 
dependent on IL-12 secretion. Previous studies have demonstrated that it is the 
expression of co-stimulatory molecules by APCs that determine. whether T cells 
are activated productively or anergised (Schwartz, 1990). iDC and mDCs also 
differ in expression of co-stimulatory molecules; these differences were defined in 
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Figure 5b. 7: The effect of IL-12 on stimulation of CL4 CD8' T cells by BMDCs 
10,000 iDCs or mDCs were co-cultured with 10,000 MACS-enriched CL4 CD8' T 
cells in the presence of KdHA at a range of concentrations; to some co-cultures 30 
ng/mt IL-12 was also added. 3H-thymidine was added in excess for the final 8 
hours of culture. After 72 hours supernatants were removed and cultures were 
harvested and cells were assayed for proliferation by incorporation of tritium. 
Supernatants were assessed for IL-2 and IFN-y by standard ELISA. Graph A shows 
CL4 CD8' proliferation in CPM. Graphs B and C show the supernatant 
concentrations of IFN-y and IL-2 respectively. 
These results are representative of three independent experiments. 
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Chapter 5a. 2. Are particular surface co-stimulatory molecules important in 
determining of the outcome of aT cell response to peptides presented by these 
DCs? To investigate the effects of individual co-stimulatory molecules, DCs were 
pre-incubated with CD40, CD80, or CD86 blocking antibodies to co-stimulatory 
molecules prior to their addition to co-cultures with CL4 CD8' T cells. 
Proliferation was measured by 3H-thymidine incorporation after 72 hours of co- 
culture to determine whether or not responses were inhibited. 
Blocking CD40, CD80 or CD86 on DCs individually with antibodies did not 
significantly alter CL4 CD8+ T cell proliferation in response to KdHA compared with 
untreated controls (Fig. 5b. 8A-C). When anti-CD40 antibodies were added in 
conjunction with either anti-CD80 or anti-CD86 antibodies, CL4 CD8+ T cells 
proliferation was reduced (Fig. 5b. 8A-C). This reduction in response was observed 
over a range of KdHA concentrations and pre-treatment had similar effects on CL4 
CD8+ T cells proliferation in response to either iDCs or mDCs. The simultaneous 
blockade of both CD80 and CD86 also suppressed the activation of CL4 CD8+ T 
cells. Indeed, very little proliferation was observed amongst CL4 CD8+ T cells co- 
cultured with iDCs treated with anti-CD80 and anti-CD86 antibodies at any peptide 
concentration. Only low CL4 CD8+ T cell proliferation was seen when the activity 
of all co-stimulatory molecules examined (CD40, CD80 and CD86) was blocked 
(Fig. 5b. 8A-C). The reduction in proliferation of CL4 CD8+ T cells stimulated with 
hi concentrations of KdHA when all three molecules were blocked was similar to 
the effect of the blockade of just CD80 and CD86 together and any difference was 
not statistically significant. These data suggest that co-stimulation by CD80 and 
CD86 is crucial for DC-mediated CL4 CD8' T cell activation. 
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Figure 5b. 8: Requirement of costimulation for the activation of CL4 CD8' T 
cells by BMDCs 
10,000 iDCs or mDCs were co-cultured with 10,000 CL4 CD8` T cells in the 
presence of KdHA at a range of concentrations plus or minus antibodies against one 
or more of the following co-stimulatory molecules: CD80, CD86 or CD40. 
Antibodies, where used, were at a concentration of 10 ýtg/ml. 3H-thymidine was 
added in excess for the final 8 hours of culture. iDCs or mDCs were co-cultured 
with CL4 CD8` T cells After 72 hours of co-culture cells were assayed for 
incorporation of 3H-thymidine. 
Panel A shows graphs demonstrating the proliferation of CL4 CD8* T cells 
responding to a range of peptides with each addition of blocking antibody. 
Proliferation data showing the effect of this blocking alongside each other is 
depicted in Graphs B-D. B shows proliferation in the presence of 1x 101 µg/ml, C, 
1x 10' Egg/ml, D, 1x 10-3 µg/ml KdHA. 
These results are representative of three independent experiments. 
Statistical analyses were carried out with two-tailed t-tests (paired). 
* significantly different to untreated controls (p <0.002) 
** significantly different to untreated controls (p <0.02) 
$ not significantly different to untreated controls (p >0.2) 
not significantly different to CD80/CD86 treatment (p >0.1) 
Statistical analyses were also carried out for co-cultures with 1x 10' ug/ml and 1 
x 10-3 tg/ml K°HA, but for clarity these data are not shown. 
Chapter 5b: Abortive activation of CL4 CD8' T cells in vitro 

















CL Z U 
0 












Figure 5b. 8: Requirement of co-stimulation for the activation of CL4 CD8' T 
cells by BMDCs 
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5b. 4 Induced abortive activation in vivo 
The data presented so far suggest that the consequences of CL4 CD8' T cell 
activation in vitro are dependent on the maturation state of the DC as defined by 
profile of co-stimulatory molecule expression and the profile of cytokine 
secretion, as well as by the availability of cognate peptide. Rather than distinct 
activation, producing either effector CTL or unactivated/anergic T cells, there 
appears to be a range of functional responses which depends upon the 
combination of activation conditions. However, if activation of self-reactive T 
cells occurs in vivo, activation can only be abortive, leading to the induction or 
self-tolerance, or if it is productive, leading to autoimmunity. It has also been 
shown in previous experiments that a BM-APC is required in the InsHA model for 
peripheral self-tolerance induction and that this APC is likely to be a DC (Morgan 
and Fraser, Unpublished data). To address how observations from in vitro studies 
of CL4 CD8' T cells activation by DCs may relate to the observations in vivo CL4 
CD8' T cells activation, we investigated the outcomes of CL4 CD8' T cells 
activation by DCs in vivo. Do iDCs activate CL4 CD8+ T cells in vivo productively or 
abortively? 
Firstly, to test whether or not ex vivo generated BMDCs can mediate responses by 
CL4 CD8` T cells in vivo, CFSE-labelled CL4 CD8' T cells were transferred into 
BALB/c mice, then challenged the following day with a further transfer of KdHA- 
pulsed DCs. Four days subsequent to DC transfer, cell suspensions were isolated 
from lymph nodes of donor mice and CL4 CD8' T cell division examined by flow 
cytometry for CL4 CD8' T cell division. Cells were also stained for activation 
markers shown to be key indicators of response and assays were carried out to 
investigate any production of IFN-y and cellular degranulation upon restimulation. 
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When mDCs pulsed with either a hi level of KdHA peptides (1 µg/ml KdHA; mDC-hi) 
or with a one-hundred-fold lower concentration (mDC-int) were adoptively 
transferred, flow cytometric analyses of CFSE levels revealed that CL4 CD8` T cells 
underwent at least seven divisions, leaving few undivided cells (Fig 5b. 9A). 
However, in mice that received iDCs pulsed with the hi concentrations of K°HA 
(iDC-hi) fewer CL4 CD8' T cells were induced to divided and more CL4 CD8' T cells 
remained undivided. However, in response to KdHA-pulsed iDCs, some CL4 CD8' T 
cells did undergo seven or more divisions. iDCs pulsed with lower peptide levels 
(iDC-int) induced very little CL4 CD8' T cells proliferation (Fig. 5b. 9A). 
In the presence of mDC-hi, dividing CL4 CD8' T cells upregulated CD25 as well 
Ly6C, while in mice that received mDC-int only some increase in CD25 and Ly6C 
expression was observed (Fig. 5b. 9). In mice that received iDC-hi, there was some 
increase in expression of both CD25 and Ly6C amongst CL4 CD8' T cells. In mice 
that received iDC-int, there was no expression of CD25 by proliferating CL-4 CD8` T 
cells, however, high levels of Ly6C were observed. In addition, proliferating CL4 
CD8' T cells activated in vivo by either mDC-hi or mDC-int degranulated and 
produced IFN-y upon restimulation, as detected by CD107a surface staining and 
intracellular cytokine staining (Fig 5b. 9). In contrast, these functional responses 
were not observed in CL4 CD8' T cells that had been previously activated in vivo 
by iDCs. 
These data indicate that transfer of ex vivo pulsed DCs can activate naive CL4 
CD8` T cells in an in vivo setting. Cell surface phenotypes, as welt as indirect 
functional analyses, `imply that CL4 CD8' T cells iDC activated in this manner do 
not. form normal effector CTL, despite becoming highly divided. To determine 
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Figure 5b. 9: Properties of CL4 CD8` T cells activated in vivo by transfer of ex 
vivo pulsed BMDC 
3x 106 CFSE-labelled MACS-enriched CL4 CD8' T cells were adoptively transferred 
i. v. into BALB/c mice. The following day, these mice also received transfers of 
suspensions of BMDCs which had been pulsed with KdHA for one hour. Groups of 
mice received either iDCs or mDCs pulsed with either high concentrations of 
peptide (1 µg/ml) or low levels (1 x 10-2 µg/ml). After three days LN were 
harvested from recipient mice and single cell suspensions generated. These cells 
were stained with anti-Thyl. 1 antibodies and antibodies against cell surface 
antibodies or were restimulated for intracellular cytokine staining and CD107a 
surface recruitment staining. Plots show CFSE indicating division on the X-axis 
against the expression of cell surface markers, or intracellular cytokine staining. 
These results are representative of three independent experiments. 
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Figure 5b. 9: Flow cytometric analyses of CL4 CD8' T cells activated in vivo 
by transfer of ex vivo KdHA peptide-pulsed BMDC 
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whether or not iDCs can activate CL4 CD8' T cells in a truly abortive manner 
studies were carried to determine if CL4 CD8' T cells activated by iDCs mount a 
productive response in vivo. As previously shown, productive activation of CL4 
CD8` T cells in a donor InsHA mice, for example by PR8 immunisation, leads to 
autoimmune diabetes unlike abortive activation, where self-tolerance is 
maintained. 
To test whether peptide-pulsed DCs induce productive or abortive activation of 
CL4 CD8` T cells in vivo, high numbers of naive CL4 CD8' T cells were adoptively 
transferred into groups of InsHA mice; the following day iDCs or mDCs pulsed with 
either hi or int concentrations of KdHA were transferred. Mice were tested for 
diabetes by measurement of urine glucose concentrations at twice-weekly 
intervals for six weeks following DC transfer. Mice were diagnosed as diabetic 
after glycosurea was detected by consecutive readings and was confirmed by 
blood glucose values above 140 mM. Table 5b. 2 reveals that only transfer of mDCs 
pulsed with high levels of KdHA peptide led to diabetes. No diabetes was observed 
when peptide pulsed iDCs were transferred. These data imply that although both 
iDCs and mDCs activate CL4 CD8' T cells in vivo, activation driven by iDCs may be 
abortive and lead to the induction of peripheral tolerance to antigens presented 
by the iDCs. 
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Table 5b. 2: Diabetes incidence following transfer of KdHA-pulsed DCs into 
InsHA mice 
3x 106 MACS-enriched CL4 CD8` T cells were adoptively transferred i. v. into InsHA 
mice. The following day, these mice also received transfers of suspensions of 
BMDCs that had been pulsed with KdHA for one hour. Groups of mice received 
either iDCs or mDCs pulsed with either high concentrations of peptide (1 µg/ml) or 
low levels (1 x 10-2 µg/ml). Mice were monitored for glycos-urea bi-weekly for '6 
weeks and diabetes was confirmed by blood glucose measurement after two 
consecutive raised urine glucose measurements. Each group contained at least 5 
animals and experiments were carried out on two independent occasions. 
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Cells transferred day 0 Pulsed with Diabetes incidence 
MC Hi KdHA 0% 
mDC Hi KdHA 100% 
iDC Int KdHA 0% 
mDC Int KdHA 
0% 
Table 5b. 2: Incidence of diabetes amongst InHA mice following transfer of 
KdHA-pulsed DCs 
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5b. 5 Discussion 
It is known that CL4 CD8' T cells are abortively activated subsequent to 
encountering a BM-APC expressing KdHA epitopes in the PLN of InsHA mice (Morgan 
and Fraser, unpublished data). Whereas CL4 CD8+ T cells activated by KdHA 
epitopes during PR8 infection mount productive responses which result in 
autoimmune diabetes (Hernandez et at., 2001). Despite the fact that the same 
TcR is expressed at the same level by all CL4 CD8' T cells and they therefore have 
the same high avidity for KdHA peptide, the context in which antigen encounter 
occurs appears to determine the functional response of the CL4 CD8+ T cells. 
Experiments described in this chapter were carried out in order to determine how 
the maturation status of the DC affects whether CL4 CD8` T cells were activated 
abortively or productively. Various types of cellular and molecular analyses were 
carried out in order to evaluate the phenotype and function of CL4 CD8` T cells 
stimulated in vitro and in vivo by iDCs versus mDCs. Importantly, further 
experiments were carried out to determine how manipulation of DC-related 
factors could alter the nature of the response. 
Initially, proliferation of CL4 CD8' T cells to a range of KdHA concentrations in the 
presence of either iDCs or mDCs were examined. To generate similar levels of CL4 
CD8' T cell proliferation iDCs require 10,000 times as much KdHA as mDCs. 
However, at the highest KdHA concentrations tested, responses to iDCs and mDCs 
were similar. In addition, experiments carried out to evaluate CL4 CD8+ T cell 
division using CFSE"labelling demonstrated that the reduction in proliferation seen 
when activated by iDCs was due to a reduction in number of responders and at the 
lowest peptide concentrations the number of rounds of division was also noted to 
be limited. These data show that there is a quantitative difference in CL4 CD8+ T 
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cell responses to antigen when stimulated with iDCs versus mDCs. Also iDCs, 
which lack surface-expressed co-stimulatory molecules, could activate CL4 CD8' T 
cells to undergo many rounds of cell division forming highly divided cells, but only 
when the peptide dose was above a certain level to cause an activation. This 
finding is consistent with earlier studies in which it was found that that high doses 
of cognate antigen can rescue CD8' T cells activated in the absence of co- 
stimulation (Cai and Sprent, 1996; Oh et at., 2003). Using immobilised anti-TcR 
antibodies, it was shown that in CD28-deficient mice, a high level of signal 1 can 
overcome the need for co-stimulation, however, responses were greater when DCs 
were used to provide co-stimulation (Cassell, 2001). Experiments where H-Y TcR 
transgenic T cells were stimulated with high doses of H-Y antigen indicate that 
CD8' T cells did require signals through CD28 co-stimulation to generate effector 
CTL (Chaff et at., 1999). Also, responses by CD8' T cells stimulated by strong TcR 
cross-linking in conjunction with co-stimulation blockade have demonstrated that, 
whilst lack of co-stimulation impairs IL-2 secretion and proliferation, cytotoxic 
effector function is unaffected (Hombach et at., 2001). Taken together, these 
data suggest that it is necessary to ensure that conclusions are not drawn by 
merely examining one readout of T cell response, as this may misrepresent the 
consequences of CL4 CD8` T cell stimulation by DCs. 
The concentration of KdHA peptide that is required to stimulate high levels of CL4 
CD8' T cell proliferation by iDCs is probably much greater than the physiological 
level present amongst APCs in the PLN of InsHA mice (Morgan, unpublished data). 
Yet under the conditions in InsHA PLN, CL4 CD8' T cells do proliferate. In the 
presence of iDCs pulsed with low levels of KdHA in vitro, the response of CL4 CD8' 
T cells matches an abortive response in vivo, both in terms of a few cells that 
divide and those that do undergo a limited number of divisions. The concept that 
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stimulating T cells with low levels of antigen presented by DCs leads to abortive 
activation and that DC mediate the induction of T cell tolerance has been 
previously indicated (Steinman et al., 2003). Studies have shown that when low 
doses of peptides are acquired by DCs and presented to CD4` and CD8' T cells, 
tolerance induction can ensue. These experiments used peptides linked to anti- 
DEC 205 antibodies to enable efficient delivery to DCs to cause deletion of HEL- 
specific TcR transgenic CD4` T cells (Hawiger et al., 2001) or OVA-specific TcR 
transgenic CD8' T cells (Bonifaz et al., 2002; Hawiger et al., 2001), in both cases 
by peripheral deletion. Interestingly, stimulation by DCs pulsed with low doses of 
peptide could lead to immunity when accompanied by administration of anti-CD40 
stimulatory antibodies, which promoted DC maturation (Bonifaz et al., 2002). 
Using our system, we wish to directly investigate the consequences of interactions 
with iDCs and mDCs to support the possibility that such activations observed with 
iDCs represent an alternative functional response by CD8' T cells between 
ignorance and cytotoxicity. In vitro data of iDCs interactions with CD8` T cells 
could both suggest an explanation of how steady state tolerance is maintained and 
provide a system for therapeutic tolerance induction. It is clear that a full 
functional readout of the responses by CL4 CD8+ T cells is required to determine 
whether or not activation is abortive. 
CL4 CD8` T cells activated by KdHA presented by mDCs expressed a fully activated 
cell surface phenotype (CD25hi, CD69`, CD62LIO, and CD95L+), secreted high levels 
of IFN-y and IL-2, but not IL-4 or IL-10, and were cytotoxic to K°HA pulsed target 
cells. In contrast, similar CL4 CD8' T cells when activated in the presence of iDCs 
did not upregulate CD95L, expressed lower levels of CD25 and did not 
downregulate CD62L as much as those activated by mDCs. This partially activated 
cell surface phenotype is similar to CL4 CD8' T cells undergoing abortive 
- 197 - 
Chapter 5b: Abortive activation of CL4 CD8' T cells in vitro 
activation in InsHA PLN (Chapter 3). iDCs did not induce IFN-y, IL-2 or IL-10 
secretion by CL4 CD8' T cells, but instead brought about IL-4 secretion and 
cytotoxic responses were reduced. The disparity in responses subsequent to 
interactions with iDCs versus mDCs was apparent at low KdHA concentrations. 
mDC-activated CL4 CD8' T cells express a similar cell surface phenotype to CD8+ T 
cells, which have been productively activated to form CTL (Cerwenka et al., 
1998); these phenotypes also match those expressed by CL4 CD8+ T cells that are 
productively activated in vivo by immunisation with PR8 (Chapter 3). CD25 is the 
a chain of the high affinity IL-2 receptor and stimulates further IL-2 production. 
Activation and proliferation of CD8+ T cells has previously been demonstrated in 
the absence of CD25 expression, but such activation has been shown to be short- 
lived (D'Souza and Lefrancois, 2003). The fact that CL4 CD8+ T cells activated by 
iDCs express low levels of CD25 and CL4 CD8+ T cells and abortively activated CL4 
CD8+ T cells in InsHA mice do not express CD25, may be indicative of a low-level 
activation which is independent of IL-2. It is therefore not surprising that this 
partially activated phenotype, CD251nt should be observed in conjunction with 
absence of IL-2 production. The lack of IL-2 stimulation may explain the limited 
proliferation of CL4 CD8' T cells that was observed in vitro/in vivo. 
Ly6C is rapidly upregulated by CL4 CD8' T cells subsequent to encounter with KdHA 
presented by iDCs, whereas, after stimulation by mDCs, CL4 CD8' T cells do not 
upregulate Ly6C. Therefore, iDCs actively induce altered CL4 CD8' T cell 
activation, rather than a partial activation due to the level of stimulation failing 
to reach a required threshold. The röte of Ly6C is generally unclear, some studies 
have identified Ly6C as an activation marker of T cells (Ortega et al., 1986), 
whilst others show it to be expressed by subsets of memory T cells, (Walunas et 
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at., 1995). Further work has suggested that Ly6C may act as an accessory 
molecule to aid cytotoxic effector function by CD8' T cells (Johnson et at., 1993). 
There is an apparent paradox that a molecule associated with activation and 
productive responses should be upregulated by aT cell that has impaired 
proliferative capabilities. Ly6C may therefore act to prevent immunity: one study 
has shown Ly6C expression coincided with inhibition IL-2 production and thus 
proliferation by CD4' T cells (Yamanouchi et at., 1998) and defects in Ly6C have 
been detected in several models of autoimmunity, for example the NOD mouse 
(Philbrick et at., 1990). Therefore in our system, Lyc6C expression may be 
upregulated to reduce T cell activation and aid the initiation of abortive 
activation. 
It has been known for a number of years that activating CD8' T cells can lead to 
two separate effector phenotypes. Classical activated CD8' T cells which secrete 
IFN-y, TNF-a and LT-1 and form potent TcR-specific cytotoxic responses are 
termed Tcl cells (Kelso and Glasebrook, 1984). While Tc2 cells secrete IL-4 (Erard 
et at., 1993), and some reports have shown Tc2 cells to posses lower efficiency 
cytotoxicity (Maggi et at., 1994). However, Tc2 clones have been generated 
which do not have impaired cytotoxic responses (Croft et at., 1994; Sad et at., 
1997; Sad et at., 1995) and other Tc2 clones produce some IFN-y (Salgame et at., 
1991). However, most studies examining Tc2 cells involve polarisation of CD8' T 
cells by in vitro culture with Th2 cytokines (IL-4,11-5 or IL-10) or with anti-Th1 
cytokine blocking antibodies (e. g. anti-IFN-y) and therefore published Tc2 
phenotypes may not reflect in vivo CD8' T cell activation. It has been previously 
shown that certain APCs may be able to mediate this differentiation, e. g. M12 B 
cells (Mosmann et at., 1997). It is conceivable that stimulation of CL4 CD8' T cells 
with low doses of KdHA in combination with iDCs may polarise CD8' T cells to 
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produce a Tc2-type response. The function of these cells is unknown, but it is 
unlikely they perform a regulatory role as they do not secrete IL-10 and no 
suppressive activity was seen in proliferation assays (data not shown). It is 
possible that in vivo partial activation and Tc2 profile is a part of a peripheral 
deletion mechanism and that iDCs play a röte in maintenance of the steady state 
in this manner. 
CL4 CD8+ T cells activated by iDCs had lower cytotoxicity than those CL4 CD8* T 
cells activated by mDCs. The difference observed related to a 1-1.5 tog 
difference in peptide level required to achieve the equivalent level of target cell 
lysis. Importantly, this occurred when CL4 CD8+ T cells were stimulated by a 
relatively high peptide dose (1 x 10.1 µg/ml), activation at lower peptide 
concentrations may be more physiologically relevant. The assays measuring 
degranulation using CD107a surface recruitment show a different trend: that there 
was a greater difference between iDC and mDC-stimulated CL4 CD8+ T cells at 
high peptide concentrations. Such a difference can be explained by several 
factors: firstly, although previous studies have suggested that cytotoxicity by CL4 
CD8+ T cells is mediated mainly through the granzyme/perforin pathway (Kreuwel 
et at., 1999), there may be some CD95L-CD95 associated killing in this model, 
which would not be indicated by measuring CD107a. However, as CD95L was not 
expressed by CL4 CD8+ T cells activated by iDCs, it must be assumed that at the 
lower recruitment of CD107a associated with such T cells corresponds to total 
cellular cytotoxicity. Secondly, the chromium release assay measures cumulative 
killing over 16 hours, whilst examining degranutation, merely indicates the 
immediate cytotoxicity of a cell. Over the course of a 16 hour incubation it is 
possible that the increase in cell death would further stimulate CTL responses and 
allow a killing maximum to occur; thus any difference in the kinetics of killing by 
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CL4 CD8` T cells activated by either iDCs or mDCs would become apparent. As 
discussed above, antigen dose may be a key factor in determining the nature of a 
CL4 CD8+ T cell functional response. Therefore, it is important to examine the 
effect of antigen dose in the primary activation of CL4 CD8' T cells. 
As shown by CD107a recruitment, following restimulation with target cells pulsed 
with a high level of peptide, there is a range of peptide doses which can generate 
effector CTL from naive CL4 CD8' T cells when presented by mDCs, but not when 
presented by iDCs. This suggests that at low peptide concentrations, the level of 
co-stimulation through cytokines or surface receptors may determine whether or 
not productive activation of CL4 CD8' T cells occurs. 
There are differences between iDCs and mDCs based on both their expression of 
co-stimulatory molecules and their secretion of cytokines. IL-12 is produced by 
mDCs, but not by iDCs, and may be key in the activation CL4 CD8' T cells to 
produce IFN-y. Addition of exogenous IL-12 to co-cultures of iDCs and CL4 CD8` T 
cells led to increased IFN-y production, yet did not restore the proliferative 
response profile of CL4 CD8' T cells to that of similar cells stimulated by mDCs. 
The influence of co-stimulatory molecules was also investigated: blocking 
individual surface molecules made little difference to the activation of CL4 CD8+ T 
cells by either iDCs or mDCs. However, blocking both CD8O and CD86 together 
greatly reduced proliferation of CL4 CD8` T cells driven by either population of 
DC. Responses could be further reduced by adding blocking antibodies against 
CD40, as well as CD80 and CD86, but mDCs could still elicit a measurable 
activation of CL4 CD8+ T cells. Blockade of such molecules was most apparent at 
low peptide concentrations. These data support the theory that high antigen dose 
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can overcome a lack in co-stimulation to induce proliferation (Rifle and Mousson, 
2002). This also shows that, at least in part, quantitative differences in activation 
of CL4 CD8' T cells by iDCs versus mDCs may be due to the lower expression of co- 
stimulatory molecules by iDCs. The fact that proliferation mediated by mDCs is 
not completely blocked by addition of antibodies against CD80, CD86, and CD40 
indicates that co-stimulation may be provided by alternative ligands expressed by 
mDCs. As the antibodies used can block all proliferation of CL4 CD8' T cells, it is 
likely that such additional co-stimulation molecules are expressed exclusively by 
mDCs. 4-1 BBL is expressed solely by mDCS (Chapter 5a. 2) and this molecule has 
been previously associated with stimulating the differentiation of CD8' T cells to 
effector CTL (Shuford et al., 1997); the effect of blockage of this molecule has yet 
to be examined. There are other co-stimulation molecules that have also been 
identified (reviewed in Chambers, 2001), but their blockade has not been 
investigated in this study. 
It has been previously demonstrated that subsets of T cells can express CD80 or 
CD86 following activation (Azuma et at., 1993; Hathcock et at., 1994). Therefore, 
an it is possible that the antibodies utilised in in vitro blocking assays bind to, and 
thus block, CD80 and CD86 expressed by activated CL4 CD8+ T cells. This would 
indicate that the upregulation of expression of CD80 and CD86 may be 
differentially controlled by iDCs versus mDC. This could be tested by further flow 
cytometric analyses of CL4 CD8' T cells following activation. However, a direct 
effect of antibody-mediated blocking on T cells is unlikely in these experiments, 
as DCs were incubated with blocking antibodies prior to addition of T cells. 
Studies have suggested that the interäction between CD40 on DCs and its ligand, 
CD40L, on T cells signals in both directions (Stout and Suttles, 1996). These 
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signals provide not only T cell co-stimulation, but also drive DC maturation (Cella 
et al., 1996). However, our studies provide an alternative explanation to the 
effects of CD40 blockade on DC co-stimulation ability. Preventing CD40-CD40L 
interaction may block the further maturation of iDCs and mDCs subsequent to T 
cell encounter; thus reducing CL4 CD8' T cell activation. It would therefore be of 
interest to examine the cell surface phenotype of DCs after encounter with T 
cells, to determine whether or not maturation occurs. Also, experiments could be 
conducted to test the effects of increasing co-stimulation: does stimulating CL4 
CD8' T cells with anti-CD28 stimulating antibodies restore normal activation in the 
presence of iDCs? It has been shown for example that increasing co-stimulation in 
CD8' T cell activation can rescue IFN-y production under low antigen 
concentrations (Santori et al., 2001). Studying co-stimulation could determine to 
what extent the lack of expression of co-stimulatory molecules by iDCs influence 
the nature of aT cell response. 
It is not surprising that addition of exogenous IL-12 can initiate IFN-y production 
by CL4 CD8' T cells activated by iDCs. The action of IL-12 on T cell subsets was 
previously shown to polarise to Thl/Tcl cell types (Manetti et at., 1993; Wu et 
at., 1993). However, our experiments suggest that activation of CL4 CD8' T cells 
is more complex, involving a balance of several factors, such as cytokine, co- 
stimulation and antigen concentration. Combinations of different levels of signals 
1,2 and 3 are able to alter the balance of T cell activation in favour of one type 
of response. However on its own, IL-12 does not appear to restore productive 
activation to CL4 CD8' T cells stimulated by iDCs. Therefore, a range of analyses 
should be carried out to measure T cell responses in order to fully determine the 
outcome of the activation. 
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Altering the antigen dose, the level of co-stimulatory surface molecules or 
cytokines can affect proliferation, cytokine production or cytotoxicity of the 
stimulated CL4 CD8+ T cell. It is hoped that further information about how these 
factors control the outcome will allow us to manipulate balance of T cell 
activation to achieve therapeutic goals. 
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The immune system protects the body against pathogens by rapid destruction of 
invading microbes and the cells they infect. It is essential that immune responses 
are restricted to pathogens as inappropriate activation of an immune response 
against self-tissues leads to horror autotoxicus - self-destruction (Ehrlich, 1900). 
In order to avoid mounting autoimmune responses, the immune system must be 
able to discriminate between self and foreign epitopes. During T cell 
development in the thymus, self-specific T cells are deleted, inducing a state of 
tolerance to self-epitopes. However, thymic tolerance is not entirely effective, 
thus mechanisms of peripheral tolerance also exist to prevent the initiation of 
productive immune responses by self-reactive T cells in the periphery. 
Experiments detailed in this thesis address the consequences of interactions 
between self-antigens and T cells which are self-specific. We have investigated 
how peripheral tolerance could be induced by populations of immature dendritic 
cells (iDCs). iDCs may sample self-epitopes in peripheral tissue and traffic such 
epitopes to lymphoid tissue where epitopes are offered to T cells. Self-specific T 
cells are activated by these self-epitopes, but do not differentiate into effector 
CTL and are instead activated abortively. This thesis investigates the fate of such 
abortively activated CD8` T cells and examines how iDCs could manipulate CD8' T 
cell responses. 
6.1 Abortive versus productive activation 
Abortive activation of CL4 CD8` T cells following their transfer into InsHA 
recipients has been previously described (Morgan et at., 1999a). Such abortive 
activation is associated with the induction of peripheral tolerance (Morgan et at., 
1999b), whereas productive activation of CL4 CD8' T cells in PR8-immunised mice 
generates effector CTL capable of inducing autoimmunity (Hernandez et at., 
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2001). While, a previous study examined some of the phenotypic features of 
abortively activated CL4 CD8# T cells (Hernandez et al., 2001), we have examined 
a more extensive range of phenotypic and functional indicators in this study. We 
also examined productive activation in the absence of HA as a self-antigen. A 
summary of the key features of abortive versus productive activation of CL4 CD8' 
T cells defined by this thesis is provided in Table 6.1. 
A major difference between abortive and productive activation is the lack of CD25 
expression amongst abortively activated CL4 CD8` T cells., It is likely that without 
CD25 expression, abortively activated CL4 CD8` T cells are unable to produce or 
respond to IL-2 efficiently. This would strongly suggest that the lack of 
expression of the IL-2 receptor (CD25) limits CL4 CD8' T cell proliferation. It has 
been suggested that co-stimulation though CD28 is required by T cells to 
upregulate CD25 and IL-2 production (Cerdan et at., 1992). Thus, abortive 
activation of CL4 CD8` T cells may result from their encounter within the PLN of 
InsHA micewith KdHA epitopes cross-presented by APCs which do not express CD80 
or CD86 co-stimulatory molecules. 
Another striking difference between abortively activated and productively 
activated CL4 CD8' T cells is the high levels of Ly6C expressed on the surface of 
CL4 CD8` T cells following abortive activation. The expression of Ly6C may 
correlate with the lack of CD25 expression, as expression of Ly6C has been 
previously associated with impaired IL-2 signalling (Yamanouchi et at., 1998). In 
addition, NOD mice, which are highly susceptible to the induction of autoimmune 
disease, have a mutation which leads to Ly6C deficiency (Philbrick et al., 1990). 
This finding supports the hypothesis that Ly6C expression may play a key röte 
preventing autoimmunity. Ly6C is also expressed by many GALT-resident T cells 
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Figure 3.1: Enrichment by CD8 positive MACS selection does not activate CL4 
CD8+ T cells 
Lymph node cells were prepared from CL4 mice. Red blood cells were lysed with 
deionised water. Unpurified cell samples were taken for flow cytometric analysis. 
The remaining cells were purified using positive MACS enrichment with anti-CD8 
antibody conjugated magnetic beads. To test CL4 CD8' T cell purity, these cells 
were stained with anti-Ma and anti-V08 antibodies and were analysed by Flow 
cytometry. 10,000 events were collected for each sample. 
Panel A depicts CD8 and Vß8 expression by unpurified CL4 LN cells (left) and 
MACS-enriched CL-4 cells (right). These plots are representative of at least four 
independent experiments. 
Enriched CL4 CD8'T cells were labelled with CFSE and a sample was taken for flow 
cytometric analysis. 1x 106 CFSE-labelled cells were then mixed with either 6x 
106 irradiated splenocytes that were either unpulsed or pulsed with KdHA peptide. 
After 72 hours cells were stained with anti-Thyl. 1 antibodies harvested analysed 
by FACS. 
Panel B shows flow cytometric analysis of Thy. 1.1` gated cells: naive CL4 CD8' T 
cells (top), similar cells co-cultured with unpulsed splenocytes for 72 hours 
(centre) and CL4 CD8' T cells co-cultured with K°HA-pulsed splenocytes for 72 
hours (bottom). Plots on the left side, show FSc/SSc properties of such cells. 
Gates indicate the proportions of small (naive) and larger (activated) 
lymphocytes. The right hand side demonstrates the level of CFSE amongst Thy1.1' 
cells. 
These plots are representative of three independent experiments. 









CD25 -ve TT 
CD62L ýL yy 
CD69 TT TT 
CD95L -ve T 
Ly6C ++ T 
IFNy production None TT 
CD107a recruitment -ve T 
Autoimmunity None Yes 
Migration to tissues 
lamina propria of the 
small intestine 
lamina propria and 
intraepithelial 
lymphocytes of the 
small intestine, 
liver, lung, ft 
pancreas 
Table 6.1: Features of abortive versus productive activation 
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which may be self-specific, but do not generate autoimmunity (Rocha et at., 1992; 
Wang et at., 2002). Instead, such T cells are considered to be associated with 
maintaining the integrity of the gut mucosa (Poussier et at., 2002). Migration to 
GALT may be involved in preventing autoimmune responses. It is possible that the 
expression of Ly6C by abortively activated T cells is involved in post-activation 
homing to GALT. Future experiments could be performed in which blocking 
antibodies against Ly6C are administered to InsHA mice. Inhibiting the function of 
Ly6C in InsHA mice to the same degree as that in NOD mice may prevent tolerance 
induction following transfer of CL4 CD8+ T cells; perhaps suggesting a key role in 
targeting tolerised T cells to the gut. Whether or not Ly6C functions in migration 
to the LPL could be tested by blocking Ly6C with mAbs. 
Loss of expression of CD62L is required for T cell migration from lymphoid tissue 
into peripheral tissues (Mobley et at., 1994). The lack of migration into the 
pancreas following abortive activation is consistent with the fact that CD62L is not 
fully downregulated by abortively activated CL4 CD8' T cells. It is possible that 
CD62Lhi abortively activated CL4 CD8` T cells form a population similar to the so- 
called central memory T cells, which have impaired effector response. Central 
memory cells, which although previously activated, have been described as 
expressing high levels of CD62L (Saltusto et at., 1999), whereas effector memory T 
cells are CD62L1° (Sallusto et at., 1999). It has been suggested that central 
memory T cells can migrate through both lymphoid and non-lymphoid tissues 
(Bingaman et at., 2005) and CD62Lh' central memory T cells from humans were 
unable to produce effector cytokines upon re-stimulation (Sallusto et at., 1999). 
However, the studies investigated CD4+ central memory T cells whilst examination 
of CD8+ central memory T cells have demonstrated similar functional responses to 
CD8` effector memory T cells (Wherry et at., 2003). 
- 209 - 
Chapter 6: Summary and general discussion 
6.2 iDCs abortively activate CD8' T cells in vitro and in vivo 
It has been previously suggested that cross-presentation of self-epitopes by iDCs 
may induce peripheral tolerance amongst potentially auto-reactive T cells (Beiz et 
al., 2002a). A major aim of this study was to investigate whether cross- 
presentation of KdHA epitopes by iDCs and mDCs activates naive CL4 CD8' T cells 
productively or abortively. Therefore, the function and cell surface expression of 
CL4 CD8' T cells activated by iDCs or mDCs was characterised and a comparison 
made with profiles of cell surface expression and function associated with 
abortive and productive activation. Table 6.2 summarises the effect of CL4 CD8` 
T cell activation mediated by iDCs or mDCs presenting high or low concentrations 
of K°HA. CL4 CD8+ T cells abortively activated in the PLN of InsHA mice share 
many of the hallmarks exhibited by CL4 CD8+ T cells activated by iDCs pulsed with 
low concentrations of KdHA. Whereas, mDC-activated CL4 CD8+ T cells have a 
similar cell surface expression profile and function to CL4 CD8+ T cells 
productively activated in P118-immunised mice. Furthermore, CL4 CD8+ T cells 
transferred into InsHA mice underwent high numbers of cell divison, but did not 
produce IFN-y or generate autoimmunity, following transfer of KdHA-pulsed iDCs. 
Transfers of K°HA-pulsed mDCs into InsHA mice that also received CL4 CD8+ T cells 
generated autoimmune diabetes. Taken together, these data indicate that in 
vitro and in vivo iDCs can-mediate abortive responses amongst CL4 CD8+ T cells, 
whereas mDCs mediate productive activation. 
6.3 Acquisition of exogenous antigen by DCs 
Abortive activation of CL4 CD8' T cells in InsHA PLN was shown to rely on cross- 
presentation by BM-APCs (Morgan and Fraser, unpublished data), however the 
exact identities of the cross-presenting BM-APC was not determined. Macrophages 
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Figure 3.2: Phenotypic characterisation of cell surface molecules expressed by 
CL4 CD8` T cells 
1x 106 CFSE-labelled nave CL4 CD8' T cells were purified by MACS as described 
(giving a purity of at least 95%) then co-cultured with 6x 106 irradiated syngeneic 
splenocytes either KdHA-pulsed or left unpulsed in 200 µl complete media in 96- 
well U bottom plates. After 24 or 72 hours, cells were stained with anti-Thyl. 1 
antibodies and antibodies against cell surface activation markers. Expression of 
cell surface molecules were analysed by flow cytometry and 10,000 Thy1.1` 
events were acquired. 
Plots show surface marker expression versus CFSE amongst Thy1.1' cells. 
These Data are representative of at least three experiments. 
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CL4 T cell iDC mDC Stimulus 
Low dose High dose Low dose High dose 
Features KdHA KdHA KdHA KdHA 
Proliferation Limited 
Highly Highly Highly 
division divided divided divided 
Cell size/ T T T T 
granularity 
CD25 -ve T TT TT 
CD62L + 444 4040 
CD69 TT TT TT TT 
Ly6C TT TT -ve -ve 
IL-2 production None None TT TT 
IFNy production None None T TT 
Il-4 production None T None None 
CD107a 
-ve T T TT recruitment 
Cytotoxicity None ++ T ++ 
Autoimmunity 
None None None Yes 
Table 6.2: Features of BMDC-mediated activation 
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can cross-present antigens in vitro (Norbury et al., 1995; Reis e Sousa and Germain, 
1995), but as macrophages do not traffic antigens to lymph nodes from tissues 
(Hemmi et al., 2001), it is unlikely that macrophages mediate abortive activation 
in InsHA mice. Although, there is evidence for cross-presentation by B cells in vitro, 
it is unlikely that in vivo B cells to traffic from naive tissues to lymph nodes (Rock et 
A, 1990; Voeten et a/., 2001). On the other hand, DCs are able to phagocytose 
virally-infected cells and cross-present antigens derived from those cells (Albert et 
a/., 1998a), as well as generating CTL responses in vivo via cross-presentation (den 
Haan et al., 2000; Inaba et a/., 1998). Also we demonstrated that iDCs, when 
pulsed with low levels of KdHA peptide, activate CL4 CD8' T cells abortively. 
Therefore, it is likely that the APC which cross-presents HA-epitopes to abortively 
activate CL4 CD8' T cells is a DC. 
In our system, iDCs and mDCs can directly acquire KdHA-epitopes from InsHA ß 
cells and cross-present such epitopes to activate CL4 CD8` T cells. iDCs co- 
cultured with high numbers of InsHA ß cells (1 x 105) elicit similar CL4 CD8+ T cell 
responses as compared with activation by mDCs. Whereas, iDCs co-cultured with 
ten-fold fewer InsHA ß cells (1 x 104) generate only a limited level of CL4 CD8' T 
cell proliferation. mDCs still induce a high level of CL4 CD8+ T cell proliferation in 
the presence of 1x 104 InsHA p cells. As iDCs and mDCs express similar levels of 
MHC class I molecules, the difference in the amount of InsHA ß cells required to 
elicit CL4 CD8+ responses is unlikely to be due to a lower level of KdHa 
presentation by iDCs. It is possible that iDCs are less effective at acquiring 
antigen from ß cells than mDCs. However, experiments with KdHA-pulsed DCs 
suggested that the level of antigen presented by iDCs is more critical in 
determining how CL4 CD8+ T cells respond to iDCs compared with mDCs. It is 
more likely that the limited proliferation of CL4 CD8+ T cells co-cultured with low 
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numbers of InsHA ß cells and iDCs results from the tower level of co-stimulation 
(signal 2) supplied to T cells by iDCs. Therefore, a higher level of signal 1 must be 
supplied by 1DCs, compared with mDCs to induce T cell activation. Although 
experiments have demonstrated that T cells require signal 2 as well as signal 1 for 
full activation (Bretscher and Cohn, 1970), T cells can be activated following 
stimulation with high doses of cognate epitope in the absence of co-stimulation 
(Cai and Sprent, 1996). Additionally, iDCs are not entirely deficient in expression 
of co-stimulatory molecules and so they may provide a low level of signal 2 
(Freeman et al., 1991). Limited proliferation is a feature of abortive activation; 
thus, it is possible that activation of CL4 CD8+ T cells following interaction with 
iDCs presenting low numbers of InsHA ß cell-derived epitopes may be abortive, as 
a result of activation through low levels of signal 1 and 2. Increasing the amount 
of antigen available for processing, by increasing the number of InsHA ß cells in 
co-cultures with iDCs, increases KdHA presentation and generates CL4 CD8` T cell 
proliferation at similar levels to that driven by mDCs. Thus, increasing the level 
of KdHA epitopes on iDCs may switch abortive activation to productive activation. 
We therefore suggest that the outcome of CL4 CD8' T cell interaction with K°HA 
epitopes in vivo may be determined by the level of available antigen. iDCs 
presenting low levels of KdHA epitopes induce abortive activation of CL4 CD8' T 
cells in InsHA PLN, leading to tolerance induction. If a higher level of self-antigen 
is available following physical trauma or infection, or in an inflammatory 
environment which promotes DC maturation, cross-presentation of self-antigens 
by DCs may lead to productive activation and generate autoimmune diseases. 
The state of maturation amongst DCs, as well as the level of epitope cross- 
presented by DCs, may relate to the initial mechanisms by which antigens are 
acquired for processing from self-tissues or pathogens. It is generally considered 
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that endocytosis of antigens by iDCs results in maturation to mDCs and migration 
to local draining lymph nodes. In such lymph nodes the migrated mDCs are able to 
initiate immunity efficiently (Brossart and Bevan, 1997). If 1DCs are responsible 
for induction of self-tolerance in the periphery, mechanisms must exist which 
allow the acquisition and trafficking of self-antigens without iDCs maturation 
leading to increased expression of co-stimulatory molecules. DCs can utilise 
several molecules for uptake of exogenous epitopes, including Fcy receptors 
(CD16/CD32, (Regnault et at., 1999), DEC-205 (Swiggard et at., 1995) CD36 (Beiz 
et at., 2002c), and CD51 (Albert et at., 1998a). Many studies have shown uptake 
of proteins by DCs from cells undergoing apoptosis or necrosis via CD51 or CD36 
(Albert et at., 1998b; Gallucci et at., 1999; Rubartelli et at., 1997). Under such 
conditions, it is likely that iDCs would receive 'danger' signals which may induce 
DC maturation (Gallucci et at., 1999). However, other studies have revealed that 
iDCs have the ability to directly 'nibble' epitopes from live cells (Harshyne et at., 
2001). Unlike iDCs which acquire antigen from cells undergoing apoptosis, iDCs 
which acquire antigen from intact tissues in absence of 'danger' signals following 
iDCs may not undergo maturation. Instead, antigens acquired from intact cells 
may be cross-presented by DCs which remain immature, thus inducing tolerance 
rather than immunity. 
Experiments were performed to determine how DCs acquire KdHA epitopes from 
InsHA ß cells to stimulate CL4 CD8' T cells. When InsHA ß cells were separated 
with transwells from co-cultures of DCs and CL-4 CD8' T cells, no proliferation was 
observed. Therefore, DCs acquire HA epitopes directly from the surface of InsHA 
ß cells through cell-cell contact and not from uptake of exogenous HA shed by 
InsHA ß cells. Activation of CL4 CD8` T cells by DCs cross-presenting ß cell-derived 
epitopes was also prevented by blocking adhesion molecules expressed at the cell 
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surface by DCs. Our data shows that, mDCs require CD36, whereas iDCs can utilise 
either CD36 or CD51, to acquire HA epitopes from InsHA p cells. We suggest that 
such adhesion molecules allow transient interactions between DCs and ß cells that 
allow HA epitopes to be acquired directly from the ß cell surface. 
If following receptor-mediated acquisition of self-antigen by iDCs in the absence 
of inflammation or microbial signals, cross-presentation self-antigens to CD8' T 
cells will be by iDCs. Thus, rather than mounting autoimmune responses to self- 
antigen T cells are toterised. Autoimmune diseases have been associated with 
viral infection or trauma (Fairweather and Rose, 2002; Fujinami et al., 2006; 
Miller et al., 2001). It is possible that in such cases, iDCs responsible for 
maintenance of steady state are matured by inflammatory signals in damaged 
tissue and induce immunity rather than tolerance induction. As mDCs may have 
an absolute requirement for CD36 for ß cell antigen uptake in the InsHA system, 
blocking adhesion using this molecule may selectively prevent self-epitope 
acquisition by mDCs, but not by iDCs. Thus, if it is generally true that CD36 is 
required for the mDC-mediated induction of autoimmune responses to self- 
antigens, the use of anti-CD36 blocking antibodies could provide an effective 
therapeutic strategy in the prevention of autoimmune disease. To test the 
efficacy of CD36 blockade, anti-CD36 blocking antibodies could be administered to 
sub-lethally irradiated InsHA mice which also receive CL4 CD8` T cells. Transfer of 
CL4 CD8` T cells into untreated irradiated InsHA mice leads to autoimmune 
diabetes (Morgan, DJ, unpublished data) possibly due to tissue damage caused by 
irradiation which leads to presentation of HA-epitopes in an inflammatory 
environment (Morgan, DJ, unpublished data). As the preferential recruitment of 
mDCs to present self-antigens induces autoimmune responses, anti-CD36 
antibodies may block the uptake of HA-epitopes by mDC, preventing productive 
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activation of transferred CL4 CD8' T cells and thus preventing the induction of 
autoimmunity. 
6.4 Mechanism of peripheral tolerance induction 
Our data demonstrate that highly divided self-specific CD8' T cells can be isolated 
from the LPL of tolerant mice. These LPL-resident CL4 CD8' T cells appear to 
have downregulated the cell surface TcR and CD8. We propose that migration to 
distal sites following abortive activation by self-epitopes may prevent the 
induction of autoimmunity and thus migration may be a mechanism of peripheral 
tolerance induction. Studies by Sherman and co-workers demonstrated that the 
induction of peripheral tolerance amongst abortively activated CL4 CD8' T cells 
could be reversed, by removing such cells from the source of antigen (Kreuwel et 
at., 2002). The fact aT cells undergoing an abortive activation does not 
immediately become functionally deleted is also shown in another study, where 
CD4' T cells undergoing peripheral tolerance were also able to carry out effector 
functions prior to the establishment of tolerance (Huang et at., 2003). It is 
possible that T cells require a prolonged stimulation by self-antigens before 
tolerance induction through deleted or anergy. The potential effector activity 
exhibited by abortively activated T cells can also be explained by the hypothesis 
that tolerance is induced by migration to distal sites: potentially auto-reactive T 
cells, which are undergoing abortive activation, when isolated from the periphery 
prior to migration, wilt be capable of mounting effector responses. The 
prevention versus generation of autoimmunity in vivo could be explained under 
this hypothesis, as abortively activated T cells prior to migration may not enter 
naive tissues unless activated by an external immunogen. 
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6.5 CD8' T cell activation 
We examined the cell surface phenotype and effector function of CL4 CD8' T cells 
which had been activated by iDCs or mDCs cross-presenting KdHA epitopes. In 
addition, we assessed the individual effects of the levels of signal 1 
(TcR/epitope), signal 2 (co-stimulation through receptor interactions) and signal 3 
(co-stimulation through secreted factors). Based on our results, we propose a 
revised scheme of CD8' activation (Fig. 6), which my explain how peripheral 
tolerance or autoimmunity can result from interactions with DCs cross-presenting 
self-epitopes. 
To activate CD8` T cells a threshold level of signals is required (Valitutti et at., 
1995). Where no stimulus is applied, T cells remain in their nave state (Fig. 6A). 
When CD8' T cells encounter their cognate epitope the response depends on the 
level of epitope and the affinity of the TcR for its epitope as well as the number 
of TcRs expressed by aT cell (Fig. 6.2B Heath et at., 1998). With a low affinity 
TcR and a low epitope level, CD8' T cells ignore their cognate epitope and do not 
respond (Fig 6B). Ignorance of a self-epitope by an auto-reactive TcR allows the 
maintenance of peripheral tolerance, either because self-epitopes are expressed 
at low levels or that the auto-reactive T cells escape deletion in the thymus as its 
TcR is of low affinity for self-epitopes (Ohashi et at., 1991; Oldstone et al., 1991). 
When the intensity of signal 1 reaches a certain level an immunological synapse 
forms. This results in initiation of a kinase cascade and altered gene expression 
(Alegre et al., 2001). However, as depicted in figure 6C, CD8' T cells expressing a 
higher affinity TcR stimulated with cognate epitope may be rendered anergic in 
the absence of co-stimulation (Fig 6.2C Kurts et at., 1997b; Fig 6.2C Quill and 
Schwartz, 1987). Such activation may involve a low level of proliferation (Kurts et 
at., 1997a) or phenotypic changes, but anergised cells do not produce IL-2 and 
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become functionally unresponsive (Blackman et al., 1990; Schwartz, 1996). 
Following transfer into InsHA mice CL4 CD8+ T cells are abortively activated 
leading to a limited number of rounds of division. It is clear that activation is 
independent of co-stimulation as proliferation is not inhibited by the 
administration of anti-CD80 or anti-CD86 antibodies (Hernandez et at., 2001), 
although other studies have indicated that peripheral tolerance induction via 
abortive activation requires CD28 expression by T cells (Vacchio and Hodes, 
2003). Also, abortive activation of CL4 CD8' T cells in InsHA PLN appears to be 
limited by the level of antigen available (Chapter 3.4). We propose that abortive 
activation of CD8+ T cells can result from stimulation by low levels of epitope and 
low levels of co-stimulation (Fig. 6D). This leads to limited number of rounds of 
cell division and a partially activated cell surface phenotype. There may also be 
some degree of production of IL-2 and some decrease in CD62L expression. 
However, an effector response is not induced as evidenced by a lack of secretion 
of IFN-y and CD107a cell surface recruitment. CL4 CD8{ T cells co-cultured with 
iDCs and low doses of KdHA proliferate, but do not form effector CTL. If CD8+ T 
cells do not generate productive responses following self-antigen recognition, 
several outcomes of activation have been described: anergy (Lechler et at., 2001), 
deletion (Critchfield et at., 1994), both anergy and deletion (Kurts et at., 1996). 
This study also suggests that abortive activation may lead to tolerance induction 
via migration from the site of activation to LPL. However, the function of these 
cells at this location is not clear. 
From our studies in which CL4 CD8' T cells were co-cultured with iDCs, we have 
demonstrated that there are a range of T cell responses. The responses depend 
on the level of the TcR stimulus, as higher levels of K°HA epitopes lead to 
increased CD25 expression. This is also true for higher levels of co-stimulation 
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(signal 2), as blocking co-stimulatory molecules reduced proliferation. Thus, the 
combination of TcR stimulation and co-stimulation determine the outcome of T 
cell activation: full productive activation, abortive activation or ignorance. In our 
studies, productive activation of CD8' T cells leading to CTL effector function can 
result from limited co-stimulation in combination with a high dose of cognate 
epitope (Fig. 6E). Previous studies support the theory that increasing either signal 
1 or signal 2 alone the balance of activation can be shifted in favour of productive 
activation, thus inducing increased levels of division, cell phenotypic changes and 
CTL responses. Increased epitope doses can stimulate T cells to divide with low 
levels of signal 2 (Fig 6.3E Cai and Sprent, 1996) and anti-CD28 superagonists have 
been utilised to induce T cell proliferation in the absence of any TcR signal 
(Beyersdorf et at., 2005; Luhder et at., 2003). It is likely that productive 
activation of CD8' T cells may also result from low levels of signal 1 and 2, if the 
affinity of the TcR for its cognate epitope is sufficiently high enough (Fig. 6F). 
Typically, productive activation results from a combination of TcR stimulation, full 
co-stimulation in the presence of an inflammatory environment. This then leads 
to acquisition of full effector responses: high levels of proliferation, CD25 
expression, the production of IFN-y and cellular cytotoxicity (Fig. 6G). In the 
presence of IFN-y or TNF-a, high levels of cognate epitope and high levels of co- 
stimulation were not required to elicit cytotoxicity by CD8' T cells (Curtsinger et 
al., 2003a). Other studies have shown that administration of soluble peptides 
leads to specific T cell proliferation, but not survival, with activated T cells 
rapidly undergoing AICD (Liblau et at., 1997). If on the other hand, a peptide is 
administered in an adjuvant such as complete Freud's adjuvant or LPS, T cell are 
productively activated and survive (Mitchell et at., 2001). It is likely that 
adjuvants increase the level of inflammatory cytokines, as well as inducing 
-219- 
Chapter 6: Summary and general discussion 
maturation of DCs which present peptides, thus increasing co-stimulation. Our 
experiments demonstrate that the addition of exogenous IL-12 to co-cultures of 
CL4 CD8` T cell and iDCs leads to productive CD8' T cell activation as evidenced by 
IFN-y production. These data support the finding that full activation of CD8' T 
cells requires a third signal (signal 3) from an inflammatory cytokine environment 
(Fig 6.4G Curtsinger et al., 2003a; Fig 6.4G Curtsinger et at., 2003b). 
As well as signals 1,2 and 3 which promote CD8' T cell activation, other studies 
reveal that populations of regulatory T cells can inhibit activation of T cells, via 
cytokines or cell/cell interaction (Fig. 6.4H reviewed in Shevach et at., 2001). 
Although CD8` T cells may receive sufficient signals 1,2 and 3 to induce 
productive activation, regulation may reduce the net stimulus below an activation 
threshold leading to ignorance or abortive activation (Fig. 6H). Another possible 
outcome of CD8' T cell activation is activation induced cell death (AICD). Such 
over activation may result from stimulation with very high levels of signals 1,2 
and 3 (Fig 61). 
In this study possible influence of TcR affinity in determining the outcome 
following T cell activation was not addressed. Another transgenic strain, the CL1 
mouse, expresses a TcR which also recognise the dominant KdHA epitope, but with 
lower affinity for KdHA than the CL4 TcR. Comparison of CL1 and CL4 CD8+ T cells 
responses following co-culture with DCs, may determine how the affinity of the 
TcR, as well as the balance of signals 1,2 and 3, effects. the outcome of 
activation. This hypothesis of CD8' cell activation where the balance of signals 1, 
2 and 3 determines whether CD8` T cells ignore antigens, become abortively or 
productively activated is important in understanding the factors influencing 
whether peripheral tolerance is maintained or autoimmunity develops. In the 
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This figure illustrates how the outcome of CD8' T cell activation may be 
controlled by a balance of signals. 
Key 
Stimuli Responder Activation Responses Outcome 
.................................... 
Stimuli: Signals, including TcR/cognate epitope interactions, co-stimulation, and 
cytokines, drive activation, whereas regulatory signals, such as cytokines and 
cell/cell contact, inhibit activation 
Responder: On the other side of the balance is the CD8' T cell, the affinity of its 
TcR 
Activation: The nature of the activation: no activation, productive versus 
abortive activation, over activation 
Responses: Increasing phenotypic and functional changes with increasing 
activation 
Outcome: Immunity, tolerance, ignorance or activation induced cell death 
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Figure 6A-C: Proposed CD8' T cell activation: Ignorance/Anergy 
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D. Abortive activation of CD8' T cells may lead to the induction of tolerance 
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Figure 6D-F: Proposed CD8' T cell activation: Abortive activation 
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H. The action of regulatory T cells can prevent CD8' T cell activation or induce anergy 
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Figure 6G-I: Proposed CD8' T cell activation: Productive activation 
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case of autoimmune diabetes, the majority of individuals maintain tolerance to ß 
cell expressed antigens, but under specific conditions, such as following Coxsackie 
B viral infections or following physical trauma to the pancreas (Fairweather and 
Rose, 2002), as well as spontaneously, such tolerance is lost. Under these 
conditions, the induction of autoimmunity may be due to increasing the danger 
signal through inflammatory cytokines or pancreatic damage may lead to 
increased levels of available epitopes, which divert abortive activation or 
ignorance-to productive activation. Such events may also induce the maturation 
of iDCs presenting pancreatic epitopes leading to stimulation of CD8' T cells with 
increased co-stimulation. Perhaps DCs maturation could be prevented by altering 
the cytokine environment through administration of non-inflammatory cytokines, 
such as TGF(3 (Kosiewicz and Alard, 2004) or by blocking antigen acquisition by 
mDCs using anti-CD36 antibodies. Whether or not diabetes results from changing 
the balance of signals by increasing epitope levels in InsHA mice could be tested 
by irradiation InsHA mice (DJ Morgan, personal communication) or by 
administrating of the islet-damaging antibiotic streptozotocin (Muller et at., 2002) 
and monitoring for diabetes. 
The findings of this thesis have wide ranging implications on many areas of 
immunology. Studies into tumour immunology investigate how harmful tumour 
cells may be destroyed by activating anti-tumour host immune responses. Tumour 
cells escape peripheral deletion through mechanisms which evade immune 
responses; for example downregulation of MHC (Garrido et at., 1997), secretion of 
immunomodulatory cytokines (Apte et at., 1997), loss of expression of tumour 
antigens (de Vries et al., 1997), or downregulation of Fas expression (Landowski et 
at., 1997). Mechanisms of immune evasion by tumour cells work by altering the 
balance of signals supplied to T cells, thus preventing the activation of anti- 
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tumour immune responses. Many studies have attempted to activate anti-tumour 
responses by altering one of these signals. However, no studies have yet 
addressed the balance of all signals in order to fine-tune an immune response 
against particular self (tumour)-epitopes, without inducing widespread 
autoimmunity. Furthermore, data presented in this thesis may also be important 
with regard to transplantation, where graft versus host disease or transplant 
rejection are likely to be induced as a result of an already damaged, inflammatory 
environment. 
6.6 Summary 
Data thus far indicate that BMDCs are able to acquire KdHA-epitopes through 
direct interactions with InsHA p cells via CD36 or CD51. Furthermore, CL4 CD8` T 
cells encountering such iDCs, which cross-present KdHA-epitopes, are partially 
activated and express similar hallmarks to CL4 CD8' T cells abortively activated 
during tolerance induction in InsHA PLN. These findings also have important 
implications on the description of CD8' T cell activation as an `on or off' switch. 
Experiments show that CD8` T cells are able to mount a range of responses 
following activation, from expression of cell surface molecules and proliferation to 
the production of effector cytokines and cytotoxicity. The--range of responses 
results from a combination of signals 1,2 and 3. Increase of any one of these 
signals can tip the balance in favour of either abortive or productive activation. 
Even those T cells which are initially activated abortively can be driven to produce 
productive responses upon restimulation, in the presence of sufficient level of 
stimuli, for example with high concentrations of cognate peptide. These studies 
reinforce the theory that analysis of a single output by T cells following activation 
is insufficient to determine the overall nature of an immune response. 
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Appendices 
Appendix 2 
Antibody Clone Isotype Concentration Reference 
CD36 CRF D-2712 Mouse IgA 50 pg/ml (Buckley, 1991) 
CD40 HM40-3 Hamster IgM 25 pg/ml (Hasbold et at., 
1994) 
CD51 H9.2B8 Hamster IgG 50 pg/mt (Larson and 
Springer, 1990 
CD80 16-1OA1 Hamster IgG2 25 pg/ml (Hathcock et at., 
1993) 
CD86 GL1 Rat IgG2a 25 pg/ml (Unkeless, 1979) 
Appendix 2: Anti-mouse monoclonal antibodies used in blocking experiments. 
N. B. All antibodies and relevant isotype matched controls were supplied by BD 
Pharmingen 
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Appendix 3 
ELISA Capture Detection Recombinant Reference 
antibody antibody cytokine 
(purified) biotin fated standard (Max. ) 
IFN-y R4-6A2 XMG1.2 25 ng/ml (Spitalny and 
Havel[, 1984) 
GM-CSF MP1-22E9 MP1-22E9 5 ng/ml (Suda et at., 
1990) 
IL-2 JES6-1AA2 JES6-5H4 5 ng/ml (Abrams et at., 
1992) 
IL-4 11 B11 BVD6-24G2 2.5 ng/ml (Ohara and 
Paul 1985 
IL-12 C15.6 C17.8 25 ng/ml (Gately, 1995) 
Appendix 3: Reagents for ELISA assays. N. B. All antibodies and recombinant 








Reaction Reagents final concentration Cycle conditions 
KCl 50 mM Hot start 94°C- 5 minutes 
Tris-HCI 10 mm Denaturing 94°C- 25 seconds 
dNTP mix 200 uM Annealing 66°C- 45 seconds 
Each primer 1 NM Extension 72°C- 1 minutes 
BSA w/v 0.125% Number of cycles 35 
MgCl2 1.5 mM Final extension 72°C-5 minutes 
Taq DNA polymerase 1 Unit Product size 454 bp 
Reaction volumes were made up to 23 pt 
with ddH2O and 2 pt cDNA added 
Reference: (Chakir et al., 2003) 
IL-10 Sense Primer TgCCTTCAgTgAAgAC (5'=*3') 
Anti-sense Primer AAACTCATTCATggCC (5'=3') 
Reaction Reagents final concentration Cycle conditions 
KCl 50 mM Hot start 94°C- 5 minutes 
Tris-HCL 10 mm Denaturing 94°C- 30 seconds 
dNTP mix 200 pM Annealing 53°C- 50 seconds 
Each primer 1 pM Extension 72°C- 45 seconds 
BSA (w/v) 0.25% Number of cycles 30 
MgCL2 3 mM Final extension 72°C-5 minutes 
Taq DNA polymerase 1 Unit Product size 346 bp 
Reaction volumes were made up to 23 pt 
with ddH2O and 2 pt cDNA added 
Reference (Chakir et at., 2003) 
IFN-Y Sense Primer AACgCTACACACTgCATCT (5'=3') 
Anti-sense Primer TgCTCATTgTAATgCTTgg (5'=3') 
Reaction Reagents final concentration Cycle conditions 
KCl 50 mM Hot start 94°C- 5 minutes 
Tris-HCl 10 mm Denaturing 94°C- 30 seconds 
dNTP mix 200 pM Annealing 53°C- 50 seconds 
Each primer 1 pM Extension 72°C- 45 seconds 
BSA (w/v) 0.125% Number of ties 30 
MgCl2 1.5 mM Final extension 72°C- 5 minutes 
Taq DNA polymerase 1 Unit Product size 1208 bp 
Reaction volumes were made up to 23 pt 
with ddH20 and 2 pt cDNA added 
Reference (Takahashi et at., 2001) 
Appendix 4: PCR reactions N. B. Reagents were supplied by Sigma, expect Primers, 
which were synthesised by Proligo (Paris, France) 
- 268 - 
Appendices 




Reaction Reagents final concentration Cycle conditions 
KCl 50 mM Hot start 94°C- 5 minutes 
Tris-HCL 10 mm Denaturing 94°C- 30 seconds 
dNTP mix 200 NM Annealing 60°C- 30 seconds 
Each primer 0.4 pM Extension 72°C- 30 secondss 
BSA (w/v) - Number of cycles 28 
MgCL2 1.5 mM Final extension 72°C- 5 minutes 
Taq DNA polymerase 1 Unit Product size 162 bp 
Reaction volumes were made up to 23 pt 
with ddH2O and 2 pt cDNA added I 
Reference (Smiley et at., 1997) 
_j 
Appendix 4: PCR reactions N. B. Reagents were supplied by Sigma, expect Primers, 
which were synthesised by Proligo (Paris, France) 
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